The visual pigment rhodopsin: immunochemical aspects and induction of experimental autoimmune uveoretinitis by Schalken, J.J.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/113404
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
THE VISUAL PIGMENT 
RHODOPSIN: 
IMMUNOCHEMICAL ASPECTS 
AND INDUCTION OF 
EXPERIMENTAL AUTOIMMUNE 
UVEORETINITIS 
J.J. Schalken 

THE VISUAL PIGMENT RHODOPSIN: 
IMMUNOCHEMICAL ASPECTS AND INDUCTION OF 
EXPERIMENTAL AUTOIMMUNE UVEORETINITIS 

THE VISUAL PIGMENT RHODOPSIN: 
IMMUNOCHEMICAL ASPECTS AND INDUCTION OF 
EXPERIMENTAL AUTOIMMUNE UVEORETINITIS 
PROEFSCHRIFT 
TER VERKRIJGING VAN DE GRAAD VAN DOCTOR IN DE 
WISKUNDE EN NATUURWETENSCHAPPEN AAN DE KATHO-
LIEKE UNIVERSITEIT TE NIJMEGEN, OP GEZAG VAN DE 
RECTOR MAGNIFICUS PROF. DR. B.M.F. VAN lERSEL 
VOLGENS BESLUIT VAN HET COLLEGE VAN DECANEN 
IN HET OPENBAAR TE VERDEDIGEN OP DONDERDAG 
25 JUNI 1987 DES NAMIDDAGS TE 1.30 UUR PRECIES. 
DOOR 
JOHANNES JACOBUS SCHALKEN 
GEBORENTE WAALWIJK 
1987 
Druk: SSN - Nijmegen 
Promotores : Prof. Dr. F.J.M. Daemen 
Prof. Dr. J.J.H.H.M, de Pont 
Co-referenten : Dr. R.M. Broekhuyse 
Dr. W.J.deGrip 
ISBN 90-9001720-8 
Ter nagedachtenis aan mijn vader, mijn moeder 
voor Sophie 

DANKWOORD 
Graag wil ik op deze plaats iedereen die op een of andere 
wi^ze heeft bijgedragen aan de totstandkoming van dit 
proefschrift hartelijk bedanken. Zonder iemand tekort te willen 
doen, wil ik toch een aantal van hen met name vermelden. 
Huub Winkens voor zijn grote inzet en deskundigheid op het 
gebied van de dierexperimenten en histologie , Anke van Vugt voor 
haar kritische inbreng en accurate werkwijze met name op het 
terrein van de immunologische bepalingen. Jullie bijdrage was van 
grote betekenis voor het m dit proefschrift beschreven 
onderzoek. 
Petra Bovee-Geurts voor de door haar ingebrachte expertise en 
met name voor het bereiden van de preparaten die essentieel waren 
voor vele van de experimenten. Rob Rutten voor de 'andere kijk' 
op zowel de retina als op het wetenschappelijke bedrijf. 
Diny van Gromngen-Luyben voor haar bijdrage aan een leerzaam 
gedeelte van het onderzoek dat niet beschreven is in dit 
proefschrift en voor de praktische inbreng, Leonoor Kuhlmann, 
Bert Jansen, Bets Tolhuizen en Jenny van Oostrum voor het 
vakkundig uitvoeren van een aantal experimenten. 
De mede-promovendi, inmiddels doctores in de Wiskunde en 
Natuurwetenschappen, Leo Mollenvanger en Ad Timmers, voor de 
prettige en bovenal leerrijke samenwerking. 
Kiek Verrijp voor haar enthousiasme en waardevolle inbreng 
aan het begin van het onderzoek en de doctoraalstudenten 
Marjolijn Peeters, Elly Franken, Jacques Janssen, Wim Schielen, 
Ed Kerckhoffs, Inge Gerads, Theo Mulder en Ronald Maatman die 
ieder op hun eigen wijze een bijdrage hebben geleverd. 
J.W. Reitsema, Geert Poelen en Henny Broekman voor hun 
deskundige hulp onder andere bij de dierexperimenten die het 
daglicht niet konden verdragen, alsmede een aantal andere 
medewerkers van het Centraal Dierenlaboratorium, met name Piet 
Spaen, Hendrik-Jan Jansen en Albert Peters. De medewerkers van de 
Medische Tekenkamer, met name Cees Nicolasen, de afdeling 
Medische Fotografie en de Mathematisch Statistische Advies-
afdeling voor hun inzet. 
De medewerkers van de afdelingen Submicroscopische Morfologie 
en Pathologische Anatomie voor hun assistentie bij het bereiden 
een aantal van de microscopische preparaten alsmede voor het 
beschikbaar stellen van apparatuur. 
Dr. S. Sanyal en H.G. Jansen (Erasmus Universiteit, 
Rotterdam) dank ik voor de prettige, vruchtbare samenwerking op 
het gebied van de rds mutante muizen. I wish to thank Russell 
Foster (University of Bristol, United Kingdom), for introducing 
me in the field of non-visual photoreception, the stimulating 
discussions and for a fruitful collaboration. 
Mijn 'vakbroeder' Jack en Marc evenals andere familieleden 
wil ik bedanken voor hun belangstelling. Ten slotte wil ik jou, 
Sophie, bedanken voor je onmisbare steun, je geduld en de inzet 
waarmee je de afgelopen periode voor een meer dan evenredig deel 
de verantwoording hebt gedragen voor de opvoeding en verzorging 
van Mare en onze kinderen Annemieke en Susanne tijdens mijn 
veelvuldige afwezigheid en afwezig-zijn. 
7 
ABBREVIATIONS 
BSA 
CFA 
CNBR 
DTE 
EAU 
EDTA 
ELISA 
F CA 
FITC 
HEPES 
HIV 
IFA 
IRBP 
kD 
LTT 
Lx 
MN 
MOPS 
OD 
OS 
PA 
PBS 
PMN 
PMSF 
ROS 
SD 
SE 
SDS 
TBS 
Tris 
SO 
bovine se 
complete 
cyanogen 1 
1,4-dithi 
experimen 
ethylene . 
enzyme-li: 
Freund's 
fluoresce 
N-2-hydro 
human imm 
incomplet 
interphoti 
kilodalto: 
lymphocyt* 
lux 
mononucle 
morpholin 
oculus de 
oculus si 
pertussis 
phosphate 
polymorphi 
phenylmet 
rod outer 
standard > 
standard ι 
sodium do 
Tris buff' 
Tris (hyd 
Sympathet 
rum albumin 
Freund's adjuvant 
bromide 
oerythritol 
tal autoimmune uveoretinitis 
diamine tetraacetic acid 
nked immunosorbent assay 
complete adjuvant 
in isothiocyanate 
xyethylpiperazine-N,-2-ethane sulphonic acid 
unodeficiency virus 
e Freund's adjuvant 
oreceptor retinoid binding protein 
η 
e transformation test 
ar 
o-propane sulfonic acid 
xter 
nister 
adjuvant 
buffered saline 
enuclear 
hansulfonylfluoride 
segment 
deviation 
error 
decyl sulfate 
ered saline 
roxymethyl) aminomethane 
ic Ophthalmia 
8 
CONTENTS page 
CHAPTER 1 INTRODUCTION 13 
CHAPTER 2 IMMUNOGENICITY OF RHODOPSIN: 
GENERATION AND CHARACTERIZATION OF ANTISERA 
CHAPTER 3 ENZYME-LINKED IMMUNOSORBENT ASSAY FOR 
QUANTITATIVE DETERMINATION OF THE VISUAL 
PIGMENT RHODOPSIN IN TOTAL-EYE EXTRACTS 
CHAPTER 4 IMMUNOLOGICAL RELATIONSHIP BETWEEN VERTEBRATE 
RHODOPSINS AS DETECTED BY ANTI-BOVINE RHODOPSIN 
ANTISERA 
CHAPTER 5 EXPERIMENTAL AUTOIMMUNE ÜVEORETINITIS IN RATS 
INDUCED BY THE VISUAL PIGMENT RHODOPSIN: 
RHODOPSIN IS MORE PATHOGENIC THAN OPSIN 
CHAPTER б RHODOPSIN-INDUCED EXPERIMENTAL AUTOIMMUNE 
ÜVEORETINITIS: DOSE DEPENDENT CLINICO-
PATHOLOGICAL FEATURES AND PATHOGENICITY OF 
C-TERMINAL DEPRIVED RHODOPSIN 
CHAPTER 7 RHODOPSIN-INDUCED EXPERIMENTAL AUTOIMMUNE 
ÜVEORETINITIS IN MONKEYS 
CHAPTER 8 GENERAL DISCUSSION 
SUMMARY 
SAMENVATTING 
REFERENCES 
PUBLICATIONS 
CURRICULUM VITAE 
39 
67 
83 
103 
123 
145 
167 
173 
179 
185 
192 
193 
9 

CHAPTER 1 
INTRODUCTION 

1.1 OCULAR INFLAMMATION AND RETINAL ANTIGENS 
The basic mechanisms underlying inflammatory diseases of the 
uvea and retina are in most cases unknown, but immunogenic and 
autoimmune factors are frequently suspected (Wacker,1981). Many 
uveitic conditions are due to infection with bacteria, viruses or 
parasites. Infective agents may initiate inflammation by directly 
damaging ocular tissues or, perhaps more important, by 
stimulating pathogenic immune responses against their antigenic 
components. In addition, infective agents may act as 'adjuvants', 
facilitating immune responses toward autologous tissue antigens 
(Gery et al., 1986). About ten percent of the visual handicap in 
the United States is due to intraocular inflammatory diseases , 
and less severe ocular inflammation is very commonly seen by 
ophthalmologists, frequently secondary to other factors such as 
ocular surgery (Nussenblatt et al.,1983). 
Ocular antigens capable of inducing an animal model of 
autoimmune uveoretinitis, useful for basic and clinical research, 
have been sought for many years. From a historical standpoint, 
this search focused on the antigenicity of the uvea, following 
the work of Elschnig (1910), who proposed the autoimmune theory 
of sympathetic ophthalmia for the first time. Sympathetic 
ophthalmia is a bilateral granulomatous uveitis which occurs as a 
rare event after uni-ocular trauma or surgery. More recently, 
attention has shifted to the retina as the source of the 
pathogenic autoantigens. This was initiated by the discovery that 
homologous retina was highly active in the production of 
experimental autoimmune or allergic uveitis (EAU) in guinea pigs 
and rabbits (Wacker and Lipton, 1965; Wacker and Lipton, 1968). 
The disease was characterized by inflammation of the uveal tract 
and outer retina, by infiltration of the aqueous and vitreous 
humors, and by loss of photoreceptor cell structure and function 
(Wacker et al., 1968; Lawwill et al., 1972). 
The observations on the antigenicity of retina were confirmed 
and extended in many laboratories, using various animal species 
and immunogenic fractions of the retina. For a recent review see 
13 
Gery et al. (1986). Up till now three retina-specific 
autoantigens have been identified. The first one, S-antigen, was 
isolated from the soluble fraction of the retinal homogenate and 
was shown to be very potent in its capacity to initiate 
autoimmune inflammatory reactions in the eye ( Faure, 1980; 
Wacker, 1981; Gery et al. , 1986). Secondly, highly purified 
preparations of the rod visual pigment rhodopsin were shown to 
induce EAU in guinea pig (Marak et al., 1980; Meyers-Elliott et 
al., 1983) and rat (Broekhuyse et al., 1984 and 1987a). Recently 
a third autoantigen was identified, the interphotoreceptor 
retinoid binding protein (IRBP), being highly uveitogenic in rat 
(Broekhuyse et al., 1986 ; Gery et al. 1986). 
The investigations described in this thesis will focus on the 
rod visual pigment rhodopsin. In the following sections 
localization, and relevant structural, functional and 
immunochemical properties of rhodopsin will be presented. In 
addition some aspects of the animal model of experimental 
autoimmune uveoretinitis will be discussed with emphasis on 
rhodopsin induced experimental ocular inflammation. 
1.2 THE VISUAL PIGMENT RHODOPSIN 
1.2.1 Structure of the eye 
The eyeball is composed of three tissue layers, which enclose 
the anterior and posterior chambers, the lens and the vitreous 
humor (Fig. 1.1) . The outermost coat is known as the fibrous 
tunic and is composed of the clear, transparant cornea and the 
white opaque sclera. These two collagenous tissues provide a 
slightly elastic envelope which maintains the shape of the eye. 
The middle layer of the three coats of the eyeball is known 
as the uveal tract and is composed of the iris anteriorly, the 
choroid posteriorly and an intermediate part, the ciliary body. 
The uveal tract carries the principal blood vessels of the eye, 
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and its function is largely nutritive. 
The innermost layer of the three coats of the eye is the 
retina, which because of its embryologie origin and histological 
structure is an extension of the nervous system. The retina 
extends from the optic nerve forward to its termination at the 
ora serrata. 
The space between the lens and retina contains the 
transparent gel-like vitreous. It plays a part in the maintenance 
of intraocular pressure, and its transparency is important for 
vision. 
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Fig. 1.1: Overall topographical anatomy of the vertebrate eye 
(human) 
1.2.2 Structure of the retina 
The retina is the photoreceptive tissue of the eye. It 
consists of a single layer of columnar neuroepithelial cells, 
termed the retinal pigment epithelium, and the major part of the 
retina, consisting of neurons and glia, termed the sensory 
retina. The most striking feature of the retinal organization is 
the separation of cell bodies and processes into distinct layers 
(Fig. 1.2). 
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Fig. 1.2: The vertebrate retina: (a) light micrograph; (b) 
corresponding diagram. ELM, external limiting membrane; 
ILM, internal limiting membrane; HC, horizontal cells; 
AC, amacrine cells; MC, Muller cell. 
The retinal neurons of the sensory retina may be classified, 
on the basis of their function, into five main cell types: 
photoreceptors, horizontal cells, bipolar cells, amacrine cells 
and ganglion cells. The perikarya (cell bodies) of these five 
types are found in three nuclear layers, and the synaptic 
contacts between the cells are confined to two so called 
plexiform layers. In addition the sensory retina contains glial 
cells, mainly the so-called Muller cells, which fill all space 
not occupied by neurons and blood vessels. 
In man the internal layers of the retina , exept the fovea, 
are supplied by branches of the central retinal artery and vein, 
which extend to the outer plexiform layer. The outer retinal 
parts (photoreceptors and pigment epithelium) are nourished by 
the choriocapillaris, situated in the choroid just external to 
the pigment epithelium and Bruch's membrane. The pigment 
epithelium has a significant role in visual pigment metabolism: 
(1) it is involved in the processing and recycling of vitamin A; 
(2) it is presumed to act as a barrier that regulates the 
exchange of substances between the choriocapillaris and the 
photoreceptors; (3) the function of the melanin granules is 
believed to reduce the random back scatter of light from the 
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sclera; (4) it is instrumental in the ingestion and removal of 
the tips of photoreceptor outer segments, which are being shed as 
a consequence of biosynthesis at the base of the outer segment in 
a circadian rhythm. 
1.2.3 Photoreceptors 
In vertebrate retina two kinds of photoreceptor cells occur: 
rods and cones. Rods mediate dim light or scotopic vision and are 
responsible for black-white vision. Their detection-treshold is 
ca. 3 orders of a magnitude lower than that of cones. Cones 
mediate photopic vision and are responsible for colour vision. In 
most vertebrates, rods outnumber cones by far. The cones are 
usually concentrated in the foveal area. 
Vertebrate photoreceptors are specialized, elongated neurons 
consisting of an outer segment, an inner segment, a cell nucleus 
and synaptic termination (Fig. 1.3). The outer segment is 
connected to the rest of the cell by a narrow cilium. 
Fig. 1.3: Schematic diagram of the 
rod photoreceptor cell. 
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The inner segment contains a mass of densely-packed 
mitochondria termed elipsoid, which lies distal to a region 
containing the Golgi apparatus and endoplasmatic reticulum, which 
is termed myoid. 
The outer segment is a highly specialized cell organelle for 
light absorption and subsequent signal transduction. It is filled 
by membranous infoldings, so-called disks. The outer segment 
contains the visual pigment rhodopsin, which is located in the 
plasma and disk membranes. The rod disks are continuously formed 
at the base of the outer segment by invagination of the plasma 
membrane. The newly formed disks move successively toward the 
tip, while loosing their continuity with the plasma membrane. At 
the tip fragments of the outer segments are removed, and 
subsequently phagocytized by the pigment epithelium in a 
circadian rhythm. 
1.2.4 Rhodopsin: structure and function 
Rhodopsin is the rod visual pigment which performs a key role 
in the visual process: it absorbs the incident photons, and 
through the subsequent conformational changes in the molecule it 
initiates visual exitation. 
The primary structure of bovine rhodopsin has recently been 
elucidated ( Ovchinikov, 1982; Hargrave et al. 1983). It consists 
of a single polypeptide chain of 348 amino acids, adding up to 
molecular weight of 39 kD. On the basis of the amino acid 
sequence, which shows a characteristic alternation of polar and 
apolar stretches, and the present knowledge of the sites in 
rhodopsin vulnerable to proteolytic attack a putative model for 
the organization of the rhodopsin polypeptide chain through the 
disk membrane has been proposed (Fig. 1.4-1.5 ; Ovchinikov, 1982; 
Hargrave et al. 1983; Dratz and Hargrave 1983). Seven, probably 
somewhat distorted, hybrophobic Ot-helical stretches pierce the 
membrane, and are interconnected by six hydrophylic stretches. 
The C-terminal is located on the cytoplasmic side of the disk or 
Plasmamembrane. This part contains a long sequence of mainly 
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hydrophylic amino acid residues bearing the тацог phosphorylation 
sites. The N-terminal, located intradiskally or extracellularly , 
contains two oligosaccharide units linked to asparagine residues 
at position 2 and 15. This adds up to a total molecular weight of 
41 kD. 
ι. f ¿л*-4*· 
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Fig. 1.4: Amino acid sequence of bovine rhodopsin with proposed 
organization through the disk membrane bilayer. 
CYTOPLASMIC 
SURFACE 
Fig. 1.5: Cross-section through the rod outer segment (a), and 
hypothetical arrangement of the seven transmembrane 
sequences (b). 
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The organization of hydrophobic conformations buried in the 
lipid bilayer and hydrophylic conformations protruding into the 
aqueous environment gives the rhodopsin structure a typical 
amphipatic character. A wide variety of detergents has been 
applied for the solubilization of rhodopsin ( Fong et al., 1982; 
De Grip, 1982). A general drawback of the use of detergents are 
the side-effects concurrent with its incorporation into micelles. 
These effects manifest themselves in a decrease in thermal 
stability, exposure of hitherto less accessible sites and partial 
loss of functional properties. The severity of these effects 
depends not only on the type of detergent used, but also on the 
animal species from which the rhodopsin is obtained. 
Essential for its function as a light receptor is the 
presence of a chromophoric group, 11-cis-retinal located in the 
interior of the protein, which is linked to lysine-296. This 
group gives rhodopsin its typical absorption spectrum with 
absorption bands at 500 and 350 nm. Absorption of a photon causes 
isomerization of the chromophore to the all-trans form. The 
resulting 'excited' protein conformation relaxes via a series of 
rapid thermal reactions called the photolytic sequence, ending 
with the release of all-trans retinal, into the apoprotein opsin. 
Illumination manifests itself spectroscopically in the 
disappearence of the 500 nm absorption band and the appearance of 
a new band at 380 nm ( all-trans retinal). The apoprotein opsin 
can be regenerated in vitro into rhodopsin by recombination with 
11-cis-retinal, but only under restricted conditions. For 
instance, the regenerability of opsin is much easier lost by 
detergent action than the 500 nm absorption of rhodopsin ( De 
Grip, 1982; De Grip and Daemen, 1982). 
1.2.5 Rhodopsin: isolation, handling and nomenclature 
Rhodopsin can be isolated in relatively large quantity and 
high purity from cattle retina in two steps. The first step is a 
mild homogenization of the retina which disruptes the connecting 
cilia , followed by sucrose-density gradient centrifugation and 
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hypotonie lysis of the released outer segments (De Grip et al., 
1980). Rhodopsin is the predominant protein of the photoreceptor 
membrane accounting for about 90 % of the total membrane protein 
content. These membranes may therefore be regarded as a fairly 
pure rhodopsin preparation, the main contaminant being lipid. 
The second step consists of affinity chromatography of 
detergent-solubilized outer segment membranes over concanavalin A 
sepharose, which nearly completely removes the remaining proteins 
and lipids from rhodopsin. 
Since rhodopsin is extremely light-sensitive, isolation and 
further handling have to be performed either in darkness or under 
dim red light ( Λ > 620 nm). Opsin is prepared by illumination of 
rhodopsin, preferably under standard conditions. 
Rhodopsin is the general name used for rod visual pigments, 
often irrespective of its state-of-illumination. In this thesis 
the pigment will be refered to as (rhod)opsin, while the 
designations rhodopsin or opsin are strictly used for the 
non-illuminated or illuminated form, respectively. 
1.2.6 Proteolytic fragments of rhodopsin 
Various proteolytic enzymes can be applied for specific 
fragmentation of rhodopsin (Ovchinikov, 1982; Hargrave, 1983). 
Proteolysis with thermolysin and proteinase К will be discussed 
here because the fragmentation pattern has been studied 
thoroughly (Hargrave et al., 1982; De Grip and Margry, 1982; 
Martynov et al., 1983 and De Grip et al. 1986). In the first 
stage both enzymes remove several sequences at the C-terminal 
end, leaving one large fragment with a molecular weight of about 
33 kD. In the second stage thermolysin clips between amino acid 
240 and 241. This finally results in two major fragments, one of 
25 kD containing the sugar moieties, and another of 13 kD 
(molecular weight according their migration behaviour on 
SDS-polyacrylamide gel). Upon prolonged incubation thermolysin 
slowly further cleaves the 25 kD fragment, somewhere in the 
135-147 loop, into a 18 kD ( with the sugar groups) and 8 kD 
21 
fragment. 
Proteinase К, in the second stage, clips the cytosolic loop 
230-250 at two potential sites at position 231 and 245. A further 
cut near position 141 cleaves the largest fragment into two 
smaller ones. Hence, proteinase К yields three major fragments of 
18 kD (with sugar residues), 12 kD and 8 kD respectively. The 18 
kD fragment is slowly further degraded into fragments of 16 and 
13 kD consecutively. 
In the unbleached state the fragments stick together. After 
treatment with either of these enzymes the original 500 nm 
absorbance due to the presence of the chromophoric group is 
largely retained and the photolytic sequence is practically 
unaffected. 
1.3 IMMUNOCHEMISTY OF RHODOPSIN 
The first studies applying immunochemical techniques to 
rhodopsin were directed towards physiological questions like 
cellular localization (Dewey et al., 1969; Jan and Revel, 1974) 
and biosynthesis (Papermaster et al., 1975,1978). Later, 
anti-rhodopsin antisera have been used to develop immunoassays 
with sensitivities in the subpicomolar range ( Lentrichia et al., 
1980; Plantner and Kean, 1982; Peterson et al., 1983; Schalken et 
al., 1983). More recently monoclonal antibodies were prepared 
which can be used to map functional sites of rhodopsin (Mackenzie 
and Molday, 1982; Molday and Mackenzie, 1983; Mackenzie et al., 
1984). 
In most of these studies antisera or monoclonal antibodies 
have been used as a research tool, while only a few studies have 
beem aimed at the investigation of the immunogenic or antigenic 
properties of rhodopsin. For a recent review see De Grip (1985). 
Before presenting a brief survey of the present knowledge on 
these aspects it is necessary to define two immunological 
characteristics of proteins. The first, immunogenicity, is the 
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capacity to elicit an immune response, manifested either by 
antibody production or by cell-mediated immunity. The second, the 
antigenicity, refers to the capacity to be recognized in a 
specific manner by antibodies or immunocompetent cells. These two 
characteristics do not necessarily coincide (Arnon, 1986). 
Macromolecular antigens, mostly proteins and glycoproteins, 
usually express a multitude of possible antigenic determinants, 
or epitopes, that dictate their specificity. In the case of 
(rhod)opsin especially its membrane-bound character and light 
sensitivity might influence its immunogenic and/or antigenic 
properties. These properties will be discussed only with respect 
to the humoral immunity and antibodies , since no data are 
available yet on the cellular immunity towards (rhod)opsin. 
1.3.1 Immunogenicity 
Rhodopsin does not appear to be strongly immunogenic, since 
immunization with entire retinal homogenate or rod outer segments 
preferentially results in production of antisera (Rahi, 1970; 
Faure, 1980) or monoclonal antibodies (Barnstable, 1980) directed 
against other retinal proteins. Relatively pure immunogen 
preparations seem to be a prerequisite for preparation of 
specific anti-rhodopsin antibodies. One has the choice between 
more native, but less pure preparations like rod outer segment 
membranes or highly purified, lipid-free rhodopsin, where 
antigenic determinants might have been changed by the use of 
detergent. This detergent-membrane protein relationship 
constitutes a general complicating factor in the immunology of 
membrane proteins. 
Various types of bovine rhodopsin preparations have been used 
to raise antisera. This includes purified rhodopsin in 1-2% 
digitonin (Dewey et al., 1969; Jan and Revel, 1974), in 0.3% 
Ammonyx LO (Lentrichia et al., 1980, Plantner and Kean, 1982) and 
in 0.1 % SDS (Papermaster et al. 1975, 1982b), but also bovine 
rod outer segment membranes solubilized in 2% digitonin (Jan and 
Revel, 1974) or 0.2% SDS (Godchaux, 1978). Most of these 
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immunizations resulted in antisera with a reasonable titer and 
specificity. A study comparing the immunogenicity of various 
bovine rhodopsin preparations showed that the 
state-of-illumination of the immunogen appears not to have a 
pronounced influence on the height of the antibody titers of the 
antisera (De Grip and Margry, 1982; Margry, 1982). No correlation 
was found between the dose of immunogen (0.1-1.0 mg/ rabbit) and 
the height of the titer. However, marked detergent effects were 
noted: rod outer segment membranes solubilized in a mild 
detergent (Tween-80) produced variable titers, but consistent low 
titers were obtained after immunization with SDS-solubilized 
membranes. 
1.3.2 Antigenic properties 
The antigenicity of rhodopsin might be influenced as well by 
its membrane-bound character and its light sensitivity. It 
appears that all antisera elicited with purified rhodopsin 
dissolved in a variety of detergents or with rod outer segments 
only approached by mild detergents (digitonin, Tween 80), 
invariably interact with both membrane-bound and solubilized 
rhodopsin (De Grip 1985). Several monoclonal antibodies have been 
characterized which bind equally well to membrane-bound rhodopsin 
as to rhodopsin solubilized in Triton X 100 or cholate (Mackenzie 
and Molday, 1982; Molday and Mackenzie, 1983; Arendt et al., 
1983). However one antibody is described which only interacts 
with the solubilized protein (Molday and Mackenzie, 1982). 
Probably in the membrane-bound and in the solubilized state of 
rhodopsin two overlapping collections of antigenic determinants 
are present, the cross-section of which is little or not changed 
upon solubilization in various detergents. The two remaining 
populations would contain 'membrane characteristic' determinants 
which are disrupted or masked upon solubilization, and 
determinants peculiar to a solubilized state which are exposed or 
generated by solubilization. 
Since most anti-rhodopsin antisera or antibodies reported 
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recognize membrane-bound rhodopsin it seems preferable to use 
membrane-bound antigens in immunoassays. However, supplemental 
information should be obtained on solubilized rhodopsin, using 
both a mild and a strong detergent. 
Some anti-rhodopsin antisera were shown to discriminate 
between rhodopsin and opsin, which was termed "configurational 
specificity" (De Grip, 1985). The configurational specificity of 
antisera is expressed only in detergents of intermediate 
strength, where the biochemical intactness of rhodopsin is 
preserved but opsin is biochemically inactivated. No selectivity 
is observed in mild detergents where opsin as well as rhodopsin 
remain biochemically intact, or in a very strong detergent like 
SDS which denatures both rhodopsin and opsin. 
1.3.3 Antigenic determinants 
Application of the method of Hopp and Woods (1981) which 
enables to locate potential linear antigenic sites of proteins on 
the basis of the average hydrophilicity of 6-8 amino acid 
residues, would predict six independent antigenic sites ( Fig. 
1.6). These sites consist of the following sequences: 1-20; 
62-69; 193-200; 229-250; 310-314 and 325-348. According to this 
analysis, the first, second fourth and sixth sequence exhibit the 
highest potential to harbour an antigenic determinant. 
Studies on the distribution of antigenic sites over rhodopsin 
and its proteolytic fragments by means of polyclonal antisera 
indicate the existence of at least three antigenic sites (De 
Grip, 1985). By examining the binding specificity of antisera and 
monoclonal antibodies using synthetic peptides from the rhodopsin 
sequence Hargrave et al. (1986) showed that rhodopsin's amino 
terminal region contains a principal antigenic site. In addition, 
at least four monoclonal antibodies were reported to interact 
with the C-terminal part of rhodopsin (Molday and Mackenzie, 
1983; Mackenzie et al., 1984). 
In conclusion, antigenic sites of rhodopsin are definitely 
located in the N-terminal region near the carbohydrate groups, 
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and in the last 20 to 25 C-terminal residues. In addition the 
cytosolic located sequences comprising residue 60-70 and 230-250 
very likely contain antigenic sites as well. No information is 
available yet on the antigenic properties of the sugar containing 
residues or on any conformational antigenic determinants of 
rhodopsin. 
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Fig. 1.6: Hydrophilicity profile of the amino acid sequence of 
bovine rhodopsin. The average of a sequence of six 
amino acids, calculated with the parameters given by 
Hopp and Woods (1981), is plotted against the third 
one. 
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1.4 EXPERIMENTAL AUTOIMMUNE UVEORETINITIS 
1.4.1 Ocular immunology 
Specific anatomical and physiological barriers exist that 
make the eye's immunological responses unique. These barriers 
include the avascularity of the cornea and lens, the absence of 
ocular lymphatic drainage and the blood-aqueous and blood-retina 
barrier. 
Yet, the eye is immunologically a highly active tissue with 
virtually all types of immune reactions present.The eye has a 
full range of immunocompetent cells , a vitreous that can act as 
a depot to enhance ocular immune responses and an uveal tract 
that can act as a lymphe node. 
The blood-tissue barriers are exerted by the tight-junctions 
at the level of the retinal capillaries, the pigment epithelium 
of the retina and the ciliary epithelium. The relevance of the 
blood-retinal barrier is demonstrated by the fact that while 
immunoglobulins are plentiful in the choroid, they are most 
uncommon in the extra-vascular tissue of the retina (Allansmith 
et al., 1973). In the absence of vascular damage or defective 
retinal pigment epithelium, immunological reactions within the 
retina probably do not occur. However, once there has been 
damage, as is often the case in retinal pathology, the retina may 
become an immunologically active tissue (Corwin and Weiter, 
1981). 
Any antigen locally released into the eye, in the absence of 
lymphatic drainage, may gain access to the systemic circulation 
and lead to a generalized immune respons. Even when antigen is 
injected inside the eye, the afferent limb of the immune respons 
occurs at extraocular sites (Smith et al., 1969). After the 
antigen is processed extraocularly, immunocompetent cells return 
to the eye. Most of the antibody production takes place within 
the eye, primarily in the uvea because of its vascular structure. 
In this way the uvea may act as an accessory lymphe node (Rahi, 
1978). 
There is evidence that several ocular tissues, especially the 
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lens, the retina and the cornea, contain organ-specific antigens 
which may participate in eye diseases initiated by some physical, 
chemical or microbial insult. An autoimmune response in this 
situation may maintain, if not initiate an intraocular 
inflammation (Rahi, 1978). 
1.4.2 Experimental autoimmune uveoretinitis 
Studies of the last three decades have established the 
pivotal role of tissue specific antigens in pathogenic autoimmune 
processes. These antigens are defined by their existence in only 
a single tissue and are usually characterized by high levels of 
cross reactivity with the corresponding antigens from other 
species (Gery et al., 1986). Immunization of animals with tissue 
specific antigens from other species ('xenogeneic'), other 
individuals from the same species ('allogeneic'), or even from 
the same animal used for immunization ('autologous') often 
triggers pathogenic processes. Some of these processes resemble 
certain human diseases of the same tissue and are considered 
as their experimental models. The homology between the human and 
experimental diseases is further indicated by findings of 
specific immune responses in the human subjects towards the same 
tissue specific antigens. 
Experimental autoimmune uveoretinitis (EAU) is an animal 
model in which uveitis-like disease is induced by extraocular 
infection (usually in the foot pad) with retinal or uveal 
antigens. A substantial number of tissue-specific antigens have 
been identified m vertebrate retinas (Faure, 1980). In early 
studies Wacker and Lipton (1968a,b) separated the retinal 
homogenate into two fractions, designated 'soluble' (S) and 
'particulate' (P) fraction. More recent investigations have 
further identified the active components of these fractions. The 
major fraction of the S fraction was identified as a highly 
immunogenic protein, designated 'S-antigen', while the active 
antigenic component of the Ρ fraction is thought to be the rod 
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visual pigment (rhod)opsin (Faure, 1980). In addition, another 
antigen with apparent tissue specificity has been identified viz. 
the interphotoreceptor retinoid binding protein (IRBP). 
Experimental systems using S-antigen have produced the bulk of 
our knowledge concerning the pathogenesis of autoimmune processes 
in the posterior segment of the eye. Therefore, some features of 
S-antigen-induced EAU will be discussed in the following section. 
1.4.3 S-antigen-induced EAU 
The S-antigen preparations used in most studies were obtained 
from bovine or guinea-pig retina and both were shown to be 
similarly potent. Experimental autoimmune uveoretimtis has been 
reproducibly induced in a variety of animals including primates, 
rabbits, guinea pigs and rats (reviews: Gery et al., 1986; Faure, 
1980). Features of EAU may differ among the tested species, due 
to anatomical or other factors (eg. absence of retinal blood 
vessels in guinea pigs). The capacity of S-antigen to induce EAU 
depends on the inclusion of adjuvants in the immunization; no 
disease is induced in animals injected with this antigen without 
the proper adjuvant. Complete Freund's adjuvant (CFA), a mixture 
of mineral oils with mycobacteria, is used by most authors for 
induction of EAU. Recent studies have shown that the induction of 
EAU is further enhanced by simultaneous injection of animals with 
Bordetella pertussis bacteria ( De Kozak et al., 1981b; Mochizuki 
et al., 1984, Gery et al., 1986). 
In the following paragraph a brief description of the most 
prominent changes observed upon induction of EAU in rat will be 
given, while changes in other species will be mentioned when they 
differ from those in rats and are pertinent to the discussion. 
Climcopathological changes. The onset of EAU was found to be 
indirectly related to the antigenic dose: rats immunized with 
high doses (50 /ig/rat) develop clinical changes as early as 11-12 
days postinjection, while rats injected with low doses (5-10 
/Ag/rat) produce disease symptoms 14-20 days postinjection (De 
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Kozak et al., 1981b). The first clinical symptoms are usually 
hyperemia of the conjuctiva, pericorneal and iris vasodilation 
and appearence of exudate and cells in the anterior chamber and 
vitreous. Within 2-4 days after onset the ocular inflammation 
reaches its peak. Thereupon, the clinical changes disappear 
rapidly and usually within 6-20 days the eyes become clinically 
quiet. No recurrences have been reported in rat. More chronic 
changes have been reported in guinea-pigs or monkeys in which 
clinical changes were recorded for up to a year or more. 
Histopathology. The histological changes in rats with EAU 
following immunization with various amounts of S-antigen 
demonstrate a high level of conformity, in contrast to the 
spectrum of changes reported in guinea-pigs. Yet, de Kozak et al. 
(1981b) noted differences between rats treated or untreated with 
B. pertussis, but the differences were only in the intensity of 
the inflammatory reaction. Early histologic changes in the retina 
of Lewis rats immunized with S-antigen in CFA are exudate 
formation and accumulation of inflammatory cells in the 
photoreceptor layer. The retina is often detached with 
accumulation of serum underneath. Other components of the eye 
become rapidly involved as well, with inflammatory cells 
infiltrating the vitreous, iris ciliary body and anterior and 
posterior chambers. The choroid becomes usually affected only at 
the peak of the pathological process. At this phase, 
photoreceptor cells are mostly degenerated and this layer as well 
as perivascular regions of the retina are massively infiltrated 
by inflammatory cells. The infiltration in the rat eye consists 
of a mixture of polymorphonuclear (PMN's) and mononuclear 
leukocytes (MN's, i.e., lymphocytes and histiocytes). The 
inflammatory cells disappear from the anterior segment first and 
from the posterior segment later on, while the photoreceptor 
layer is partially or completely absent in retinas recovering 
from the inflammatory process. 
Guinea-pigs developing EAU exhibit a wide spectrum of 
histological changes, ranging from the local 'mild' to the 
panuveitic 'hyperacute' inflammation, directly related to the 
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immunizing dose (Rao et al., 1979; Paure, 1980). 
Of particular interest are the changes in primates with EAU, 
because of their possible relation to those in certain human 
uveitic conditions. In Cynomolgus monkeys immunized with bovine 
or monkey S-antigen, the changes consisted of vasculitis an 
chorioretinitis with a remarkable involvement of plasma cells and 
PMN's ( Paure and De Kozak, 1981). The disease induced in rhesus 
monkeys consisted of inflammation in both anterior and posterior 
segments. The retinal changes included mainly loss of 
photoreceptor cells as well as areas of subretinal inflammation 
and occasional bulging of the retina into the vitreous, whereas 
minimal changes were observed in the choroid (Nussenblatt et al., 
1981a). 
Pathogenic mechanisms of EAU. Immunopathogenic processes are 
usually classified into four types, three of which are mediated 
by antibodies (types I and II) or their complexes with antigens 
(type III), and one is cell mediated (type IV). Studies 
concerning the immunopathogenesis of EAU have produced some 
support for the possible involvement of antibodies, while the 
majority of data have indicated that cell mediated responses play 
the major role in these processes. 
A possible involvement of antibodies in EAU was indicated by 
the histological finding that the inflammatory infiltration in 
the eye often consists of PMN's, which is typical for the 
Arthus-like reaction which is mediated by antigen-antibody 
complexes. Another indication of the participation of an 
Arthus-like mechanism was provided by Marak et al. (1979) , who 
reported that depletion of complement (by injection of cobra 
venom factor) reduced the intensity of EAU in guinea-pigs. 
Reaginic (IgE) type of antibodies might be involved also, since 
choroidal mast cell numbers increase a few days before onset of 
EAU, while intensive degranulation occurs shortly before the 
onset (de Kozak et al., 1981a). In addition, IgE antibodies to 
S-antigen were detected in sera of rats as soon as day seven 
after immunization. However contradictory results have been 
reported with respect to transfer experiments using hyperimmune 
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sera, most of the experiments showing no effect ( Gery et al. 
1986). 
Indirect evidence in support of the role of cell mediated 
immunity in the pathogenesis of EAU was obtained in two systems. 
(1) Athymic nude rats were found incapable of developing EAU when 
immunized with S-antigen. Yet, EAU was induced in these rats by 
adoptive transfer of lymphocytes from heterozygous donors 
immunized with S-antigen (Salinas-Carmona et al., 1982). (2) 
Development of EAU was inhibited in rats by treatment with 
cyclosporine, an immunosuppressive drug which selectively affects 
T-lymphocytes ( Nussenblatt et al., 1981b, 1983 ). Although the 
role of T-lymphocytes in both systems could hypothetically be 
just to 'help' B-lymphocytes to produce antibodies, other data, 
using the system of adoptive transfer, have directly demonstrated 
the capacity of T-lymphocytes to induce EAU (Gery et al. 1986). 
1.4.4 (Rhod)opsin induced EAU 
The particulate fraction of the retina was found to contain 
an organ specific antigen which was termed P-antigen (Wacker and 
Lipton, 1986a,b). It is thought that P-antigen is rhodopsin or 
its protein component, opsin (Kalsow and Wacker, 1975; Faure, 
1980). A reaction of identity between P-antigen and purified 
(rhod)opsin using antisera specific for these antigens was shown 
by Marak et al. (1980). The participation of (rhod)opsin in 
immunopathogenic processes has been a contraversial issue since 
many of the preparations used for immunization were not pure and 
a contamination with S-antigen could be responsible for the 
uveitogenic activity. Such partially pure preparations of 
(rhod)opsin were reported to induce uveoretinic changes in 
guinea-pigs (Faure, 1980; Faure et al. 1977) and primates (Wong 
et al., 1977). However , more purified preparations of 
(rhod)opsin, without any apparent contamination with S-antigen 
were also reported to induce EAU in guinea-pig (Marak et al., 
1980; Meyers-Elliott et al.,1983) and in rat (Broekhuyse et al., 
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1984,1987a). 
Clinicopathological and histopathological changes. Marak et al. 
(1980) used high doses of purified (rhod)opsin to immunize 
guinea-pigs (0.5-1 mg/guinea-pig) and reported the development of 
non-granulomatous choroiditis consisting almost entirely of 
mononuclear cells. The inflammation was accompanied by focal 
retinal extension and destruction of rod outer segments, whereas 
no changes in the anterior segment were reported. Illumination of 
rhodopsin did not appreciably alter the freguency or severity of 
EAU. In another study smaller amounts of (rhod)opsin (5-500 
^g/guinea-pig) were shown to induce a mild inflammatory 
infiltration in the choroid of immunized guinea-pigs, along with 
destruction of the rod outer segments with no cellular 
involvement (Meyers-Elliott et al., 1983). On the other hand, no 
disease was observed by Faure et al. (1977) in guinea-pigs 
immunized with purified (rhod)opsin. 
Opsin was shown to induce EAU in Lewis rats by injection in 
combination with CFA and pertussis adjuvant (Broekhuyse et al., 
1984).The pathogenicity of opsin has been shown to depend on the 
detergent used for solubilization of the protein. Opsin prepared 
in the denaturing detergent SDS is less pathogenic than prepared 
in the non-ionic, milder detergent Triton X-100. A dose of 250 
μg/rat of opsin prepared in Triton X-100 induced moderate to 
severe non-granulomatous uveitis (predominantly retinitis) in 70 
% of the rats at the end of the second week after injection. The 
photoreceptor layer was destructed within a few days. 
Co-injection of pertussis adjuvant appeared to be a prereguisite 
for induction of severe EAU, even if higher doses of this 
preparation (0.5-1.0 mg/rat) were injected (Broekhuyse et al. 
1987a). Low opsin doses (50-100 μg/rat) seldomly induced severe 
EAU, while the incidence of mild pathology was low. Opsin appears 
to be much less pathogenic than S-antigen and IRBP. The minimal 
doses of Triton-solubilized opsin reguired to induce ocular 
inflammation is a factor of 10-100 higher than for the other 
antigens (Broekhuyse et al., 1986). Apart from a possible low 
uveitogenicity, this might also be caused by a relatively lower 
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immunogenicity due to the poor solubility of opsin. 
The first clinical signs in severe EAU were iris hyperemia of 
variable intensity, the appearence of some cells in the anterior 
chamber and lack of pupilary reaction, while a dense cell 
infiltration of the vitreous developed. Histologically 
mononuclear and polymorphonuclear cell infiltrations of the 
retina were found in severe inflammatory responses. The choroid 
seemed to be less involved, while the anterior uvea was 
infiltrated with MN cells. 
Immunopathology. No direct evidence has been reported with 
respect to the involvement of antibodies in (rhod)opsin induced 
EAU. A possible involvement is indicated by the presence of PMN 
cells in the inflammatory ocular infiltrates, like in EAU induced 
by S-antigen (Broekhuyse et al., 1984). Antibody titers in rats 
developing severe EAU following immunization with opsin were low, 
whereas cellular immune responses , determined by in vitro 
lymphocyte transformation, were high. This may signify that 
cellular rather than humoral immune mechanisms play a major role 
in opsin-induced EAU in rats (Broekhuyse et al., 1984). In 
general, higher immune responses appeared to correlate with more 
frequent induction of the acute, severe type of inflammation. 
Indirect evidence in support of the important role of cell 
mediated immunity was obtained by experiments using cyclosporine. 
Development of opsin-induced EAU was inhibited by this drug, 
while antibody responses were lowered and in vitro 
antigen-stimulated lymphocyte transformation was eliminated 
(Broekhuyse et al., 1987a). 
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1.5 AIMS OF INVESTIGATION AND OUTLINE OF THESIS 
Immunogenic and autoimmune factors are frequently suspected 
to play an important role in inflammatory diseases of the uvea 
and the retina. Experimental autoimmune uveoretmitis is 
considered to be a model for certain uveitic conditions m man. 
The rod visual pigment (rhod)opsin has been shown to induce EAU 
in guinea-pig and rat. However, it appears to be considerably 
less pathogenic than two other retina-specific proteins, IRBP and 
S-antigen. 
The aim of this investigation was to study the 
immunochemistry of (rhod)opsin as well as its immunopathogemcity 
in experimental autoimmune uveoretmitis. 
The immune responses elicited by immunization with 
(rhod)opsin seem to correlate with its pathogenicity. In chapter 
2, the evaluation of the immunogemcity of various bovine 
rhodopsin preparations is described by the preparation and 
characterization of antisera. 
In chapter 3 the development of an enzyme-linked 
immunosorbent assay for quantitative determination of (rhod)opsin 
in total-eye extracts, using the obtained sera is presented. 
Antigens which play an important role in pathogenic 
autoimmune processes usually display low species specificity. 
Using the ELISA in the titration and inhibition mode as well as 
immunohistochemical detection the immunochemical cross-reactivity 
of some of the anti-bovine rhodopsin antisera with (rhod)opsins 
from other vertebrate species was studied (chapter 4). 
In chapter 5 and 6 an investigation of the 
immunopathogemcity of (rhod)opsin in the Lewis rat is described. 
Rat was chosen as experimental model because it has, like man, 
well developed vascular systems in both uvea and retina. The 
pathogenicity of rhodopsin was compared to that of opsin (chapter 
5). Also dose-dependency of the climcopathologic features of EAU 
and the pathogenicity of C-terminal deprived rhodopsin was 
studied (chapter 6). 
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Finally, in chapter 7, clinicopathological features of EAU in 
monkeys induced by rhodopsin, as well as the concomitant immune 
responses are presented. 
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CHAPTER 2 
IMMUNOGENICITY OF RHODOPSIN: GENERATION AND 
CHARACTERIZATION OF ANTISERA 

2.1 INTRODUCTION 
Antibodies to (rhod)opsin have been prepared and employed by 
several investigators for assay purposes and in order to study 
localization, functional properties and antigenic determinants of 
(rhod)opsin. Various immunization procedures have been applied 
for the preparation of antisera and monoclonal antibodies (De 
Grip, 1985). While for such studies selection of the animal for 
immunization, the amount of antigen to be injected, the adjuvant 
to be used and the number and timing of booster injections are 
important considerations, selection of the type of immunogen 
seems to be crucial (De Grip, 1985). 
Membrane proteins like rhodopsin present an additional 
problem because of their insolubility, which requires the use of 
a detergent for solubilization. One has the choice between native 
but less pure preparations like retinal homogenates e.g. rod 
outer segment membranes or purified preparations like lipid-free 
rhodopsin. In the latter preparation antigenic determinants might 
have been changed by the use of detergent. In addition, the 
immunogenicity of the visual pigment might depend on its 
state-of-illumination. 
Selection of the type of rhodopsin preparation for 
immunization and choice between preparation of monoclonal 
antibodies or (polyclonal) antisera depends in part on the 
objective. For studies addressing the histological localization 
of rhodopsin or its immunoassay, a pure rhodopsin preparation is 
preferable as immunogen and polyclonal antisera are suitable 
(Dewey et al., 1969; Jan and Revel, 1974; Lentrichia et al., 
1980; Peterson et al., 1983; Schalken et al., 1983). Studies on 
the antigenic determinants or on functional aspects of 
(rhod)opsin may require the use of a more native preparation as 
immunogen and are only feasible with monoclonal antibodies 
(MacKenzie and Molday, 1982; Mackenzie et al., 1984; Hargrave et 
al., 1986). 
A systematic investigation of the immunogenicity of different 
rhodopsin preparations and the resulting antigenic specificity 
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has been initiated before ( De Grip and Margry, 1982). The 
state-of-illumination of the immunogen appeared not to have a 
pronounced influence on the height of the titers of the antisera. 
This was confirmed by a more recent study ( Plantner and Kean, 
1984). Low titer antisera were obtained when rabbits were 
immunized with sodium dodecyl sulfate solubilized rod outer 
segment membranes. No correlation was found between the dose of 
immunogen (0.1-1.0 mg) and the height of the titer. 
In this study, we extend the evaluation of the immunogenic 
potential of several rhodopsin preparations with the following 
objectives. Firstly, we wanted to investigate which type of 
preparation is most suitable for application as immunogen in 
studies on rhodopsin-induced experimental autoimmune 
uveoretinitis (EAU), an animal model for uveitis-like disease. 
For such studies, which address the immunopathogenicity of 
rhodopsin, a "native" preparation seems preferable but it should 
contain no or only very small amounts of other immunogenic 
retinal proteins. Especially the presence of the so-called 
S-antigen might present a problem since it is very pathogenic and 
easily adsorbs to rod outer segment membranes (Gery et al., 
1986). This aspect is addressed by analyzing titers and 
monospecificity of the produced antisera. 
Antigens which play a pivotal role in pathogenic autoimmune 
processes are usually characterized by high levels of cross 
reactivity between various species (Gery et al., 1986). Thus, the 
immunochemical cross-reactivity profile of the anti-bovine 
rhodopsin antisera with (rhod)opsins from other vertebrates is a 
second important parameter. 
Thirdly, we wanted to apply the antisera in an immunoassay 
for quantitative determination of (rhod)opsin present in crude 
preparations like total ocular homogenates. For this purpose the 
antisera were evaluated in an inhibition enzyme-linked 
immunosorbent assay (ELISA). This aspect will be addressed in 
chapter 3 and 4. 
We compared the immunogenicity of various bovine rhodopsin 
preparations by generation and characterization of polyclonal 
antisera, and not via production of monoclonal antibodies. Apart 
40 
from the fact that such a comparison is difficult to make on the 
basis of monoclonal antibodies, polyclonal antisera are much 
easier to produce and they probably will be more versatile in 
immunoassays thanks to their multisite interaction. 
Four types of non-illuminated rhodopsin preparations were 
tested as immunogen: (1) a suspension of rod outer segment 
membranes,(2) purified lipid-free rhodopsin in the mild detergent 
nonylglucose,(3) rod outer segment membranes solubilized in 
nonylglucose and (4) rod outer segment membranes solubilized in 
Barlox IOS (decyldimethylaminoxide). Barlox IOS was selected as 
detergent, since solutions of opsin in this detergent produced 
antisera with high antibody titers (De Grip and Margry, 1982). 
Nonylglucose was selected as second detergent since a correlation 
seems to exist between biochemical integrity of a preparation and 
its immunogenic or even pathogenic potential (Margry, 1983; 
Broekhuyse et al., 1984), and both rhodopsin and opsin are more 
stable in nonylglucose then in Barlox IOS (De Grip, 1982). The 
immunogenicity of these preparations was evaluated by measuring 
the level of the antibody response. The specificity of the sera 
was tested by immunoblotting, ELISA and immunohistochemistry on 
the level of both light and electron microscopy. The 
cross-reactivity of the sera will be evaluated in chapter 4. 
2.2 MATERIALS AND METHODS 
2.2.1 Materials 
Polystyrene, 96 well flat bottom plates were obtained from 
Flow Lab (Amsterdam, The Netherlands), Concanavalin A-sepharose 
from Pharmacia (Uppsala, Sweden) and Ammonyx LO, bovine serum 
albumin and o-phenylene diamine from Sigma (St. Louis, USA). 
Proteinase K, 1,4-dithioerythritol (DTE) and Tris-hydroxymethyl 
aminomethane (Tris) were obtained from Boehringer (Mannheim, 
F.R.G.), phenylmethansulfonylfluoride (PMSF) from Merck 
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(Darmstadt, F.R.G.), Tween 80 from Boom (Meppel, The Netherlands) 
and Barlox 10S from Lonza, (Rotterdam, The Netherlands). 
Nonylglucose was prepared as described before (De Grip and 
Bovee-Geurts, 1979). 
2.2.2 Preparation of antigens 
Bovine rod outer segment membranes were prepared by sucrose 
density centrifugation ( De Grip et al., 1980). The membrane 
preparation was washed three times by redispersion in distilled 
water and centrifugation (100,000 g, 30 min, 4 0C), was 
resuspended in water to a final concentration of 50-70 nmoles 
rhodopsin /ml and was stored at -70ο0. The A278/A500 ratio of 
this preparation was 2.1-2.2. The rhodopsin concentration was 
calculated from the difference in absorbance at 500 nm before and 
after illumination (10 min by a 300 W tungsten lamp through a 
heat filter and a Schott-Jena 425 nm cut-off filter) in the 
presence of 1% Ammonyx LO, using a molar absorbance coefficient 
of 40,500 1 mol cm . All manipulations involving 
rhodopsin were performed under dim red light ( Λ > 620 nm). 
Purified lipid-free rhodopsin was prepared by concanavalin 
A-sepharose affinity chromatography of rod outer segment 
membranes solubilized in 20 mM nonylglucose ( De Grip et al., 
1980). This resulted in a preparation with a A278/A500 ratio of 
1.6-1.7. 
Proteolysis by thermolysin or proteinase К of rod outer 
segment membranes solubilized in 20 mM nonylglucose in MOPS 
buffer (20 mM MOPS, 140 mM NaCl, 5mM KCl, 3mM MgCl-, 2 mM 
CaCl-, pH 7.2), was carried out with an enzyme/rhodopsin ratio 
of 0.2 (w/w). The reaction was stopped after an incubation for 2 
hr at 30 0C by addition of an equal volume of MOPS buffer 
containing an appropriate protease inhibitor: 10 mM EDTA for 
thermolysin or 1 mM PMSF for proteinase K. Proteolytic digests 
were reconstituted in rhodopsin's natural lipids by stepwise 
dilution with the same buffer (De Grip et al., 1983) and 
recovered by centrifugation (16 hr , 100,000 g, 4 0C). The 
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sediments were washed twice with distilled water, removing 
residual enzymes and soluble products, and were subsequently 
resuspended in water to a final concentration of 50-70 nmoles 
rhodopsin per ml. 
Bovine retinas were solubilized in 0.02 M phosphate buffered 
saline, pH 7.4 (PBS), containing 1% Ammonyx LO (1 ml per retina). 
After gentle rotation for 16 hr at 4 С the preparations were 
centrifuged to remove undissolved material ( 30,000 g,30 min, 4 
С ).The concentration of rhodopsin was determined by 
absorbance spectroscopy. 
The soluble fraction of bovine retina (ReSo) and bovine 
S-antigen were prepared as described before (Brinkman and 
Broekhuyse, 1978; Broekhuyse and Bessems, 1985). Protein assay 
was carried out according to Lowry et al. (1951) using bovine 
serum albumin as a standard. 
2.2.3 Preparation of immunogens and immunization 
Four different rhodopsin preparations were applied as 
immunogen: rod outer segment membranes (ROS), rod outer segment 
membranes solubilized in Barlox IOS (ROS-B), ROS solubilized in 
nonylglucose (ROS-N) and purified lipid-free rhodopsin (Rhod). 
Rod outer segment membranes were used as immunogen without 
further treatment. Booster injections were given at day 32,49 and 
57 postinjection. The other immunogens were prepared as follows. 
Rod outer segment membranes were solubilized in 2% Barlox 10S or 
2% nonylglucose. To these preparations as well as to the 
lipid-free rhodopsin preparation 2% Tween 80 was added. 
Subsequently excess Barlox 10S or nonylglucose was removed by 
dialysis against PBS (3 days, 40C, three changes of buffer), 
and the resulting preparations were used as immunogen. Booster 
injections were given at day 42,56 and 69 postinjection. 
For the immunization the following protocol was used: albino 
female, New Zealand rabbits were injected intracutaneously at 
multiple sites on the back with an emulsion prepared from 1 ml of 
immunogen solution, containing 0.15 mg rhodopsin (on basis of 
absorbance spectroscopy) ,and 1 ml of Freund's complete adjuvant. 
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absorbance spectroscopy) ,and 1 ml of Freund's complete adjuvant. 
Subsequent booster injections were given intramuscularly with 
Freund's incomplete adjuvant. Injection was carried out under dim 
red light, while the rabbits were subsequently housed under 
normal diurnal light-dark conditions. Test bleedings to determine 
antibody titers were taken about 5 weeks after the first 
injection and 9-10 days after each booster. Finally, the rabbits 
were exsanguinated by cardiac puncture and the serum was isolated 
and stored at -20oC. 
2.2.4 Enzyme-linked immunosorbent assay (ELISA) for titer 
determination 
Two slightly differing protocols were followed for the 
determination of antibody titers. The first (short) procedure 
(ELISA-1) was mainly applied to monitor the titers during the 
immunization and to compare the titers of the final bleedings. 
The second procedure (ELISA-2) was used for the determination of 
cross reaction of the antisera with S-antigen. The latter method 
is more sensitive but also more time-consuming. 
ELISA-1. This assay was carried out essentially as described by 
Papermaster (1982 ). Illuminated rod outer segment membranes 
suspended in 0.02 M phosphate buffered saline pH 7.4 (PBS) were 
coated onto polystyrene wells by an incubation for 16 hr at 4 
0C ( 150 μΐ, 60 pmoles per ml on the basis of rhodopsin). The 
wells were washed three times with assay buffer ( PBS containing 
0.1% bovine serum albumin and 0.01% Ammonyx LO). A serial 
dilution of antiserum in assay buffer (100 μΐ) was added to the 
wells and was incubated for 1 hr at room temperature. The wells 
were washed again (5 times), followed by an 1 hr incubation at 
room temperature with 100 μΐ of 1:2000 diluted swine-anti rabbit 
immunoglobulins conjugated to horseradish peroxidase (Dako, 
Amsterdam, The Netherlands). After another washing (5 times) 
bound peroxidase was assayed enzymatically with 
o-phenylenediamine ( 100 μΐ per well of a solution containing 40 
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mg o-phenylenediamine, 40 μΐ 30 % H 9 0 . per ml of 0.1 M 
citrate-phosphate buffer, pH 5.0). After 30 min the reaction was 
stopped by addition of 100 μΐ 2 M H.SO. and the absorbance 
was measured at 492 nm with a Titertek Multiskan photometer. 
ELISA-2. Coating of the polystyrene wells was performed by 
incubating 200 μΐ/well of a solution consisting of 1 μg S-antigen 
or 2 μg rod outer segment membrane protein per ml PBS, for 24 hr, 
4 0C. The wells were washed with PBS containing 0.05% Tween 20 
and serial dilutions (150 μΐ/well) of antiserum in incubation 
buffer ( PBS containing 0.1% bovine serum albumin and 0.05% Tween 
20, pH 7.4) were incubated for 16 hr, 4 0C. After washing (3 
times), 200 μΐ of 1:1000 diluted anti-rabbit/IgG-alkaline 
phosphatase conjugate was added to the wells followed by 
incubation for 5 hr at 37 0C. The wells were washed again (3 
times) and 200 μΐ substrate solution containing 1 mg 
p-nitrophenyl phosphate per ml 0.1 M diethanolamine buffer (pH 
9.8), was added and incubated for 30 min at room temperature. The 
reaction was stopped by addition of 50 μΐ 3M NaOH and absorbances 
were measured at 405 nm using a Titertek Multiskan photometer. 
Antibody titer determination. Antibody titration curves were 
constructed by a semilog plot of the absorbance versus the 
corresponding dilution of antiserum. All values were corrected 
for non-specific binding by using non-immune serum. Titers were 
determined graphically as the reciprocal of the dilution required 
to give 50% of the maximal absorbance. Maximal absorbances were 
obtained by application of low dilutions of antiserum, typically 
1:100 or 1:200. 
2.2.5 SDS-polyacrylamide gel electrophoresis 
SDS-polyacrylamide gel electrophoresis was performed in 10% 
or 10-18% (w/v) slab gels ( 0.8 mm thickness) containing 0.2% SDS 
(w/w) essentially according to Laemmli (1970). Samples 
containing 2-4 μg protein per μΐ water or PBS were solubilized at 
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room temperature, by addition of an equal volume of twice 
concentrated sample buffer consisting of 4% SDS, 15 mM DTE, 20% 
glycerol and 0.01% bromophenol blue in 100 mM Tris-HCl buffer (pH 
6.8). The gels were run at 15-20 mA for 4-6 hr and subsequently 
fixed for 1-2 hr in isopropanol/acetic acid/water (25:10:65, 
vol/vol) or directly used for electroblotting. The gels were 
stained at 60 C,for 30-60 min in methanol/water/acetic acid ( 
45:45:10) containing 3.5 g Coomassie blue R-250 per 100 ml and 
destained in water/acetic acid/methanol (875:75:50, vol/vol), for 
6-8 hr at 60 0C. 
The following molecular weight standards were used 
(Pharmacia,Uppsala, Sweden ) : Phosphorylase A (94 kD), bovine 
serum albumin (67 kD), ovalbumin (43 kD), carbonic anhydrase (30 
kD ), trypsin inhibitor (20.1 kD) and a-lactalbumin (14.4 kD). 
2.2.6 Immunoblotting 
Electrophoretic transfer of proteins from SDS-gels to 
nitrocellulose paper (Schleicher and Schuil BA 85, pore size 0.45 
um ) and subsequent immunodetection was carried out as described 
by Towbin et al.( 1979 ) and Burnette ( 1981 ). The buffer used 
for the electrophoretic transfer was 25 mM Tris-192 mM glycine 
containing 20% (v/v) methanol. A voltage of 6 V/cm was applied 
for 16-20 hr at 4 0C. Immediately after blotting the 
nitrocellulose filters were soaked in 20 mM Tris-HCl buffered 
saline, pH 7.5 (TBS), containing 3% gelatine, for 4-6 hr at room 
temperature to saturate additional protein binding sites. 
Subsequently the blots were incubated for 16 hr at room 
temperature, with antiserum at an appropriate dilution in TBS-1% 
gelatin and washed with three changes of the same buffer. 
Detection of the antigen-antibody complexes bound to the 
125 blots was performed by incubation with I protein A. 
Incubation of the blots was carried out for 90 min at room 
125 temperature with 0.5 //Ci/ml I protein A ( specific activity 
1.7 jUCi/ug) in a buffer consisting of 1% gelatine, 1% Triton 
X-100, 0.5% sodium deoxycholate, 0.1 mM PMSF and 0.15 M NaCl in 
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0.01 M Tris-HCl (pH 7.5, blot buffer ). The blots were washed 
with three changes of buffer and after drying of the blots for 20 
min at 60 0C an autoradiograph was prepared by exposure to 
Kodak X-Omat AR film for 48-72 hr at room temperature. 
Mannose containing glycoproteins were detected by incubation 
14 
with C-concanavalin A. Concanavalin A was labeled by 
14 
reductive methylation with C-formaldehyde ( Fretheim et al., 
1979; Jentoft and Dearborn, 1979). The blots were incubated with 
a solution containing 0.03 /tCi/ml C-concanavalin A ( 0.05 
μΟί/ηπιοΙ) in blot buffer for 2 hr at 4 0C. The blots were 
washed thrice with the same buffer, dried at 60 С and 
autoradiography was performed for 1-2 weeks at - 70 0C. 
2.2.7 Immunohistochemistry 
Immunofluorescence. Bovine retinas were fixed immediately 
post-mortem by pouring Bouin fluid (a mixture of picric acid, 37 
% formalin and glacial acetic acid; 15:5:1, v/v/v) in an eye-cup 
preparation obtained by removal of cornea, lens and vitreous. 
After fixation for 1 hr the posterior part of the eye was cut 
into small pieces of tissue and fixation was continued for 
another 3-4 hr. Subsequently the tissue blocks were dehydrated 
through a series of graded aceton and embedded in paraplast 
according to standard procedures. Sections of 3 μιη were mounted 
on glass-slides coated with chrome-alum gelatin ( 0.1 gr 
chrome-alum and 1 g gelatin per 100 ml distilled water). 
Before immunostaining the paraffin sections were dewaxed in 
xylene (2x10 min, room temperature). The sections were then 
incubated with an appropiate diliution of antiserum in PBS, 
containing 1% bovine serum albumin, either for 1 hr at room 
temperature or for 16 hr at 40C in a moist chamber. Following a 
rinse with PBS the sections were incubated incubated for 2 hr at 
room temperature with swine-anti rabbit immunoglobulins labeled 
with fluorescein isothiocyanate (Dako, Amsterdam, The 
Netherlands), diluted 1:200 in PBS-1% BSA. After rinsing with PBS 
the sections were mounted in a mixture of glycerin and PBS (1:1) 
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and examined in a Zeiss microscope equipped for fluorescence 
analysis. 
Immunogold labeling for electron microscopy. Bovine retina in 
an eye-cup preparation obtained as described above was fixed for 
1 hr at room temperature in 3% paraformaldehyde, 1% 
glutaraldehyde and 0.2 % picric acid in 0.1 M sodium cacodylate 
buffer, pH 7.4. Small tissue blocks containing choroid and retina 
were cut and fixation was prolonged for another 3 hr. The small 
blocks of tissue were dehydrated in graded series of ethanol and 
embedded in Lowicryl K4M resin (Polysciences, Warrington USA), 
essentially as described by Altman et al. (1984). The freshly 
prepared polymerization mixture consisted of 2 g monomer A, 13 g 
monomer В and 75 mg initiator. Infiltration with Lowicryl was 
carried out by gentle agitation, at room temperature, in 2:1 
ethanol:Lowicryl (1 hr), 1:1 ethanol:Lowicryl (1 hr), 1:2 
ethanol:Lowicryl (1 hr) and three changes of 100% Lowicryl for 1 
hr, 16hr and Ihr. Polymerization was performed by exposition to 
uv irradiation for 1 day at 4 0C followed by 3-4 days at room 
temperature. 
Thin sections (silver-gold) were cut with a diamond knife and 
were mounted on Formvar films supported by copper grids. The 
grids were floated sequentially on drops of diluted antiserum in 
PBS-1% BSA and 1 : 50 diluted goat-anti rabbit-gold 5 nm 
conjugate ( Janssen Pharmaceutica , Beerse, Belgium ) in TBS-1% 
BSA ( 20mM Tris-HCl, 0.9% NaCl, pH 8.2). Each of these 
incubations was performed for 1 hr and was followed by a rinse 
with PBS. For contrast enhancement the sections were then exposed 
for 2 min to osmium tetroxide vapour. Subsequently the sections 
were stained with aqeous uranyl acetate ( 3.3%) and lead citrate 
according to Reynolds (1963). The sections were examined in a 
Philips 301 electron microscope. 
48 
2.3 RESULTS 
2.3.1 Immunogenicity of different rhodopsin preparations 
Since most anti-(rhod)opsin antisera reported recognize 
membrane-bound (rhod)opsin (De Grip,1985) a thouroughly washed 
rod outer segment membrane preparation was used as test antigen 
in the ELISA. 
Development of the titers following immunization of rabbits 
with one of the four selected immunogens ( ROS, ROS-B, ROS-N and 
Rhod) is shown in Figure 2.1. For each of these immunogens the 
titers in the individual rabbits developed dissimilarly. The 
responses obtained after injection with ROS-B appeared more 
homogenous as compared to those obtained after injection with one 
of the other immunogens. In all animals a rise in titer by a 
factor of 2-8 was observed following the first booster injection. 
Most sera exhibited no further rise in titer after the second or 
third booster and the achieved, maximal level was maintained for 
several weeks. After 75-85 days the titer decreased by a factor 
of 2-4 in some animals. 
Only in two rabbits antibody titers exhibited an increase by 
a factor of 2-4 after repeated boosting. Moreover, this resulted 
in antisera with the highest titers. The antibody titers of the 
final bleedings demonstrate the large individual variation (Table 
2.1). 
Already after the first injection the responses were very 
heterogeneous (Table 2.1). No correlation was observed between 
the type of immunogen and the heighth of the titers obtained 
after one injection. 
For the experiments addressing the specificity of the 
antisera final bleedings were used. The sera were designated 
according to the immunogen applied and the number of the rabbit 
injected (Table 2.2). In each group the serum with the lowest 
titer was discarded. 
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Fig. ,1 Development of antibody titers of antisera raise 
immunization with four different types of rhod 
preparations. The rabbits received a dose of 0.1 
rhodopsin per injection. Booster injections 
indicated by arrows. The following immunogens 
injected: (a) Rod outer segment membranes (ROS), (b 
outer segment membranes solubilized in nonylgl 
(ROS-N), (c) rod outer segment membranes solubilize 
Barlox IOS (ROS-B) and (d) purified lipid-free rhod 
(Rhod). For each of the immunogens the rabbits 
numbered, as indicated. 
d by 
opsin 
5 mg 
are 
were 
) rod 
ucose 
d in 
opsin 
are 
50 
Table 2.1: Titers of antisera raised by immunization with various 
types of bovine rhodopsin preparations. 
Immunogen Rabbit 
After one Maximum Final 
injection bleeding 
ROS 1 1600 6400 3200 
2 8O0 3200 3200 
3 4O0 25600 25600 
ROS-B 1 B00 3200 800 
2 1600 3200 1600 
3 400 3200 3200 
4 400 3200 3200 
5 Θ00 3200 3200 
ROS-N 1 3200 6400 1600 
2 1600 3200 3200 
3 800 3200 800 
Rhod 1 3200 12800 X2800 
2 1600 3200 1600 
3 400 1600 800 
a
 ROS, rod outer segment membranes; ROS-B, rod outer segment 
membranes solubilized in Barlox IOS; ROS-N, rod outer 
segment membranes solubilized in nonylglucose; Rhod, 
, purified lipid-free rhodopsin. 
Titer is expressed as the reciprocal of the antiserum 
dilution which yielded 50% of maximal absorbance (ELISA-1). 
2.3.2 Specificity of the antisera 
The specificity of the obtained antisera was evaluated by 
immunoblotting and ELISA using various preparations of retinal 
proteins. 
Antisera were incubated with electroblots of SDS-gels 
containing total retina-homogenate, rod outer segment membranes, 
the soluble fraction of retina (ReSo) or S-antigen (Fig. 2.2 and 
2.3). Each of the antisera showed reaction with the opsin band in 
rod outer segment membranes and retina-homogenate, whereas no 
reaction was observed with any of the other retinal proteins 
(Fig. 2.2). However some antisera exhibited reaction with the 
S-antigen band (50 kD) both in the purified S-antigen preparation 
and in the mixture of soluble retinal proteins (ReSo, Fig. 2.3). 
Reaction with S-antigen present in retina-homogenate was probably 
not detected because of the relatively low amount present in this 
preparation. 
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In o rde r to de te rmine the r e l a t i v e r e a c t i v i t y of the a n t i s e r a 
towards S -an t igen as compared to t h a t towards ( r h o d ) o p s i n , 
an t ibody t i t e r s a g a i n s t the r e s p e c t i v e a n t i g e n s were measured 
with ELISA-2 (Table 2 . 2 ) . With ( rhod )ops in as t e s t a n t i g e n a good 
c o r r e l a t i o n was observed between the an t ibody t i t e r s de termined 
by ELISA-1 or ELISA-2, t he l a t t e r a ssay y i e l d i n g two to f o u r - f o l d 
h igher v a l u e s . Each of t he se ra e l i c i t e d a g a i n s t ROS-B or ROS-N 
e x h i b i t e d low but measurable t i t e r s a g a i n s t S - a n t i g e n . V i r t u a l l y 
no r e a c t i o n was d e t e c t a b l e between S -an t igen and anti-ROS or a n t i 
Rhod s e r a . These r e s u l t s q u a n t a t i v e l y suppor t the q u a l i t a t i v e 
r e s u l t s ob ta ined by immunoblo t t ing . 
Table 2.2: Reactivity of antisera with opsin and S-antigen 
Antiserum9 
anti-ROS-1 
anti-ROS-3 
anti-ROS-B-
anti-ROS-B-
anti-ROS-B-
anti-ROS-B-
anti-ROS-N-
anti-ROS-N-
anti-Rhod-] 
•2 
•3 
•4 
•5 
•1 
•2 
anti-Rhod-2 
ELISA-
3200 
25600 
1600 
3200 
3200 
3200 
1600 
3200 
12800 
1600 
ROS 
•Ie 
Test 
-mb 
ELISA-2C 
12800 
102400 
6400 
6400 
6400 
12800 
6400 
12800 
51200 
6400 
antigen 
ELISA-
L O 
40 
640 
320 
640 
320 
320 
640 
<10 
<10 
s-
•2C 
-antigen 
Immunoblotting' 
. 
-
_ 
+ 
+/-
+ 
+/-
+ 
. 
-
, Immunogen and number of the r a b b i t as in Table 2 . 1 . 
ROS, rod outer segment membranes. 
j T i t e r i s expressed as described in Table 1. 
+ c l ea r r e a c t i o n , + / - weak r e a c t i o n , - no r e a c t i o n . 
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2.3.3 Reaction with proteo ly t ic fragments of rhodopsin 
For a f i r s t analysis of the d i s t r i b u t i o n of ant igenic 
determinants over (rhod)opsin, a n t i s e r a were incubated with 
e l e c t r o b l o t s of SDS-gels containing p r o t e o l y t i c fragments of 
rhodopsin, obtained by digestion with proteinase К (ROS-PK) or 
thermolysin (ROS-Th). Fragments containing carbohydrate residues 
14 were i d e n t i f i e d by react ion with C-concanavalin A (Fig. 2.4, 
Table 2 .3) . The various ant i sera yielded s imilar r e s u l t s . All 
N-terminal carbohydrate containing fragments were immunopositive. 
The C-terminal fragment (12 to 13 kD; residue 240-330) and a 
central fragment lacking carbohydrate (8 kD; residue 140-240) 
were immunonegative. 
Table 2.3: Reactivity of anti-rhodopsin antisera with 
proteolytic fragments of rhodopsin 
Fragment3 Enzyme Presence of carbohydratec Immunoreactivity 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
Apparent molecular weight on SDS-gradient Polyacrylamide gels. 
Th = Thermolysin, PK = Proteinase K, - = no enzyme. 
с 14 
C-concanavalin A labeling on electroblots. 
Immunoblotting with antisera as in Table 2.2. 
36 
33 
25 
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16 
13 
13 
12 
θ 
-
Th 
Th,PK 
PK, Th 
PK 
PK 
Th 
PK 
PK 
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2.3.4 Immunohistochemistry 
With each of the antisera a similar pattern of 
immunofluorescent staining of sections of retina and choroid was 
observed (Fig. 2.5). Strong fluorescence was observed in the 
outer segment layer, while inner segment and outer nuclear layer 
were also stained, albeit to a lesser extent. Antisera with high 
titers showed a more intense staining of these layers as compared 
to sera with low antibody titers. No fluorescence was observed in 
other parts of retina or choroid with any of the antisera. 
Fig. 2.5 Immunofluorescence photomicrographs of bovine 
retina-choroid sections stained with anti-Rhod-1 (a) or 
non-immune serum (b). Dilution 1:200. Bar represents 50 
μη. 
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Lowicryl thin sections of retina were incubated with anti-
Rhod-1 and anti-ROS-3 (Fig. 2.6-2.7). The pattern of labeling 
with immunogold markers was similar for both antisera. Rod outer 
segments and some of the phagosomes in the retinal pigment 
epithelium exhibited intense immunolabeling, about 1200 
о 
particles/^m . Back-ground labeling was low, usually about 30 
2 
particles^m . Only faint, patchy labeling was observed at the 
level of the rod inner segment and connecting cilium. Due to the 
relatively poor preservation of ultrastructure and contrast in 
Lowicryl thin sections, the subcellular localization of 
immunolabeling could not be determined. Labeling of cone outer or 
inner segments or other parts of the retina was not observed in 
any of the experiments. 
Fig. 2.6 Lowicryl thin sections of bovine retina labeled with 
anti Rhod-1 and immunogold markers. (a) Rod outer 
segments and retinal pigment epithelium, (b) Detail of 
rod outer segments, (c) Detail of pigment epithelium. 
Note immunoreactivity in phagosomes. Bars represent 0.25 
μπι. 
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Fig. 2.7 Specificity of immunolabeling with anti Rhod-1 on 
lowicryl thin sections of retina: 
(a) overview , with corresponding magnifications of (b) 
rod outer segment, (c) rod inner segment (d) cone outer 
segment. Further shown are (e) cone inner segment and 
(f) a part of the outer nuclear layer. Bars represent 
0.25 /¿m. 
2.4 DISCUSSION 
2.4.1 Immunogenicity of rhodopsin 
Each of the four types of rhodopsin preparations induced a 
measurable humoral response against the rod visual pigment as 
determined by ELISA, immunoblotting and immunohistochemistry. No 
correlation was observed between the type of immunogen and the 
height of the elicited antibody titers. These results suggest 
that solubilization of rhodopsin in mild detergents does not 
affect its immunogenicity, and that purified preparations are 
suitable as immunogen. Over the last 2 years we have produced 
several batches of antisera with purified rhodopsin as immunogen, 
which have similar properties. 
2.4.2 Specificity of antisera 
Anti-ROS-B and anti-ROS-N antisera demonstrated low but 
measurable titers against S-antigen, probably due to the presence 
of low amounts of this highly immunogenic protein in these 
immunogens. This type of preparation contains about 0.5-1.0% of 
S-antigen as estimated by immunoblotting. However, no or only 
very low reactivity towards S-antigen was detectable in the 
anti-ROS antisera, although the same amount of S-antigen is 
present in the rod outer segment membrane preparation. For this 
phenomenon no explanation is available. Possibly the S-antigen 
present in the rod outer segment membrane preparation is less 
immunogenic due to interaction with (rhod)opsin,and 
solubilization in detergent will release S-antigen. 
The fact that all carbohydrate containing proteolytic 
fragments of rhodopsin were immun-opositive confirms earlier 
findings ( De Grip, 1985; Hargrave et al., 1986) that rhodopsin's 
amino terminal end forms a principal antigenic determinant. 
Further studies using purified proteolytic fragments or synthetic 
peptides are in progress in order to elucidate the exact 
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localization of the antigenic determinants for these antibodies . 
Prelimenary results suggest that the antibody population in these 
sera is directed against a similar set of antigenic sites, but 
that the distribution is different. The anti-Rhod-1 serum seems 
to have a lower proportion of anti-C-terminal directed 
antibodies. 
2.4.3 Immunohistochemical characterization 
The pattern of immunofluorescent staining of sections of 
bovine retina observed after incubation with the anti-bovine 
rhodopsin antisera is in accordance with results obtained before 
either with antisera (Dewey et al., 1969; Jan and Revel, 1974) or 
with monoclonal antibodies (Fekete and Barnstable, 1983). 
The inner segment staining, which most likely represents 
opsin in biosynthesis or on transport to the disk assembly site 
(Papermaster, 1982), is less intense than the outer segment 
staining because of the scattered antigen distribution, possibly 
in combination with a lower antigenicity as long as protein has 
not yet gone through the complete post-translational modification 
line. 
The general pattern of immunogold labeling of Lowicryl 
sections of bovine retina is in agreement with previous studies 
on mice (Jan and Revel, 1974), frog (Papermaster et al., 1978), 
chicken (Araki et al., 1984) and cattle (Hicks and Molday, 1986). 
Depending on the depth of penetration of the immunolabel the 
labeling density observed in the rod outer segments indicates 
that at most 10 % of the (rhod)opsin molecules has been labeled. 
Although the two immunohistochemical techniques applied 
cannot be compared on a quantitative basis, the staining of the 
inner segments appears to be relatively more intense by 
immunofluorescence than by immunogold labeling of retina. 
Presumably this reflects differences between the two methods with 
respect to fixative , embedding medium or thickness of the 
sections. 
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2.5 CONCLUSIONS 
Purified lipid-free rhodopsin solubilized in nonylglucose 
appears to be the most suitable preparation for the study of the 
immunopathogenicity of (rhod)opsin in experimental autoimmune 
uveoretinitis. This type of preparation combines a level of 
immunogenicity similar to that of the more native rod outer 
segment preparation, with the quality to induce a highly specific 
humoral immune response directed towards (rhod)opsin without any 
measurable response against other retinal proteins. 
Because of the lack of reaction with other retinal proteins, 
anti-ROS and anti-Rhod antisera are evidently useful for the 
study of the immunochemical cross-reactivity with other 
vertebrate rhodopsins as well as for the development of a 
quantitative ELISA. 
Finally, these sera are present a powerful tool in studies 
addressing the histochemical and ultrastructural localization of 
opsin-like immunoreactivity, both in retinal and extra-retinal 
photoreceptive tissue. 
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CHAPTER 3 
ENZYME-LINKED IMMUNOSORBENT ASSAY FOR QUANTITATIVE DETERMINATION 
OF THE VISUAL PIGMENT RHODOPSIN IN TOTAL-EYE EXTRACTS 
J.J. Schalken and W.J. De Grip 

3.1 INTRODUCTION 
Several radioimmunoassays for bovine rhodopsin have been 
described which allow quantitation of this protein in the 
sub-picomolar range (Mackenzie and Molday, 1982; Plantner et al., 
1982; Peterson et al., 1983; Schalken et al., 1983). For a recent 
review see De Grip (1985). As an alternative to the use of 
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I-iodinated antigens -a drawback, particularly when working 
in the dark is required- enzyme-linked immunoglobulins have found 
extensive application in immunoassays (Schuurs and Van Weemen, 
1982). To date no quantitative enzyme-linked immunosorbent assay 
(ELISA) of opsin has been reported, although this type of assay 
has been described for estimating rhodopsin antibodies 
(Papermaster, 1982). 
The assay we developed is a modification of the technique 
described by Voller, Bidwell and Bartlett (1979) using 
horseradish peroxidase conjugated to anti-rabbit immunoglobulins. 
It is rapid, easy to perform and has a sensitivity comparable to 
the radioimmunoassay of bovine (rhod)opsin. 
The sensitivity of the assay was optimized with respect to 
amount of coating antigen and to serum and conjugate dilutions. 
Various types of bovine rhodopsin preparations were tested as 
inhibitory and coating antigen. Because of considerable 
cross-reactivity of the antiserum with opsin from different 
species as well as its high specificity, the assay can easily be 
adapted to the determination of opsin contents in crude eye 
extracts from a variety of species with a sensitivity comparable 
to that for bovine opsin. 
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3.2 MATERIALS AND METHODS 
3.2.1 Materials 
Polystyrene, 96-well flat-bottom microtiter plates were 
obtained from Flow Lab (Amsterdam, The Netherlands), swine anti-
rabbit immunoglobulin conjugated to horse-radish peroxidase from 
Dako (Amsterdam, The Netherlands) and o-phenylenediamine, 
Ammonyx LO, Emulphogene BC-720 and bovine serum albumin from 
Sigma (St Louis, USA). 
Bovine rod outer segment membranes were prepared and stored 
as decribed by De Grip et al. (1980). The final preparation 
contains 50-75 nmol rhodopsin per ml with an A280:A500 ratio of 
2.1-2.2. 
Opsin standards were prepared by illumination of extracts of 
rod outer segment membranes (30-40 nmol per ml) in 0.02 M 
phosphate buffered saline containing 1 % Ammonyx LO, folowed by a 
dilution to final concentrations ranging from 0.001-10.0 pmol 
opsin in 50 μΐ assay buffer (0.02 M phosphate buffered saline 
containing 0.1 % bovine serum albumin and 0.01 % Ammonyx LO, pH 
7.4). 
(Rhod)opsin was extracted from retinas (bovine, monkey or 
human) or from whole eyes (rat, mouse and quail) of dark-adapted 
animals as follows: the retinas or eyes were homogenized in 0.02 
M phosphate-buffered saline containing 1 % Ammonyx LO (0.05-0.5 
ml per eye or retina, depending on rhodopsin concentration). 
After gentle rotating overnight at 40C, the samples were 
centrifuged (30 min, 15,000 g) to remove debris. The rhodopsin 
concentration was measured spectrophotometrically and the samples 
diluted appropriately for calibration of the inhibition 
enzyme-linked immunosorbent assay. Under our conditions bovine 
retinas contain maximally 5% opsin (De Grip et al., 1980), which 
is within the experimental error of the assay. 
Antiserum against dark-adapted, Barlox 10S-solubilized, rod 
outer segment membranes is obtained as described before (section 
2.2; Margry et al., 1983). The antiserum is monospecific for 
68 
opsin since no binding to other ocular proteins is observed upon 
SDS-polyacrylamide gel electrophoresis and Western bloting 
(Burnette, 1981) of whole eye homogenates. More specifically, no 
reaction could be detected with the interphotoreceptor retinoid 
binding protein (IRBP) and S-antigen (the 48 kD protein). 
3.2.2 Antibody titration assay 
Coating of polystyrene wells with antigen was performed by 
incubation for 16 hr at 4 С with bovine rod outer segment 
membranes suspended in 0.02 M phosphate buffered saline (150 μΐ) 
or with the same volume of crude extracts of whole retina or eyes 
diluted to a detergent concentration below 0.01 % in the same 
buffer. The wells were washed three times with assay buffer. 
Subseguent titration with antibodies and the detection of 
antigen-bound antibody were carried out at room temperature 
essentially as described by Papermaster et al. (1982). A serial 
dilution of antiserum in assay buffer (100 μΐ) was added to the 
wells and incubated for 1 hr. The wells were washed (5 times) 
followed by an 1 hr incubation with 100 μΐ of 1:2000 diluted 
swine anti-rabbit immunoglobulins conjugated to horse-raddish 
peroxidase. After washing (5 times), the bound peroxidase was 
assyed enzymatically with o-phenylenediamine (100 μΐ per well of 
a solution containing 40 mg o-phenylenediamine, 40 μΐ 30 % 
H-O. per 100 ml of 0.1 M citrate-phosphate buffer, pH 5.0). 
After 30 min the reaction was stopped by adding 100 μΐ 2 M 
H_SO. and the absorbance is measured at 492 nm with a 2 4 
Titertek Multiskan photometer. Antibody titration curves are 
constructed by a semilog plot of the resulting absorbance at 492 
nm vs. the corresponding dilution of antiserum. 
3.2.3 Antigen inhibition assay 
Duplicates of the following mixtures were incubated for 1 hr 
at room temperature in wells coated with opsin: 50 μΐ of a 
69 
previous determined dilution of antibody in assay buffer together 
with 50 μΐ of opsin in assay buffer, containing either between 
0.001 and 10 pmol opsin for the calibration curve or between 0.2 
and 2.0 pmol opsin for the unknown sample. An antibody dilution 
was chosen from the antibody titration assay which resulted in 70 
% of the maximal absorbance. The plates were washed (3 times) and 
the relative amount of antibody bound was determined as described 
above. Inhibition (calibration) curves were constructed by a 
semi-log plot of the percentage of maximal absorbance (obtained 
with no inhibiting antigen present) vs. the amount of opsin 
added. The latter was calculated from the spectroscopic assay, 
taking the dilution factor into account. All absorbance values 
were corrected for non-specific binding using non-immune serum 
(usually less than 4 % of the maximal value) 
In the preincubation mode the antigen-antibody mixtures were 
pre-incubated for 1 hr at room temperature. This is performed in 
wells which are coated with 2 % bovine serum albumin to prevent 
non-specific adsorption. Subsequently 100 μΐ of the reaction 
mixtures were incubated for another hour in wells coated with 
opsin and the procedure described above is followed. 
3.3 RESULTS AND DISCUSSION 
3.3.1 Coating conditions 
We made the important observation that the optimal working 
range (0.2-1.5 O.D. at 492 nm) and the sensitivity of the ELISA 
were dependent on a parameter, related to the coating of the 
antigen to the polystyrene wall, the coating efficiency (Fig. 
3.1). The concentration of opsin which (either in the form of 
solubilized or in the form of non-solubilized bovine rod outer 
segment membranes), will yield optimal coating efficiency is 
experimentally determined by performing the antibody titration 
assay on coatings obtained with a range of opsin concentrations. 
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The maximal absorbance thus obtained indicates whether different 
coating procedures are comparable. 
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Fig. 3.1 Dependence of coating efficiency on concentration of 
opsin and detergent in coating solution. Two types of 
bovine rod outer segment membrane preparations are used 
for coating: (1) membranes suspended in phosphate 
buffered saline ( Π ) ; (2) membranes solubilized in 1 % 
Ammonyx LO and than diluted to 0.01 % detergent (625 
pmol opsin/ml). The latter solution is further diluted, 
either with phosphate buffered saline containing 0.01 % 
Ammonyx LO ( О ) , or with buffer ( · ) . Subseguently an 
antibody titration is performed against the three types 
of coating. The maximal absorbance at 492 nm obtained in 
this assay is plotted against the opsin concentration in 
the coating solution. Absorbance values at 492 nm above 
2.0 OD units are calculated from the absorbance measured 
at 450 nm. 
Coating with a photoreceptor membrane suspension yields very 
satisfactory results. Suitable absorbance values are obtained for 
a concentration range of 25-60 pmol of opsin per ml (Fig. 
3.1,Π )· Upon solubilization of photoreceptor membranes in 1 % 
detergent solution (Emulphogene or Ammonyx LO), and dilution with 
phosphate buffered saline to 0.01 % detergent, low coating 
efficiences are attained (Fig. 3.1, О ). However, when the 
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membranes a r e s o l u b i l i z e d in 1% Emulphogene or Ammonyx LO and t h e 
s o l u t i o n i s s u b s e q u e n t l y d i l u t e d in p h o s p h a t e buf fered s a l i n e t o 
0.001 % in d e t e r g e n t or l e s s , very e f f i c i e n t c o a t i n g i s achieved 
a t much lower o p s i n c o n c e n t r a t i o n s than r e q u i r e d with the rod 
o u t e r segment membrane s u s p e n s i o n ( F i g . 3 . 1 , · ) . The i m p o r t a n t 
f e a t u r e of t h i s p r o c e d u r e i s t h a t i t a l lows c o a t i n g with 
d e t e r g e n t e x t r a c t s of whole r e t i n a or e n t i r e e y e s . Using t h r e e 
d i f f e r e n t t y p e s of bovine o p s i n p r e p a r a t i o n s for c o a t i n g , (1) 
s o l u b i l i z e d or (2) n o n - s o l u b i l i z e d rod o u t e r segment membranes or 
(3) crude r e t i n a e x t r a c t s , comparable t i t r a t i o n curves a r e 
o b t a i n e d with only a s l i g h t d e c r e a s e in t i t e r (Table 3 . 1 ) . This 
i n d i c a t e s t h a t the a n t i s e r u m has a s i m i l a r a f f i n i t y for t h e s e 
t h r e e t y p e s of ops in c o a t i n g . Hence, t h e high s p e c i f i c i t y of t h e 
a n t i s e r u m for o p s i n a l l o w s c o a t i n g with crude r e t i n a l e x t r a c t s , 
t h e r e b y o b v i a t i n g t h e l a b o r i o u s i s o l a t i o n of p h o t o r e c e p t o r 
membranes. 
Table 3.1: Comparison of antibody t i t e r s using different types 
of bovine opsin preparations for coating 
Coat 
Source of 
antigen 
ROS 
ROS-A 
Retina 
ing procedure 
Detergent 
solubilized 
+ 
+ 
Rhodopsin 
concentration 
(pmol/ml) 
60 
5 
5 
Titer 
25600 
12800-25600 
12800 
Coating with bovine opsin i s performed using three kinds 
of p r e p a r a t i o n s : ROS, rod outer segment membranes; 
ROS-Α, rod outer segment membranes s o l u b i l i z e d in 1 % 
Ammonyx LO followed by a 1000-fold d i l u t i o n with buffer; 
Ret ina , r e t i n a l homogenate s o l u b i l i z e d in 1 % Ammonyx LO 
and d i l u t e d as with ROS-Α. An antibody t i t r a t i o n assay 
with the same ant iserum i s performed a g a i n s t these t h r e e 
types of c o a t i n g . The t i t e r i s expressed as the 
r e c i p r o c a l of the antiserum d i l u t i o n which gives 50 % of 
maximal absorbance a t 492 nm. 
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In order to t e s t t h i s approach fur ther , as well as to check 
the c r o s s - r e a c t i v i t y of the antiserum with opsins of d i f ferent 
species , coating with crude ex t rac t s e i the r of human or monkey 
re t ina or of whole eyes of r a t , mouse and quai l has been 
invest igated (Table 3 .2) . I t appears that the procedure works 
equally well for a l l these e x t r a c t s . Furthermore, the 
small reduction in antibody t i t e r measured for other species 
indicates considerable c ros s - r eac t iv i t y of the antiserum with 
opsin of these spec ies . The order in c r o s s - r e a c t i v i t y derived 
from the t i t e r i s as follows: bovine > mouse, ra t > monkey, man > 
qua i l . 
Table 3 . 2 : S u i t a b i l i t y of an t i -bov ine rhodopsin serum to de t ec t 
opsin of other s p e c i e s . 
Species 
Cattle 
Mouse 
Rat 
Monkey 
Man 
Quail 
Source 
coating 
Retina 
Eye 
Eye 
Retina 
Retina 
Eye 
of 
antigen 
Titer 
12800 
6400-12800 
6400-12800 
6400 
6400 
3200 
Antibody t i t r a t i o n assays performed aga ins t opsin from 
var ious spec ies as coat ing a n t i g e n . Retina or ocu la r e x t r a c t s 
in 1 % Ammonyx LO are used for coa t ing , a f t e r d i l u t i o n with 
buffer to a f i n a l concent ra t ion of ca . 5 pmol/ml in opsin and 
0.001 % in de t e rgen t . The t i t e r i s expressed as the 
r e c i p r o c a l of the antiserum d i l u t i o n which gives 50 % of 
maximal absorbance. 
3.3.2 Antigen inhibi ton assay using bovine rod outer segment 
membranes 
The antibody assay can be converted in to an antigen assay by 
including soluble antigen at a fixed antibody d i l u t i o n . The 
s e n s i t i v i t y of such an assay i s defined as the amount of added 
inhibi tory antigen giving 85 % of maximal absorbance. The assay 
was optimized with respect to coating concentration and the 
effect of preincubation of antigen and antibody (Fig. 3 .2) . 
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Highest sensitivity, i.e. 0.04 pmol of opsin per well, is 
achieved by including a preincubation step and by coating with a 
rod outer segment membrane suspension containing ca. 25 pmol of 
opsin per ml. This sensitivity approaches that of the 
radioimmunoassay we developed recently (0.01 pmol opsin per tube, 
Schalken et al., 1983). It is, however, somewhat better than that 
of several radioimmunoassays described elsewhere (0.1 pmol of 
opsin per tube; cf. Mackenzie and Molday, 1982; Plantner et al., 
1982; Peterson et al., 1983). By preincubation of the 
antigen-antibody mixtures the sensitivity of the assay is 
increased two-fold but the assay becomes somewhat more 
time-consuming. 
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3.3.3 Antigen inhibiton assay using retina or eye extracts 
When a bovine retina extract is used as the source for 
inhibitory antigen (opsin), an inhibition curve results which 
completely coincides with that of solubilized rod outer segment 
membranes purified by density centrifugation (not shown). Thus, 
the assay of opsin does not require previous isolation and 
purification of rod outer segment membranes. 
Extracts of eyes of several species (mouse, rat, men, quail) 
inhibit the binding of the anti-bovine antibody to the 
solid-phase bound bovine antigen up to 50-60 % (Fig. 3.3, · ). 
This indicates only partial cross-reactivity with opsin from 
these species in agreement with the results of the antibody 
titration assay. This limits the usefulness of the assay for 
other species. However, we reasoned we could recover the full 
working range of the assay (0-100 %) by using opsin of the 
corresponding species for coating. Therefore, a combination of 
both coating and inhibition with opsin from ocular extracts of 
the same species was investigated. The extracts indeed did 
inhibit the antibody binding to the corresponding solid-phase 
bound antigen up to 100 %, as shown for mouse in Fig. 3.3 
(O). Furthermore, the sensitivity of the inhibition assay for 
opsin from mouse, rat and quail is in the same order as that for 
bovine opsin viz. 0.05-0.1 pmol per well. This feature of high 
cross-reactivity between different opsins considerably expands 
the potential of a highly monospecific antiserum raised against 
bovine opsin. 
The assay for mouse opsin has already enabled us to 
quantitate the minute amounts" of opsin present in eyes of 
rds-mutant mice, which lack photoreceptor outer segments 
(Schalken et al., 1985). The assay for quail opsin has allowed us 
to quantitate the amount of visual pigment in the quail pineal 
gland as opsin equivalents (Foster and Schalken, in preparation). 
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Fig. 3.3 Antigen inhibition curves using bovine or mouse opsin as 
coating and/or inhibition antigen. Inhibition of 
antibody binding to coating antigen is performed (a) 
with solubilized bovine rod outer segment membranes vs. 
coated bovine rod outer segments ( Π , complete 
inhibition), (b) with mouse eye extracts vs. coated 
bovine rod outer segment membranes ( · , partial 
inhibition) or (c) with mouse eye extracts vs. coated 
mouse eye extracts (O, complete inhibiton). The assay 
was performed in the presence of 0.01 % Ammonyx LO. The 
percentage of maximal absorbance at 492 nm is plotted 
semi-logarithmically against the amount of opsin added. 
3.3.4 Detergent concentration 
In order to achieve optimal sensitivity in the ELISA, the 
detergent concentration in the assay should be reduced to or 
below 0.01 %. Since complete extraction of whole eyes requires a 
detergent concentration of at least 1 % (Fong et al., 1982; 
Schalken et al., 1985), the assay of such extracts requires a 
100-fold dilution with buffer. At very low (rhod)opsin levels, 
the (rhod)opsin concentration in the diluted extract may then be 
reduced below the detection level of the ELISA (0.04 pmol per 50 
μΐ ). In the hope of minizing this drawback, we investigated 
whether increasing Emulphogene or Ammonyx LO concentrations would 
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affect the sensitivity of the ELISA. We observed that, upon using 
photoreceptor membranes for coating, the maximum detergent 
concentration tolerated in the assay is about 0.02 %. Higher 
concentrations are completely unworkable, probably because they 
dissolve and/or mask the membrane coating. However, upon coating 
with diluted detergent extracts,whether obtained from purified 
photoreceptor membranes or from entire eyes, detergent 
concentrations up to 1 % can be tolerated with only a slight loss 
in sensitivity (working range 0.25-5 pmol per sample, Fig. 3.4). 
rh 
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Fig. 3.4 Working range of inhibition assay as a function of 
concentration of detergent. The effect of the detergent 
concentration in the assay buffer on working range and 
reproducibility of the inhibition assay is investigated 
by performing the assay in the presence of various 
detergent concentrations. Coating is carried out with 
solubilized rod outer segment membranes (5 pmol of opsin 
per ml, 0.001 % Ammonyx LO). As inhibitory antigen rod 
outer segment membranes have been used, which are 
solubilized in 1 % Ammonyx LO . The resulting solution 
is subsequently diluted with phosphate buffered saline 
to the specified detergent concentration. (The same 
detergent concentration is present during the 
preincubation and inhibition phase). From the resulting 
inhibiton curves the working range is calculated as 
follows. The lower limit represents the amount of opsin 
which decreases the binding to 85 % of the maximal level 
(hatched bars; mean + S.E). The upper limit represents 
the amount of opsin which leaves 15 % of maximal binding 
(open bars; mean + S.E.). The limits are averaged for 
three specified ranges in detergent concentration (n 
3-5). 
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Under these conditions, opsin levels as low as 5 pmol/g wet 
tissue can still be detected. Although Ammonyx LO was used 
throughout, preliminary experiments suggest that Emulphogene ВС 
720 and sodium dodecyl sulfate yield similar results. The use of 
detergent concentrations above 0.1 % occasionally gives erroneous 
results, which manifest themselves in high non-specific binding 
and/or lack of inhibition. The coating is probably the critical 
factor and should be performed with great care. 
3.4 CONCLUSIONS 
An enzyme-linked immunosorbent assay for the visual pigment 
(rhod)opsin is presented which is rapid, easy to perform, allows 
detergent concentrations up to 1 %, and has a sensitivity for 
bovine opsin similar to reported radioimmunoassays. Rhodopsin can 
be assayed after conversion into opsin by illumination. The 
apoprotein opsin can be quantitated using standards prepared by 
illumination of spectrophotometrically determined amounts of 
rhodopsin. The developed immunoassay is superior to the tedious 
opsin determination by regeneration with 11-cis retinal. 
(Rhod)opsin in crude bovine retnal extracts can be measured 
without interference of other retinal compounds. Hence, 
(rhod)opsin determination does not require isolation of rod outer 
segment membranes. 
The assay can easily be adapted to different kinds of 
(rhod)opsin preparations from a variety of species, using 
these preparations both as coating and as inhibitory antigen. 
Quantitative inhibition assays using ocular extracts from mouse, 
rat and quail have already been developed. They show 
sensitivities similar to that for bovine opsin (0.05-0.1 pmol per 
well), without the need for purification of the antigen. 
Such a versatile immunoassay will be of considerable value in 
quantitation of the rod like visual pigment content of 
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photosensitive tissues of a range of species, epecially in cases 
in which spectrophotometry is not sensitive enough or not 
applicable because samples have been illuminated or thermally 
denatured. 
The combination of a monospecific antiserum and a highly 
conserved antigen might present an in general valuable approach 
to develop quantitative multispecies immunoassays. This will 
permit assay of the antigen in crude tissue extracts using 
antiserum elicited against that species which is experimentally 
accessible. 

CHAPTER 4 
IMMUNOLOGICAL RELATIONSHIP BETWEEN VERTEBRATE RHODOPSINS 
AS DETECTED BY ANTI-BOVINE RHODOPSIN ANTISERA 
J.J. Schalken, R.G.J. Rutten and W.J. De Grip 

4.1 INTRODUCTION 
Antigens which play an important role in pathogenic 
autoimmune processes are usually characterized by limited species 
specificity (Gery et al., 1986). Hence, in the context of our 
studies on the potential of (rhod)opsin as autoantigen in 
experimental autoimmune uveoretinitis, information on the degree 
of species specificity of (rhod)opsin would be valuable. In 
addition, the degree of species specificity will determine to 
what extent anti-bovine (rhod)opsin antisera can be used in 
multi-species immunoassays. 
Information on the homology between (rhod)opsins of different 
species is limited. Spectral properties and bleaching sequence of 
(rhod)opsins from various vertebrate species extensively have 
been studied and are highly similar (Ostroy, 1977; Cresciteli!, 
1972; Cresciteli!, 1985). However this only indicates that 
essential elements of the protein structure are functionally 
highly conserved. The difference in thermal stability between 
vertebrate (rhod)opsins in detergent solution (Fong et al., 1982) 
indicates that structural differences, which should reflect 
differences in amino acid sequence, do exist. Up till now the 
complete amino-acid sequence of bovine and of human (rhod)opsin 
has been established (Ovchinikov, 1982; Hargrave et al., 1983, 
Nathans and Hogness, 1984). These data indicate a high degree of 
homology. Human (rhod)opsin has the same length (348 residues) as 
bovine (rhod)opsin, and is 93.4% homologous with the bovine 
visual pigment. 
In general, the degree of cross-reactivity of polyclonal 
antisera with related proteins depends on the relative number of 
amino acid substitutions or 'evolutionary distance' between these 
proteins (Benjamin et al., 1984). The specificity of a monoclonal 
antibody is not related to this distance, because it recognizes 
only a single site and does not average over a number of 
determinants. 
Studies on the cross-reactivity of anti-bovine (rhod)opsin 
monoclonal antibodies with (rhod)opsins of various mammalian 
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species demonstrate that the C-terminal end of (rhod)opsin is 
highly conserved. In fact, these antibodies even cross-react with 
frog (rhod)opsin (MacKenzie et al., 1984). Information on the 
cross-reactivity of polyclonal anti-(rhod)opsin antisera with 
other vertebrate visual pigments is as yet limited (De Grip, 
1985). 
In order to investigate the potential of a quantitative 
multi-species enzyme-linked immunosorbent assay, we have 
previously studied the cross-reactivity of an anti-bovine 
rhodopsin serum elicited against photoreceptor membranes 
solubilized in detergent (Barlox IOS, chapter 3). Antibody 
titration was performed against a coating of retinal- or 
eye-extracts of various species. A reduction in antiserum titer 
relative to the one obtained against the original inmmunogen 
(bovine (rhod)opsin), indicates a reduction in antibody avidity 
for that respective species. For the species investigated (rat, 
mouse, monkey, man and quail), a reduction in titer of only two 
to four fold was measured, which indicates a considerable degree 
of cross-reactivity. The antibody titer, however, only provides 
global information. More direct information can be extracted from 
an antigen inhibition assay, where the competetive potential of 
(rhod)opsins of various species as inhibiting antigen is measured 
against the original immunogen, bovine (rhod)opsin. With respect 
to the antiserum investigated in chapter 3 this was carried out 
for only one species (mouse). 
In this chapter the study of the cross-reactivity of 
anti-bovine rhodopsin antisera with vertebrate (rhod)opsins is 
extended by including additional species covering a larger range 
of classes of vertebrates (Table 4.2) and by evaluating four 
antisera elicited against various types of bovine rhodopsin ( rod 
outer segment membranes, purified lipid-free rhodopsin in 
nonylglucose, rod outer segment membranes solubilized in either 
nonylglucose or in Barlox IOS). Generation and characterization 
of these sera is described in chapter 2. These sera are 
investigated since the micro-environment of rhodopsin (membrane, 
, detergent) does influence its structural properties and hence 
may influence its antigenic properties. Different states of 
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rhodopsin might elicit a different population of antibodies which 
show a different kind of cross-reactivity profile. 
From the inhibition curves we have derived two sets of data 
to compare the various species: 1. The concentration of 
inhibiting antigen required to give 50 % inhibition (C-50). 2. 
The maximal percentage of inhibition achieved at an excess of 
inhibitory antigen. The latter was routinely determined at 10 
pmol opsin per well, which is 5-10 fold the concentration 
of bovine opsin required to get 100 % inhibition. The C-50 of the 
inhibiting opsin relative to bovine opsin, is a measure for the 
relative average affinity of the antiserum for that particular 
species. The maximal percentage of inhibition provides the 
fraction of the antibody population which is able to bind the 
"other" opsin. 
Since this type of ELISA-analyses requires that the antiserum 
used is monospecific for (rhod)opsin, all species were examined 
by immunoblotting. Finally, cross-reactivity of the antisera with 
photoreceptors of selected species, representative of various 
classes of vertebrates, was investigated by means of 
immunohistochemistry (immunofluorescence). 
4.2 MATERIALS AND METHODS 
4.2.1 Preparation of antigens 
Eyes of the following vertebrate species were used: 
1. Mammals: cattle (Bos taurus), sheep (Ovis aries), mouse 
(Mus musculus), rat (Rattus norvegicus), monkey (Macaca mulatta) 
and man (Homo sapiens). 
2. Birds: chicken (Gallus gallus) and Japanese quail (Coturnix 
coturnix). 
3. Reptile: gekko (Gekko gecko). 
4. Amphibian: xenopus (Xenopus laevis). 
5. Fish (Teleostei): roach (Rutilus rutilus) and trout (Salmo 
85 
trutta farlo). 
Bovine rod outer segment membranes were prepared as described 
in section 2.2. 
For extraction of the various rhodopsins eyes were enucleated 
after dark-adaptation of the animals for 16 hr. Only the human 
eye could not be dark-adapted. Retinas of cattle, sheep, monkey 
and man, or whole eyes of the other species were homogenized in 
0.02 M phosphate buffered saline pH 7.4 (PBS) and after gentle 
mixing for 30 min at 40C the samples were centrifuged (30 
min, 15,000 g, 4 0C). The pellets were resuspended in PBS 
containing 1% Ammonyx LO ( 0.05-0.5 ml per eye or retina, 
depending on the rhodopsin concentration), gently mixed for 16 
hr at 4 С to extract the rhodopsin and centrifuged (15,000 , 
30 min, 4 0c) to remove unsoluble material. The pellets were 
discarded and the rhodopsin concentration in the supernatant was 
determined by absorbance spectroscopy. 
All procedures involving rhodopsin were carried out under dim 
red light ( Л> 620 nm). Opsin was prepared just before use by 
illumination under standard conditions (section 2.2). 
4.2.2 Antisera 
Antisera were obtained by immunization with various types of 
bovine rhodopsin preparations (Table 4.1). The generation and 
characterization of three sera (anti-ROS-3, anti-ROS-N-2 and 
anti-Rhod-1) is described in chapter 2. The fourth antiserum, 
anti-ROS-B-6, was elicited with rod outer segment membranes 
solubilized in Barlox 10S as immunogen, analogous to the 
anti-ROS-B sera described in chapter 2. 
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Table 4 . 1 : Spec i f i c a t i ons of an t i -bov ine rhodopsin a n t i s e r a used 
in t h i s s tudy. 
Antiserum Immunogen t i t e r 
anti-ROS-3 rod outer segment membranes (ROS) 25600 
anti-ROS-N-2 ROS s o l u b i l i z e d in nonylglucuse 3200 
ant i -Rhod-1 p u r i f i e d , l i p i d - f r e e rhodopsin 12800 
anti-ROS-B-6 ROS solubul ized in Barlox 10S 25600 
aThe a n t i s e r a a re labeled a f t e r the immunogen and the number 
.of the r a b b i t , as in Table 2.2 
T i t e r as determined with ELISA ( sec t ion 2 . 2 ) . I t i s 
expressed as the r ec ip roca l of the d i l u t i o n of antiserum 
which r e s u l t e d in 50 % of maximal absorbance, using 
i l lumina ted bovine rod outer segment membranes (60 pmol per 
ml, on the bas i s of rhodopsin) as coat ing an t igen . 
4 . 2 . 3 Immunoassays 
G e l - e l e c t r o p h o r e s i s , i m m u n o b l o t t i n g and ELISA ( t y p e 1 : 
a n t i b o d y t i t r a t i o n mode and a n t i g e n i n h i b i t i o n mode) were 
p e r f o r m e d a s d e s c r i b e d i n s e c t i o n 2 . 2 . T h e s e p r o c e d u r e s c o u l d be 
p e r f o r m e d i n t h e l i g h t s i n c e o p s i n p r e p a r a t i o n s were u s e d f o r 
c o a t i n g and i n h i b i t i o n . 
4 . 2 . 4 I m m u n o f l u o r e s c e n c e 
I m m u n o f l u o r e s c e n c e was p e r f o r m e d on B o u i n - f i x e d , p a r a p l a s t 
embedded , 3-5 /m s e c t i o n s of r e t i n a ( c a t t l e ) o r w h o le e y e . A f t e r 
30 mm of f i x a t i o n t h e l e n s was removed from t h e e y e and f i x a t i o n 
was t h e n c o n t i n u e d f o r 3-4 h r . I n c u b a t i o n w i t h a n t i s e r u m and 
s w i n e - a n t i - r a b b i t / F I T C and e x a m i n a t i o n of t h e s e c t i o n s was 
c a r r i e d o u t a s d e s c r i b e d i n s e c t i o n 2 . 2 . 
87 
4.3 RESULTS 
4.3.1 Immunoblotting 
Electroblots of SDS-gels containing extracts of eyes or 
retinas of several species were incubated with anti-Rhod-1 or 
anti-ROS-B-6. Both antisera yielded a similar pattern of 
immunostaining (Fig. 4.1). In most preparations a band of 38-40 
kD was recognized, representing interaction with opsin. No or 
only very weak staining of other bands was detectable. In the 
preparation of the trout-eye a band of a somewhat higher 
molecular weight (42-44 kD) was stained. 
4.3.2 Antibody titration 
Antibody titration was performed after coating with detergent 
extracts of retina or eye (Table 4.2). For each of the species 
the coating was optimized in previous experiments. The coating 
efficiency depended on the concentration of antigen as well as on 
the amount of detergent (section 3.3). The following 
concentrations were applied: 0.15 nmol for cattle and sheep 
retina, and 2.5-7.5 pmol for the eyes and monkey retina (opsin 
protein per ml PBS; final detergent concentration 0.00125-0.005 
% ) . 
All antisera exhibited considerable cross-reactivity with the 
vertebrate opsin preparations tested (Table 4.2). The order of 
cross-reactivity derived from the titers yield a similar pattern 
for all four sera: cattle > sheep, mouse, rat, man, xenopus > 
monkey, trout > chicken, quail, gekko. 
Fig. 4.1: Specificity of anti-Rhod-1, evaluated by immunoblotting 
of retinal or ocular extracts of various vertebrate 
species. (A) Coomassie blue stained 10-18 % (w/v) 
SDS-polyacrylamide gradient gel containing extracts of 
cattle (1), mouse (2), monkey (3), man (4), sheep (5), 
xenopus (6) and trout (7), 0.02-0.06 nmoles opsin per 
lane. Molecular weight standards as indicated. (B) 
Corresponding electroblot incubated with 1:500 diluted 
anti-Rhod-1. 
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MW 1 2 3 4 5 6 7 
2 Π Ί MMÉte 
1 4 . 4 
^ ^ ^ 
1 2 3 4 5 6 7 
Table 4.2: Cross-reactivity of anti-bovine rhodopsin antisera 
with vertebrate opsins determined by antibody 
t i t r a t i o n . 
Species Antiserum t i t e r ' 
anti ROS-3 anti ROS-B-6 anti ROS-N-2 anti Rhod-1 
Cattle 
Sheep 
Mouse 
Rat 
Man 
Monkey 
Xenopus 
Trout 
Gekko 
Chicken 
Quail 
12800 
3200 ι 
3200 ι 
3200 ι 
3200 ι 
1600 1 
1600 1 
1600 1 
1600 ι 
1600 ι 
1600 I 
(.25) 
(.25) 
(.25) 
(.25) 
(.13) 
(.13) 
(.13) 
1.13) 
(.13) 
(.13) 
25600 
6400 1 
6400 1 
3200 1 
3200 1 
3200 1 
6400 I 
3200 1 
3200 1 
1600 1 
3200 1 
(.25) 
(.25) 
(.13) 
(.13) 
(.13) 
:.25) 
:.i3) 
;.i3) 
:.об) 
;.із) 
3200 
1600 ι 
1600 1 
1600 ι 
1600 1 
800 1 
1600 1 
800 1 
400 1 
400 1 
400 1 
1.5) 
(.5) 
(.5) 
(.5) 
(.25) 
(.5) 
(.25) 
(.13) 
(.13) 
(.13) 
12800 
3200 1 
3200 1 
3200 1 
3200 1 
1600 1 
3200 ( 
1600 1 
1600 1 
1600 1 
1600 1 
: .25) 
(.25) 
(.25) 
:.25) 
:.i3) 
:.із) 
:.із) 
;.із) 
;.із) 
:.із) 
For c a t t l e , sheep, monkey and man ret ina was the source 
, of antigen, for the other species whole eyes were used. 
Titer i s expressed as the reciprocal of the dilution of ant i ­
serum which resulted in 50% of maximal absorbance. 
Values in parentheses are normalized with respect to bovine 
ops in . 
4 . 3 . 3 Antigen i n h i b i t i o n 
The c r o s s - r e a c t i v i t y p r o f i l e of two a n t i s e r a with a high 
t i t e r ( a n t i - R h o d - 1 and anti-ROS-B-6) was a n a l y z e d in more d e t a i l 
by means of t h e ELISA in the i n h i b i t i o n mode. These a n t i g e n 
i n h i b i t i o n a s s a y s were performed with bovine rod o u t e r segment 
membranes s o l u b i l i z e d in Ammonyx LO as c o a t i n g a n t i g e n and 
e x t r a c t s of r e t i n a or eye from v a r i o u s s p e c i e s as i n h i b i t i n g 
a n t i g e n . Optimal d i l u t i o n of a n t i s e r u m was determined in t h e 
a n t i b o d y t i t r a t i o n a s s a y . The r e s u l t s of t h e s e exper iments a r e 
summarized in Table 4 . 3 . 
The b i n d i n g of e i t h e r serum t o bovine o p s i n was i n h i b i t e d by 
a l l v e r t e b r a t e o p s i n s t e s t e d , a l b e i t t o a v a r i a b l e e x t e n t . For 
e i t h e r a n t i s e r u m , t h e i n h i b i t i o n curves o b t a i n e d with the v a r i o u s 
ops in s p e c i e s were p a r a l l e l . In g e n e r a l , anti-ROS-B-б showed a 
lower l e v e l of c r o s s - r e a c t i v i t y than a n t i - R h o d - 1 . Apart from 
gekko o p s i n a l l v e r t e b r a t e o p s i n s t e s t e d e f f e c t u a t e d t o t a l 
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inhibition of the binding of anti-Rhod-1 at a concentration of 10 
pmol/well. For antiserum anti-ROS-B-6 this was only observed for 
cattle and sheep. In particular large differences in 
cross-reactivity were observed between the two antisera with 
regard to xenopus and trout, and to a lesser extent with regard 
to monkey, chicken and quail. Nevertheless, the order of 
cross-reactivity derived from the 'maximal' inhibition and the 
C-50 was similar for both antisera and was in fair agreement with 
that derived from antibody titration. 
Table 4.3: Inhibition of binding of anti-bovine rhodopsin 
antisera to bovine opsin by various vertebrate opsins. 
Species anti Rhod-l" anti ROS-B-6 
C-50 10 pmol C-50 10 pmol 
inhibitor inhibitor 
(pmol/well) (% inhibition) (pmol/well) (% inhibition) 
Cattle 
Sheep 
Mouse 
Rat 
Monkey 
Xenopus 
Trout 
Chicken 
Quail 
Gekko 
0.4 
0.6 
1.0 
0.6 
1.7 
0.4 
0.4 
2.4 
2.θ 
11.5 
100 
100 
100 
100 
100 
loo 
100 
100 
100 
40 
0.6 
0.5 
6.3 
2.3 
12.6 
4.0 
3.2 
n.a£ 
n.a 
13.8 
100 
100 
70 
Θ5 
40 
n.d' 
75 
40 
40 
40 
For cattle, sheep and monkey the source of antigen was retina, 
.for the other species whole eyes were used. 
Anti-Rhod-1 was obtained by mmunization with purified 
rhodopsin, anti-ROS-B-6 by immunization with rod outer segment 
membranes solubilized m Barlox 10S. 
Amount of inhibiting antigen required to get 50% inhibition of 
the binding of anti-bovine rhodopsin antisera to bovine opsin. 
.The antisera are used at a final dilution of 1:6000. 
Percentage of inhibition of the binding of anti-bovine 
rhodopsin antisera to bovine opsin by 10 pmol/well inhibiting 
ant igen. 
fn.d, not determined 
n.a, not achieved at the maximal concentration of inhibiting 
opsin used (10-20 pmol/well). 
The highest degree of cross-reactivity was observed with 
mammalian opsins (sheepf mouserrat). Gekko,chicken and quail 
exhibited the lowest cross-reactivity with either antiserum, but 
only gekko demonstrated a relative low degree of cross-reactivity 
with both antisera. Contrasting results were obtained with 
respect to trout and xenopus preparations, which showed a very 
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high degree of cross-reactivity with anti-Rhod-1 but a relatively 
lower reactivity with anti-ROS-B-6. These differences were much 
more explicit than in the antiserum titration experiments. 
The human opsin preparation behaved rather similar to monkey. 
At a relative high opsin concentration, it exhibited total 
inhibition with respect to anti-Rhod-1 and only 40 % inhibition 
with respect to anti-ROS-B-6. Since the human retinas were not 
dark adapted the amount of opsin required to obtain 50 % 
inhibition or the level of inhibition caused by 10 pmol/well 
opsin could not be determined. Using known amounts of monkey 
rhodopsin for calibration, the amount of human rhodopsin per eye 
could be estimated in monkey equivalents. The two sera yielded 
comparable results: 5.3 + 0.6 nmol/eye (anti-Rhod-1) and 4.7 
+ 0.8 nmol/eye (anti-ROS-B-6) (mean + standard deviation, η = 
3-4). 
4.3.4 Immunofluorescent studies 
Sections of eyes or retinas of various species were incubated 
with anti-ROS-3, anti-ROS-B-6, anti-ROS-N-2 or anti-Rhod-1. All 
antisera yielded similar results and representative examples 
obtained with anti-Rhod-1 are given in Fig. 4.2 and 4.3. 
Photoreceptor cells of all vertebrate species exhibited strong 
fluorescence. No staining was observed in other parts of the eye. 
The outer segments were very strongly labeled. In cattle, mouse, 
rat and monkey faint fluorescence was observed at the level of 
the inner segments and outer nuclear layer. 
In monkey, cone inner segments appeared not to be labeled. In 
chicken only 20-30% of the photoreceptors appeared to be labeled. 
In the sections of gekko and xenopus eyes we could not very well 
distinguish the different types of photoreceptor cells (red and 
green rods, double rods ). Hence, we could not determine whether 
these cells could be identified by differential immunostaining 
with these antisera. 
In control experiments, using non-immune serum instead of 
anti-rhodopsin antiserum, no immunofluorescent staining was 
observed in any part of the sections. 
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Fig. 4.2: Immunofluorescent staining of mammalian photoreceptor 
cells with anti-Rhod-1 (dilution 1:200), (a) mouse, (b) 
rat, (c) monkey and (d) man. Bar represents 50 μ,τη. 
· « i » 
Fig. 4.3: Immunofluorescent staining of non-mammalian vertebrate 
photoreceptor cells with anti Rhod-1 (dilution 1:200), 
(a) chicken, (b) gekko, (c) xenopus and (d) trout. Bar 
represents 50 μ,ιτι. 
4.4 DISCUSSION 
4.4.1 General aspects 
Four anti-bovine rhodopsin antisera elicited against various 
types of bovine rhodopsin preparations show considerable 
cross-reactivity with (rhod)opsins of a variety of vertebrates. 
This indicates a high evolutionary conservation of the rod visual 
pigment. However, caution has to be taken with interpretation of 
qualitative or quantitative variations in immunoreactivity 
between the various (rhod)opsin preparations or between 
compartments of photoreceptor cells. The possible influence of 
methodological factors (use of fixative, detergent) or 
environmental factors (e.g. circadian rythm) has to be taken in 
account. 
For instance, detergents or state-of-illumination might have 
variable effects on the integrity and stability of (rhod)opsin 
preparations from different vertebrates. As stated above the 
differential reactivity of polyclonal antibodies with 
cross-reacting proteins is generally related to the number of 
amino acid substitutions between these proteins. In addition 
changes in conformational epitopes may be detected. Such epitopes 
reflect molecular arrangements not necessarily linked to a linear 
sequence of amino acid but rather determined by the juxtaposition 
of amino acids, carbohydrate residues or both, which are brought 
together by the folding of the protein. In the case of a membrane 
protein such as (rhod)opsin the use of detergent to solubilize 
the protein might have a variable influence on these epitopes. In 
addition, differences in epitopes distribution might exist 
between rhodopsin and opsin. 
However, conformational epitopes are probably of little 
relevance for these four antisera. This can be deduced from the 
fact that bovine opsin exposed to detergent solution, which 
represents a partially denatured preparation, can completely 
inhibit the binding of these sera to (rhod)opsin in the relative 
native photoreceptor membrane. Hence, in order to eliminate as 
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much as possible any differences in conformational stability 
between various (rhod)opsin species during the innunochemical 
assay of the cross-reactivity profile of the four antisera, both 
the coating antigen and the inhibiting antigen were dissolved in 
detergent and illuminated. This results in a solution of 
partially denatured opsin (De Grip and Daemen, 1982; De Grip, 
1982) . 
4.4.2 Immunochemical cross-reactivity of vertebrate (rhod)opsins 
Upon immunoblotting the anti-bovine rhodopsin antisera only 
react with the respective opsin bands in extracts of vertebrate 
retinas or eyes. The very low activity against S-antigen detected 
in some sera (section 2.3) is not relevant for the present 
investigation, since it is diluted out beyond activity in all 
assays described. 
Antibody titration is performed against a coating of retinal 
or ocular extracts of various species. As stated above, a 
reduction in antiserum titer relative to the one obtained against 
the original immunogen (bovine opsin), indicates a reduction in 
antibody avidity for that respective species. For most of the 
species investigated a reduction in titer of each of the four 
sera was observed of only a factor of 2-8. This demonstrates that 
a considerable degree of immunochemical cross-reactivity exists 
between these species. The order in cross-reactivity derived from 
the titers is similar for all four tested antisera. Small 
differences appear to be present e.g. between anti Rhod-1 and 
anti ROS-B-6. These data are not conclusive due to the limited 
precision with which the titer can be estimated. 
More direct information can be derived from an antigen 
inhibition assay, where the competitive potential of (rhod)opsins 
of various species as inhibiting antigen is measured against the 
original immunogen, bovine opsin. The results obtained with the 
antigen inhibition assay suggest that anti-Rhod-1 has a markedly 
higher inter-species cross-reactivity than anti-ROS-B-6. For this 
phenomenon no satisfactory explanation is available yet. It is 
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conceivable that the micro-environment of (rhod)opsin (membrane, 
type of detergent), which does influence its structural 
properties, will also influence its antigenic properties. Hence, 
different states might elicit a different population of 
antibodies. Nevertheless, the characterization presented in 
chapter 2 indicates that the antisera recognize similar antigenic 
sites. The epitope distribution of monoclonal antibodies 
demonstrated that two principal antigenic sites of bovine 
(rhod)opsin , the 30 N-terminal and 20 C-terminal located 
residues, each contain a subset of antigenic determinants. These 
subsets show a variable evolutionary conservation (Nathans and 
Hogness, 1986). This suggests that different states of 
(rhod)opsin may emphasize a different subset of antigenic 
determinants, which may have a different pattern of 
cross-reactivity. 
The detected order in cross-reactivity derived from antibody 
titration and antigen inhibition is similar for the two tested 
sera. The amount of inhibiting antigen needed to achive 50 % 
inhibition is of the same order of magnitude for most of the 
vertebrate (rhod(opsins. This level of cross-reactivity is 
remarkable and indeed much higher than that reported by Peterson 
et al. (1983) for an anti-bovine rhodopsin antiserum evaluated by 
radioimmunoassay in the dark. Their antiserum required 200 and 
800 times more rat and frog rhodopsin respectively than bovine 
rhodopsin in order to inhibit the antibody binding to bovine 
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I rhodopsin by 50 %. Since partially denatured opsin, however, 
competed poorly with rhodopsin their antiserum might have high 
affinity for conformational epitopes and consequently be very 
'conformation- sensitive'. 
The homology in amino acid sequence between human and bovine 
opsin is very high (ca. 94 % ; Nathans and Hogness, 1984). Since 
the mammalian opsins tested react with similar or even higher 
avidity to both antisera as compared to human opsin, it is very 
likely that the homology between those species is at least 90 %, 
with sheep and bovine approaching 100 %. Remarkebly, the teleost 
(trout) and amphibian (xenopus) opsins also fall in this 
catagory. The degree of homology between vertebrate and insect 
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opsins is in the order of 35 % ( Baehr et al., 1986), and between 
human rod and cone opsins in the order of 40 % (Nathans et al., 
1986). Since our antisera do not interact with insect and cone 
opsins, they do apparently not detect these lower levels of 
homology. Therefore we estimate that the degree of homology 
between bovine opsin and avian (chicken, quail) opsin is in the 
higher range of 40-90 % and gekko opsin in the lower range of 
40-90 %. Nevertheless, for these species the amount of opsin 
required to get 50 % inhibition with anti-Rhod-1 is only a factor 
of 10-20 higher than the amount of mammalian pigment. The lower 
reactivity of the gekko opsin might be related with the special 
character of the gekko rod photoreceptor and its pigment, which 
have characteristics intermediate between those of mammalian rod 
and cone photoreceptors (Cresciteli!, 1972). 
4.4.3 Immunohistochemical localization of (rhod)opsin 
Retinal photoreceptors. The pattern of immunofluorescent 
staining in sections of the vertebrate eyes described in this 
chapter resembles that in bovine retina (section 2.3 ) and is in 
accordance with results reported in frog using anti-frog 
rhodopsin antisera ( Dewey et al. 1969) and in rat using anti-rat 
and anti-bovine monoclonal antibodi-es (Fekete and Barnstable, 
1983). In the meantime the range of species has been further 
extended (hamster, dog, dormouse, lizard and European minnow), 
and the pattern observed is completely consistent. 
The labeling of the inner segments probably represents opsin, 
which is in the process of biosynthesis and transport to the 
ciliary ridge (Papermaster, 1982). The variable staining of the 
inner segments is due to a combination of factors: 1) relative 
low concentration and scattered distribution of opsin in the 
inner segment, 2) the degree of cross-reactivity of the antiserum 
and 3) the titer of the antiserum. At the dilution routinely used 
for immunohistochemistry (1:200) high-titer antisera produce more 
intense staining of the inner segments than low-titer antisera 
and at a dilution of 1:1000 inner segment staining is no longer 
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detectable. 
The antisera react only with a part of the chicken 
photoreceptors (20-30%). This suggests that these antisera are 
rod specific, which would confirm our immunocytochemical findings 
obtained by electron microcopy, where no immunogold labeling was 
detectable in cone outer or inner segments of bovine retina 
(section 2.3), or mouse eye (Jansen et al., 1987). No reaction 
was observed with invertebrate photoreceptors tested so far 
(fly and crayfish). This is not unexpected since for instance the 
drosophila visual pigment shows only 35-40 % homology with bovine 
opsin, and the most conserved stretches are located in the more 
shielded intramembranous part of the protein (Baehr, 1986). 
Extra-retinal photoreceptors. The retina and pineal complex of 
vertebrates share several common characteristics and have 
developed as diencephalic evaginations (Korf et al., 1986). The 
anti-Rhod-1 serum has been shown to give a specific histochemical 
reaction with the pineal organ of fish ( Ekstrom et al., 1987), 
quail (Foster et al., 1987) and several mammalian species 
including mouse, dog, rat and man (Korf et al., 1985). Thus, 
(rhod)opsin immunocytochemistry appears to be a valuable tool to 
establish similarities between retina and pinal organ on a 
comparative basis. Specific immunostaining was also observed in 
human pineacytomas and medulloblastomas (Korf et al., 1987). 
Anti-bovine (rhod)opsin antibodies with low species specificity 
might become an important tool in pathohistological 
investigations of brain tumours of man that are related to 
derivatives of the photoreceptor-producing primodium. 
4.5 CONCLUSIONS 
We have raised antibodies against four types of bovine 
rhodopsin preparations. The resulting antisera share common 
linear antigenic sites, but probably recognize different subsets 
of epitopes. Nevertheless, all four antisera show a considerable 
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level of cross-reactivity with a range of vertebrate 
(rhod)opsins. This indicates high evolutionary conservation of 
the rod visual pigment. This quality renders (rhod)opsin a 
potential autoantigen. For such studies a purified rhodopsin 
preparation seems to be the immunogen of choice since it does not 
contain contaminating antigens (section 2.3) and produces sera 
with a high cross-reactive potential. 
Thanks to their low species specificity the developed 
antisera are very suitable for immunoassays with the purpose of 
micro determination of (rhod)opsin and in immunocytochemical 
studies of retinal and extra-retinal photoreceptor systems in a 
range of vertebrate species. 
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CHAPTER 5 
EXPERIMENTAL AUTOIMMUNE UVEORETINITIS IN RATS INDUCED BY 
ROD VISUAL PIGMENT: RHODOPSIN IS MORE PATHOGENIC THAN OPSIN 
J.J. Schalken, A.H.M, van Vugt, H.J. Winkens, 
P.H.M. Bovee-Geurts, W.J. De Grip and R.M. Broekhuyse 

5.1 INTRODUCTION 
Experimental autoimmune or allergic uveitis (EAU) is a model 
in which uveitis-like disease is provoked in animals by injection 
of retina-specific proteins (for a recent review, see Gery et al. 
1986). As such it is an ocular model for organ-specific disease 
and it has been widely used for the search of factors which are 
important in the pathogenesis of human uveitis. Up till now three 
major uveitogenic proteins have been reported, S-antigen (Wacker 
1981; De Kozak et al. 1981b; Marak and Rao 1982), (rhod)opsin 
(Wong et al. 1977; Marak et al. 1980; Meyers-Elliott et al. 1983; 
Broekhuyse et al. 1984) and the interphotoreceptor retinoid 
binding protein (IRBP; Gery et al. 1986; Broekhuyse et al. 1986, 
1987c). In particular S-antigen and IRBP are very potent in 
their capacity of inducing uveitis, even doses as low as 1-10 μς 
appeared to be pathogenic in Lewis rats (Gery et al. 1986; De 
Kozak et al. 1981b; Broekhuyse et al. 1986). Studies on the 
uveitogenicity of the rod visual pigment rhodopsin have been 
hampered by the fact that in early reports the preparations used 
to induce uveoretinitis were probably contaminated by S-antigen. 
However, highly purified (rhod)opsin preparations have recently 
been shown to induce uveoretinitis in guinea pigs (Marak et al. 
1980; Meyers-Elliott et al. 1983), rats (Broekhuyse et al. 1984) 
and monkeys (Broekhuyse et al. 1987b). 
Rhodopsin is an intrinsic membrane glycoprotein with a 
molecular weight of 41 kD, which is embedded in the plasma 
membrane and disk membranes of the rod outer segment (Dratz and 
Hargrave, 1983). Essential for its function as a light receptor 
is the presence of a chromophore, 11-cis retinal, in the interior 
of the protein. Light causes a photoisomerization of the 
chromophore to all-trans retinal, which is subsequently released. 
The pigment then relaxes into the chromophore free apoprotein 
opsin. Both its solvation state (membrane-bound or detergent 
solibilized) and its light sensitivity (an illuminated and 
non-illuminated form) may influence the immunogenicity of 
rhodopsin (for a recent review, see De Grip, 1985). The 
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pathogenicity of opsin has been shown to depend on the detergent 
used for solubilization of the protein. Opsin prepared in the 
denaturing detergent dodecyl sulfate is less pathogenic and 
immunogenic than prepared in the milder detergent Triton X-100 
(Broekhuyse et al., 1984). 
In this study we investigated the pathogenicity of highly 
purified bovine visual pigment preparations in the very mild 
detergent nonylglucose both in the illuminated (opsin) and in the 
non-illuminated (rhodopsin) state. 
5.2 MATERIALS AND METHODS 
5.2.1 Preparation of antigens 
Bovine rod outer segment membranes were prepared by 
sucrose-density centrifugation and stored as described before (De 
Grip et al., 1980). Highly purified lipid-free rhodopsin was 
prepared by concanavalin A-sepharose affinity chromatography in 
20 mM nonylglucose (De Grip et al., 1980). The purity of this 
preparation was checked by Polyacrylamide gel electrophoresis and 
Western-blotting using antisera against bovine S-antigen or IRBP 
125 in combination with I-protein A (Broekhuyse et al., 1984). 
Only trace amounts of S-antigen ( < 0.01%) and no IRBP could be 
detected. 
Because detergent may interfere with the tests for the immune 
responses, a reconstituted rhodopsin preparation was used as 
antigen in ELISA and lymphocyte transformation tests. Rod outer 
segment membranes (3 times water washed) were solubilized in 20 
mM nonylglucose in MOPS buffer (20 mM MOPS, 140 mM NaCl, 5 mM 
KCl, 3 mM MgCl2, 2 mM CaCl», pH 7.2). Subsequently, rhodopsin was 
reconstituted into its natural lipids by stepwise dilution 
with MOPS buffer (De Grip et al., 1983). The reconstituted rod 
outer segment membranes were washed once with water and stored at 
-70 C. In this way the amount of S-antigen present was reduced to 
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about 0.05-0.1% as compared to 1% in water-washed rod outer 
segment membranes. This minor amount was shown not to interfere 
with the immunological assays. All procedures involving rhodopsin 
were performed under dim red light ( Λ >620 nm). In order to 
prepare opsin, a rhodopsin preparation was illuminated ^ust 
before use for 10 m m at room temperature by means of a 100 W 
tungsten lamp at 30 cm distance. 
Bovine S-antigen and IRBP were prepared as described before 
(Broekhuyse et al., 1984, 1986). Protein was determined according 
to Lowry et al. (1951) with bovine serum albumin as standard. 
5.2.2 Immunization, clinical observation and histological 
evaluation 
Female Lewis rats weighing 180-200 g were purchased from the 
Zentral Institut fur Versuchtieren in Hannover (Germany). In 
Table 5.1 the experimental set up is shown for the investigated 
group of rats. For group 1-4 and 6-8 half of the immunogen dose 
(125 μg) was emulsified in Freund's complete adjuvant (Difco, 
Detroit) and 0.1 ml was injected into each of the hind foot pads. 
The other half was injected intraperitoneally in 1 ml pertussis 
α 
vaccin (Hemophilus pertussis, 10 microorganisms, Institut 
Pasteur, Pans) (Broekhuyse et al., 1984). Group 5 was injected 
with 250 ¿¿g rhodopsin in Freund's complete adjuvant alone. 
Rhodopsin was injected under dim red light and the animals were 
housed as described in Table 5.1. Animals were housed for the 
first 8 days postinjection in a dark room in order to prevent 
conversion of injected rhodopsin into opsin by light. 
Clinical signs of uveoretimtis were monitored by daily 
slit-lamp examination starting on day 8 postinjection. Uveitis 
was scored essentially as described (De Kozak et al., 1978; 
Forrester et al., 1985) on a scale from 0-4. In mild uveitis 
(score 1+/2+) a few cells up to a mild infiltration of cells was 
present in vitreous or anterior chamber, accompanied by a good 
fundal view. In severe uveitis (score 3+/4+) many cells to a 
dense infiltration in vitreous and/or anterior chamber were 
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p r e s e n t and t h e f u n d a l v i e w was p o o r o r n o t p o s s i b l e a t a l l . 
I n j e c t i o n of FCA and PA w i t h o u t a n t i g e n d i d n o t i n d u c e any 
d e t e c t a b l e c h a n g e s i n t h e e y e ( B r o e k h u y s e e t a l . , 1 9 8 7 a ) . 
For h i s t o l o g y , a n i m a l s were k i l l e d by i n j e c t i o n w i t h 
p e n t o b a r b i t a l a t v a r i o u s s t a g e s of t h e d i s e a s e . E y e s w e r e f i x e d 
m B o u i n f l u i d , embedded m p a r a f f i n , and s a g i t t a l s e c t i o n s 
(5 μπι) w e r e s t a i n e d by h e m a t o x y l i n and e o s i n . 
Table 5 . 1 : Immunization p r o t o c o l s in the study of experimental 
autoimmune u v e o r e t i m t i s (EAU) induced by rhodopsin and 
opsin 
Group Number of Antigen 
n r . r a t s 
Adjuvants 3 Housing Phenomenon 
c o n d i t i o n s s tudied 
13 
6 
12 
б 
б 
б 
б 
10 
Rhodopsin 
Rhodopsin 
Opsin 
Opsin 
Rhodopsin 
Rhodopsin 
Opsin 
Rhodopsin 
FCA+PA 
FCA+PA 
FCA+PA 
FCA+PA 
FCA 
FCA+PA 
FCA+PA 
FCA+PA 
D/L-
L-D 
L-D 
D/L-
D/L-
D/L-
L-D 
D/L-
-D 
-D 
-D 
•D 
•D 
Development of EAU 
Development of EAU 
Development of EAU 
Development of EAU 
Development of EAU 
Immune responses 
Immune responses 
Histopathology 
A dose of 125 /tg ant igen in Freund's complete adjuvant (FCA) and 125 
¿¿g ant igen in p e r t u s s i s adjuvant (PA), or 250 /ig of ant igen in 
.FCA (group 5) was i n j e c t e d . 
The animals were e i t h e r housed for θ days under dark room c o n d i t i o n s 
and subsequently under normal l i g h t - d a r k c o n d i t i o n s (D/L-D), or 
cont inuous ly under normal l i g h t - d a r k c o n d i t i o n s (L-D). The l a t t e r 
r e p r e s e n t s a 12 hr l i g h t (250 lx)/12 hr dark c y c l e . 
5 . 2 . 3 Immune r e s p o n s e s 
Humoral r e s p o n s e s w e r e d e t e r m i n e d u s i n g an e n z y m e - l i n k e d 
i m m u n o s o r b e n t a s s a y m o d i f i e d a f t e r a d e s c r i b e d m e t h o d ( B r o e k h u y s e 
e t a l . , 1 9 8 7 a ) . F o r c o a t i n g , a r e c o n s t i t u t e d r o d o u t e r s e g m e n t 
membrane s u s p e n s i o n was u s e d . H i g h e s t c o a t i n g e f f i c i e n c i e s w e r s 
a t t a i n e d by membrane s o l u b i l i z a t i o n i n d e t e r g e n t and s u b s e q u e n t 
d i l u t i o n i n b u f f e r ( S c h a l k e n and De G r i p , 1 9 8 6 ) . A membrane 
s u s p e n s i o n c o n t a i n i n g a b o u t 25 n m o l e s r h o d o p s i n / m l ( b a s e d on 
a b s o r b a n c e s p e c t r o s c o p y ) was s o l u b i l i z e d i n 20 mM n o n y l g l u c o s e . 
T h i s p r e p a r a t i o n was e i t h e r d i r e c t l y ( r h o d o p s i n ) , o r f o l l o w i n g 
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illumination (opsin), diluted with 0.02 M phosphate buffered 
saline (pH 7.4) to a final concentration of 0.02 nmoles/ml. 
Coating of micro-ELISA plates with 96 wells (Flow Laboratories, 
Amsterdam) was performed by incubation for 24 hr, 40C, 200 
μΐ/well. Optimal coating concentrations were determined in 
previous experiments and were equal for opsin and rhodopsin. The 
wells were rinsed with phosphate buffered saline containing 0.05% 
Tween 20, and serial dilutions of antiserum in incubation buffer 
(0.02 M phosphate buffered saline containing 0.1% bovine serum 
albumin and 0.05% Tween 20, pH 7.4) were incubated for 16 hr, 
4°, 150 μΐ/well. After rinsing (3 times), 200 μΐ of 1 to 1000 
fold diluted anti-Rat/IgG alkaline phosphatase conjugate (Sigma, 
St. Louis) in incubation buffer was added and the incubation was 
continued for 5 hr at 370C. The wells were rinsed again (5 
times), followed by addition of 200 μΐ substrate solution (1 ml 
p-nitrophenyl phosphate/ml diethanolamine buffer, pH 9.8). After 
30 min (room temperature) the reaction was stopped by addition of 
50 μΐ 3M NaOH and absorbances were measured at 405 nm using 
Titertek Multiskan (Flow Lab, Amsterdam). Titers were determined 
graphically as the dilution required to give an absorbance over a 
background of 0.5. A dilution of 1:12.5 corresponded to a titer 
of 1, 1:25 to a titer of 2, 1:50 to a titer of 3 and so on. 
Cellular immune responses were determined using spleen cells 
as described before (Broekhuyse et al., 1984). The cells were 
incubated at a density of 10 lymphocytes per ml MEM-medium 
(Gibco, Breda) containing 20 mM HEPES, 10% freshly isolated heat 
inactivated normal rat serum, 100 lU/ml penicillin and 100 /tg/ml 
streptomycin in presence or absence of antigen (Nunc tubes). 
Concentrations of antigen and conditions of cell culture were 
optimized in previous experiments. The optimal concentrations for 
opsin and rhodopsin were equal. Five micrograms of one of the 
following antigens were added per ml cell suspension: opsin, 
rhodopsin, S-antigen or IRBP. Functional viability of the 
lymphocytes was tested by addition of 25 ^g phytohemagglutinin Ρ 
(Difco). Triplicate determinations were carried out. After 4 days 
culture at 370C, Η-thymidine (Amersham) was added at a 
concentration of 0.5 μ ^ per tube. The incubation was then 
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continued for 24 hr and the cells were subsequently harvested and 
filter-bound radioactivity was determined. The samples containing 
rhodopsin were manipulated under dark room conditions until the 
cells were harvested. Results were expressed as stimulation 
indices (SI) and calculated as follows: 
SI= counts per minute in presence of antigen/counts per minute 
in absence of antigen 
A stimulation index >2 was considered to be positive (Broekhuyse 
et al., 1984) . 
5.3 RESULTS 
5.3.1 Comparison of rhodopsin and opsin induced uveoretinitis 
Clinical evaluation. The effect of illumination on the 
pathogenicity of the visual pigment was investigated by injection 
of Lewis rats with 250 ^ g rhodopsin (group 1 ) and opsin (group 
4). Both groups were housed in darkness for the first 8 days 
postinjection. The results are shown in Figure 5.1 (differences 
in severity and development) and Table 5.2 (differences in days 
of onset ) . 
The first clinical signs of inflammation were detected at day 
10 and 12, respectively. These phenomena consisted of iris 
hyperemia and cells in the anterior chamber. In moderate cases, 
cells could be observed in the vitreous in the course of the next 
days. All rats in the rhodopsin group developed bilateral severe 
uveoretinitis (100% of the eyes). Once started, this type of 
inflammation fully developed within one day. The group reached 
the maximum mean score of 8.0 at day 15 postinjection and 
remained at this level for at least 3 days. In the opsin group 
83% of the animals (Figure 5.1b) and 75% of the eyes (Figure 
5.1c) developed uveoretinitis. At day 18 a mean score of 5.7 +_ 
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1.3 was reached (F igure 5 . 1 a ) . During the whole per iod of 
development of u v e o r e t i n i t i s the s c o r e of rhodops in group 1 was 
markedly h igher than t h a t of ops in group 4 (F igure 5 . 1 a ) , a t day 
14 more than twice as h igh . In a d d i t i o n , t he mean day of onse t of 
d i s e a s e in the rhodopsin group was s i g n i f i c a n t l y e a r l i e r than in 
the opsin groups (Table 5 . 2 ) . 
Table 5.2: Clinical features of uveoret ini t is induced by 250 jig 
rhodopsin or opsin 
Group Antigen3 Light- Adjuvant Animals with Day of onset 
nr. conditions3 uveoret ini t is (pos i t ive / to ta l ) (mean +S.D.) 
Mild Severe 
1 Rhodopsin D/L-D FCA+PA 0/12 12/12 
2 Rhodopsin L-D FCA+PA 1/6 5/6 
3 Opsin L-D FCA+PA 2/13 9/13 
4 Opsin D/L-D FCA+PA 1/6 5/6 
"See note a and b in Table 5.1 . 
The Mann and Whitney U test was applied for s t a t i s t i c a l evaluation. 
T^wo animals did not respond. 
Significantly different from group 1 (p < 0.001). 
fSignificantly different from group 1 (p £ 0.01). Not significantly different from group 2 or 4 (p > 0.05). gNot significantly different from group 2 (p > 0.05). 
Whether or not animals were housed in darkness dur ing the 
f i r s t 8 days seemed to have no s i g n i f i c a n t i n f l u e n c e on the 
development of u v e o r e t i n i t i s in t he o p s i n - i n ^ e c t e d groups (F igure 
5 . 1 a - c , Table 5 . 2 ) . Group 4 ( i n i t i a l l y 8 days in da rkness ) 
seemed to s t a r t somewhat l a t e r (mean day 15.0 +3.2) than group 
3 ( d i u r n a l l i g h t c o n d i t i o n s ; mean day of onse t 12.0 + 1 . 9 ) , but 
t h i s d i f f e r e n c e was not s t a t i s t i c a l l y s i g n i f i c a n t (Table 5 . 2 ) . 
However, when r h o d o p s i n - i n ^ e c t e d r a t s were immediately housed in 
d i u r n a l l i g h t c o n d i t i o n s (group 2) development and l e v e l of 
u v e o r e t i n i t i s were s i g n i f i c a n t l y d i f f e r e n t from p a r a l l e l group 1 
i n i t i a l l y housed in d a r k n e s s , and a c t u a l l y were very s i m i l a r to 
the opsin groups 3 and 4. Appa ren t ly , the i n j e c t e d rhodops in was 
10.5 + 1.2. 
14.2 + 2.4' 
12.0 + 1.9 
15.0 + 3.2 
e.f 
d,g 
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Fig. 5.1: Clinical observations in rhodopsin- and opsin-induced 
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All rats injected with rhodopsin in Freund's complete 
adjuvant alone (group 5) developed severe uveoretinitis (mean day 
of onset 13.2 + 2.3). This is later than rhodopsin group 1 (p < 
0.01). Clinical and histopathological development of disease was 
similar whether pertussis adjuvant was applied or not. However, 
coinjection of pertussis adjuvant accelerated the onset of 
inflammation. 
Groups 6, 7 and 8 were only examined on day 10 postinjection. 
At that day all 16 animals injected with rhodopsin in groups 6 
and 8 (Table 5.1) exhibited clinical signs of ocular 
inflammation. In opsin group 7 only 1 animal with uveoretinitis 
was observed. Hence, these results completly corroborate those 
described above. 
Immunological responses. Cellular immune responses were 
determined by the lymphocyte transformation test using spleen 
cells from animals at 10 days postinjection (group 6 and 7; Table 
5.3). At that day there was a pronounced difference in freguency 
of clinical disease between rats injected with rhodopsin and 
opsin, respectively. No sensitization against S-antigen or IRBP 
was found in any of the animals tested. The group injected with 
opsin exhibited a somewhat higher stimulation index than that 
injected with rhodopsin, against both rhodopsin and opsin as test 
antigen. The stimulation indices determined against both antigens 
showed a relatively large variance (Table 5.3). The differences 
in these indices between rhodopsin- or opsin-injected animals 
were not significant (p=0.49 for rhodopsin and p=0.25 for opsin 
as test antigen according to the two-sample t test). 
The antibody titers of the animals receiving opsin were 
slightly higher than those of rats receiving rhodopsin, but for 
neither of the test antigens a significant difference in titer 
was found (p = 0.1 for rhodopsin and ρ = 0.33 for opsin as test 
antigen; two-sample t test). No or only traces of immune 
reactivity against IRBP or S-antigen could be detected in the 
sera (titers < 2). 
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In all animals tested the stimulation index measured against 
rhodopsin as test antigen was significantly higher than that 
against opsin (p = 0.05), whereas for the antibody titers the 
reverse phenomenon was observed (p= 0.002; paired sample t 
test). 
Table 5.3: Cellular and humoral immune respons of animals injected 
with 250 μ<3 rhodopsin or opsin 
Group Immunogen Stimulation indexa Antibody titer 
nr. 
Rhodopsin Opsin Rhodopsin Opsin 
6 Rhodopsin 5.6 + 2.9 3.9 + 1.4 11.3 + 0.2 12.2 + 0.2 
7 Opsin 6.7 + 2.8 5.0 + 1.6 11.8 + 0.7 12.5 + 0.6 
The values represent the mean of the stimulation indices or antibody titers 
(± standard deviation; η = 6). Either rhodopsin or opsin was used as test 
antigen. 
5.3.2 Histopathology 
Animals injected with 250 μq rhodopsin (group 8) were killed 
at various stages of the disease in order to study 
histopathology. At the first signs of clinical onset iris, 
ciliary body and pars plana exhibited mild polymorphonuclear and 
mononuclear cell infiltrations. At that stage cells were scarely 
detectable in retina and choroid. This stage was soon followed by 
the appearance of transient edematous areas in both nuclear 
layers of the retina, accompanied by a slight cell infiltration 
in the photoreceptor layer and a mild perivasculitis mainly in 
the peripheral retina (Figure 5.2). A few days after clinical 
onset of the disease the photoreceptor layer and the perivascular 
regions of the peripheral and central retina were heavily 
infiltrated with polymorphonuclear and mononuclear cells 
accompanied by subretinal exudations and detachments (Figure 
5.3a). 
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Fig. 5.2: Early events in the development of inflammation induced 
by 250 μд rhodopsin: 
a) a few mononuclear cells and polymorphonuclear cells 
in ciliary body and pars plana, b) mild retinal 
perivasculitis, c) edematous areas in the nuclear 
layers and d) peripapillitus. Bars represent 50 μ.πι. 
Fig. 5.3: Uveoretinitis induced by 250 μg rhodopsin: 
a) severe inflammation, 1-2 days after clinical onset, 
dense cell infiltration in photoreceptor layer and 
subretinal exudates, b) eyes partially recovered from 
the inflammation about 3 weeks after clinical onset, 
note the complete absence of the photoreceptor layer. 
Bars represent 50 μ,ιπ. 
Choroidal involvement was only detected in the severe 
stages. In the regression stage inflammatory cells disappeared 
first from iris, ciliary body and pars plana, whereas in the 
retina these cells were detectable up till 3 weeks after clinical 
onset. In retinas recovering from inflammation the photoreceptor 
cells were completely absent (Fig. 5.3b), but the structure of 
the iris, ciliary body, pars plana and choroid appeared normal. 
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5.4 DISCUSSION 
5.4.1 Pathogenicity of rhodopsin and opsin 
Rhodopsin appears to be more pathogenic than opsin as can be 
concluded from the following lines of evidence. Rhodopsin induced 
severe uveoretinitis with higher frequency than that induced by 
opsin. Time of onset was significantly earlier and inflammation 
was significantly more severe in the rhodopsin group than in the 
other groups. In addition, we noticed a pronounced difference in 
frequency of clinical disease on day 10 postinjection between 
rats injected with rhodopsin and those injected with opsin in the 
study of the immune responses and histopathology. Finally, for 
induction of severe uveoretinitis by rhodopsin no co-injection of 
pertussis adjuvant was required. For the induction of severe 
disease by Triton X-100-solubilized opsin, pertussis adjuvant 
appeared to be essential (Broekhuyse et al., 1984, 1987a). The 
difference in pathogenicity between rhodopsin and opsin becomes 
even more pronounced at low doses (Schalken et al., chapter 6). 
Our finding is quite different from that of Marak et al. 
(1980), who reported that illumination of rhodopsin did not 
appreciably alter the frequency or severity of uveitis elicited 
in the guinea pig. Apart from species differences, another 
important difference with respect to our procedures is that their 
animals were kept under dim red light for only 24 hr after 
injection. We observed that rhodopsin-injected Lewis rats housed 
under normal light-dark conditions exhibited similar frequency 
and development of uveoretinitis as opsin-injected rats. This 
indicates that rhodopsin was converted into opsin by illumination 
even after injection. Very likely a period of 24 hr is too short 
to realize optimal exposure of the rhodopsin structure to the 
immune system. Our experiments do not exclude that prolonged dark 
adaptation after rhodopsin injection influences to some extent 
the development of uveoretinitis. However, for opsin this 
condition rather seems to slow down the development of EAU (Table 
5.2, groups 3 and 4). 
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Recently we reported that purified opsin preparations induced 
a moderate to severe uveitis (predominantly retinitis) in 70% of 
the rats at the end of the second week after infection 
(Broekhuyse et al., 1984). The pathogenicity of opsin was shown 
to depend on the type of detergent used to solubilize this 
intrinsic membrane protein. Opsin solubilized in the strongly 
denaturing detergent dodecyl sulfate displayed a lower 
pathogenicity than opsin solubilized in the milder detergent 
Triton X-100. The present study shows that opsin solubilized in 
nonylglucose yields results similar to those of Triton 
X-100-solubilized opsin, both with regard to frequency, to day of 
onset and to pattern of the development of inflammation 
(Broekhuyse et al., 1984, 1987a). 
Combining these results with our present data, we conclude 
that the pathogenicity of the visual pigment appears to be 
related to the biochemical integrity of the protein. Dodecyl 
sulfate strongly denatures both rhodopsin and opsin. Triton X-100 
and nonylglucose are milder, but opsin is not stable in either 
detergent and very rapidly loses its regenerability. Rhodopsin is 
thermally stable in both detergents at physiological temperatures 
(De Grip, 1982). This agrees well with our observation that 
rhodopsin is more pathogenic than opsin. 
5.4.2 Immunogenicity of rhodopsin 
At day 10 postinjection both cellular and humoral immune 
responses were lower in animals injected with rhodopsin as 
compared to those injected with opsin (Table 5.2). However, these 
differences were not significant. Nevertheless the results 
indicate that the immunogenicity of opsin might be somewhat 
higher than that of rhodopsin. The level of the immune responses 
on day 10 postinjection does therefore not account for the 
pronounced difference in pathogenicity between rhodopsin and 
opsin. Possibly, immediate hypersensitivity phenomena play a more 
dominant role as reported for S-antigen induced uveoretinitis (De 
Kozak et al., 1981a; Broekhuyse et al., 1986). 
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5.4.3 Development of inflammation 
The general pattern of development of rhodopsin-induced 
uveoretinitis is similar to that of opsin-induced uveoretinitis 
described previously (Broekhuyse et al. 1984). However, rhodopsin 
causes a more severe inflammation with increased involvement of 
the anterior segment. The histological changes after injection of 
the relatively high dose of 250 ¿tg rhodopsin show some 
resemblance to those reported for uveoretinitis induced by 10-20 
μg S-antigen in rats (Marak and Rao, 1982; Gery et al. 1986). The 
possibility that this is due to very small amounts of S-antigen 
or IRBP present in our rhodopsin preparations can be excluded. 
First of all no IRBP could be detected and the amount of 
S-antigen present in our rhodopsin preparations was determined to 
be less than 0.01%, which means that less than 25 ng of S-antigen 
was injected per animal. This amount of S-antigen is far below 
the minimal dosage (1-5 μg ) required to induce uveitis in rats 
(Gery et al., 1986 and Broekhuyse et al., unpublished results). 
Secondly, the experiments using rhodopsin and opsin were carried 
out starting from the same preparation and short illumination was 
the only difference. Finally, no cellular immune responses 
against S-antigen or IRBP could be detected. Only occassionally 
an extremely low humoral immune response against these antigens 
was measured. 
The involvement of the anterior chamber seems incompatible 
with our knowledge of the localization of rhodopsin. We suppose 
that this involvement reflects the severity of the induced 
inflammation. The severity of rhodopsin-induced uveoretinitis is 
similar to that induced by S-antigen and IRBP. The latter 
antigens, although soluble, are also localized in the retina. Yet 
these antigens couse a heavy anterior chamber inflammation. For 
this phenomenon a satisfactory explanation is not yet available. 
In opsin-induced experimental autoimmune uveoretinitis in the 
guinea pig, deviating results are reported with respect to the 
pattern of development of uveitis. Marak et al. (1980) describe a 
primarily posterior non-granulomatous mononuclear choroiditis 
after immunization with the high dose of 1.0 mg (rhod)opsin per 
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animal. In the mild opsin-induced non-granulomatous choroiditis 
with retinopathy described by Meyers-Elliott et al. (1983) in 
guinea pigs, inflammatory cells were exclusively detected in the 
choroid. At no time was a substantial inflammatory cell 
infiltrate detectable in the retina. The results of both studies 
differ from the pattern which develops in rats as observed in the 
present study. Retinitis dominates in rats and choroidal 
involvement is only detected in the severe stages of 
inflammation. As we discussed previously (Broekhuyse et al., 
1984) the fact that the guinea pig has no retinal vessels is 
probably of major importance. Inflammatory cells can penetrate 
the guinea pig retina exclusively via the choroidal vessels. 
5.4.4 Retinal antigens in human uveitis 
Up till now S-antigen has been the only purified retinal 
protein used in studies on the involvement of immune responses to 
retina-specific antigens in human uveitis. However, other retinal 
antigens may be involved as well, which might partially explain 
the great diversity in types of uveitis. In support of the 
findings of a previous report (Brinkman et al., 1980), our 
present results indicate that in this type of study in addition 
to S-antigen and IRBP, rhodopsin should be definitely included as 
test antigen. 
5.5 CONCLUSIONS 
Rhodopsin appears to be more potent than opsin in inducing 
experimental autoimmune uveoretinitis. A dose of 250 /ig injected 
in Freund's complete adjuvant and pertussis adjuvant induces a 
non-granulomatous inflammation with higher freguency, which 
starts earlier and is more severe than that induced by opsin. 
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The high pathogenicity of rhodopsin appears to be related 
to the biochemical integrity of the protein. 
The levels of the immune responses measured at day 10 
postinjection (close to the day of onset of EAU) do not account 
for the pronounced difference in pathogenicity between rhodopsin 
and opsin. 
The patterns of development of severe uveoretinitis induced 
by rhodopsin or opsin appear to be similar. However, rhodopsin 
causes a more pronounced involvement of ciliary body, pars plana 
and anterior chamber. 
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CHAPTER 6 
RHODOPSIN-INDUCED EXPERIMENTAL AUTOIMMUNE UVEORETINITIS: 
DOSE DEPENDENT CLINICOPATHOLOGICAL FEATURES 
AND PATHOGENICITY OF C-TERMINAL DEPRIVED RHODOPSIN 
J.J. Schalken, H.J. Winkens, A.H.M. van Vugt, 
W.J. De Grip and R.M. Broekhuyse 

6.1 INTRODUCTION 
In the previous chapter we showed rhodopsin to be more potent 
in inducing experimental autoimmune uveoretinitis (EAU) in Lewis 
rats than opsin. In an extension of our studies on 
rhodopsin-induced EAU we have investigated the 
clinicopathological features associated with varying doses of 
rhodopsin and opsin, and also the effect of pertussis adjuvant on 
these features. The immunogenicity of rhodopsin and opsin was 
again compared, but now by injection of a dose which yielded a 
maximal difference in pathogenicity between the two forms of the 
protein. 
To our best knowledge no data on the uveitogenic sites of 
(rhod)opsin have been reported yet. Data on the antigenic 
structure of rhodopsin are accumulating. Studies on the 
distribution of antigenic sites over rhodopsin by means of 
polyclonal antisera indicate the existence of at least three 
antigenic sites ( De Grip, 1985). By examination of the binding 
specificity of anti-rhodopsin antisera and monoclonal antibodies 
using synthetic peptides from the rhodopsin sequence, Hargrave et 
al. (1986) showed that rhodopsin's amino terminal region (ca. 30 
amino acids), is a principal antigenic site. Furthermore, at 
least four monoclonal antibodies were reported to interact with 
the C-terminal end of (rhod)opsin (Molday and MacKenzie, 1983; 
Mackenzie et al., 1984). In a first approach to localize the 
uveitogenic sites of (rhod)opsin, the pathogenicity of 
(rhod)opsin lacking the 3 kD C-terminal fragment, which contains 
all C-terminal antigenic sites, was evaluated. 
123 
6.2 MATERIALS AND METHODS 
6.2.1 Preparation of antigens 
Bovine rod outer segment membranes were isolated by 
sucrose-density centrifugation, and highly purified lipid-free 
rhodopsin was prepared by concanavalin A-sepharose affinity 
chromatography as described before (De Grip et al., 1980). 
Proteolysis of rod outer segment membranes by thermolysin or 
proteinase К was performed after solubilization of the membranes 
in 20 mM nonylglucose in MOPS buffer (pH 7.2), with an 
enzyme/rhodopsin ratio of 0.2 (w/w). After incubation for 2 hr at 
30 0C the reaction was stopped by addition of an equal volume 
MOPS buffer containing an appropriate protease-inhibitor: lOmM 
EDTA for thermolysin, ImM PMSF for proteinase K. Subsequently the 
proteolytic fragments were reconstituted in rhodopsin's natural 
lipids by stepwise dilution with MOPS buffer containing 
protease-inhibitors ( De Grip et al., 1985). The sediments were 
washed twice, in order to remove ths last traces of enzymes and 
soluble proteolytic products. 
In these preparations and in the purified rhodopsin 
preparation only trace amounts of S-antigen ( < 0.01%) and no 
interphotoreceptor retinoid binding protein (IRBP) could be 
detected by Western-blotting ( Broekhuyse et al., 1984; section 
5.2). No undigested rhodopsin was detectable in the preparations 
of proteolytic fragments (section 2.3). 
A reconstituted rod outer segment membrane suspension was 
prepared as described before (De Grip et al., 1983; section 5.2), 
and was used as test antigen in the immunological assays. 
Unless stated otherwise all procedures involving rhodopsin 
were carried out under dim red light ( Л > 620 nm). In order to 
prepare opsin , a rhodopsin preparation was illuminated just 
before use by means of a 100 W tungsten lamp at 30 cm distance 
for 10 minutes, at room temperature. 
The preparation of S-antigen and IRBP has been described 
before (Broekhuyse and Bessems, 1985; Broekhuyse et al., 1986). 
124 
6.2.2 Immunization,clinical observation and histologic 
evaluation 
Female Lewis rats weighing 180-200 g received a single 
injection according to two different protocols. In one mode the 
total dose of antigen was emulsified in Freund's complete 
adjuvant ( Difco, Detroit ) and 0.1 ml was injected into each of 
the hind foot pads. In the other mode, half of the immunogen dose 
was emulsified in Freund's complete adjuvant (FCA) and injected 
as described above, whereas the other half was injected 
intraperitoneally in 1 ml pertussis adjuvant (PA) ( Hemophillus 
g 
pertussis, 10 microorganism and 1.25 mg aluminium hydroxide 
per ml, Institut Pasteur, Pans). 
Rhodopsin was injected under dim red light, the animals were 
housed under dark room conditions for 8 days and subsequently 
under normal light-dark conditions (cycles of 12 hr light, 250 lx 
/ 12 hr dark). The rats injected with opsin remained in the 
normal light-dark conditions, since housing in darkness during 
the first 8 days seemed to have no significant influence on the 
development of uveoretimtis in comparison to housing in normal 
daily light-dark cycle (section 5.3.1). Clinical signs of 
uveoretimtis were monitored by daily slit-lamp examination 
starting on day 8 postinjection and were scored on a scale from 
0-4 (Broekhuyse et al., 1987a; section 5.2). The antigen dose was 
bases on protein determinations according to Lowry et al. (1951) 
using bovine serum albumin as standard. 
Eyes were fixed in Bouin fluid for histological examination 
and processed as described before (Broekhuyse et al., 1984). 
6.2.3 Immune responses 
Humoral immune responses were determined by an enzyme-linked 
immunosorbent assay (ELISA; section 5.2; Broekhuyse et al., 
1987a). As test antigens, rhodopsin and opsin were coated into 
the wells using a solution of 0.02 nmoles rhodopsin or opsin per 
ml 0.02 M phosphate buffered salme (pH 7.4; 0.001% 
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nonylglucose). Titers were determined graphically as the serum 
dilution required to give an absorbance over a background of 0.5. 
A dilution of 1:12.5 corresponded to a titer of 1, 1:25 to a 
titer of 2, 1:50 to a titer of 3 and so on. Normal (negative) rat 
sera exhibited a titer of 1. 
Cellular immune responses were determined by the lymphocyte 
transformation test (LTT) using spleen cells (section 5.2; 
Broekhuyse et al., 1987a). As test antigen 5 μg rhodopsin, opsin, 
S-antigen or IRBP was added per ml cell suspension. Functional 
viability of the lymphocytes was tested by addition of 25 дд 
phytohemagglutin P. Results were expressed as stimulation indices 
(SI) as follows: 
SI=counts per minute in presence of antigen/counts per minute in 
absence of antigen 
In both assays the concentration of the test antigens was 
optimized in previous experiments. Optimal concentrations for 
rhodopsin and opsin appeared to be equal. 
6.3 RESULTS 
6.3.1 Clinical features of uveoretinitis induced by rhodopsin and 
opsin 
For both modes of injection, the onset of uveoretinitis was 
found to be related to the antigenic dose. Higher doses caused an 
earlier onset. For each of the doses injected, severe 
inflammation always started earlier than mild inflammation (Table 
6.1). 
Rhodopsin in FCA+PA. All rats injected with 100-250 μg 
rhodopsin developed bilateral, severe uveoretinitis (Table 6.1). 
First signs were iris hyperemia and dense cell infiltrations in 
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the anterior chamber which impaired observation of the vitreous. 
A dose of 50 дд rhodopsin induced severe inflammation in 80% 
of the injected rats. In most eyes first signs were detectable in 
the anterior chamber. Sometimes inflammatory cells were first 
observed in the vitreous. In all eyes which exhibited severe 
inflammation, the anterior segment was markedly involved. It 
became clear within 2-3 weeks after onset, but some cells 
persisted in the vitreous for another 1-2 weeks. 
After infection of a dose of 20 ¿tg rhodopsin, only one rat 
developed severe uveoretinitis. About 60% of the rats exhibited 
transient, mild ocular inflammation mainly consisting of cells in 
the vitreous. 
Table 6.1: Clinical features of uveoretinitis induced by rhodopsin and 
opsin. 
Antigen 
dose 
(i»g) 
Rhodopsin 
250 
100 
50 
20 
250 
100 
50 
Opsin 0 
250 
100 
50 
250 
Adjuvants 
Ь 
FCA+PA 
FCA+PA 
FCA+PA 
FCA+PA 
FCA 
F CA 
FCA 
FCA+PA 
FCA+PA 
FCA+PA 
FCA 
Animals 
Incidence 
Wl 
(positive/total ) 
12/12 
11/11 
5/5 
10/15 
6/6 
6/6 
5/6 
11/13 
6/6 
3/6 
6/6 
th uveoretinitis 
Mild 
0 
0 
1 
9 
0 
0 
2 
2 
6 
3 
3 
Severe 
12 
il 
4 
1 
6 
6 
3 
9 
0 
0 
3 
Day of 
(mean ; 
10.5 
11.6 
13.в 
19.7 
13.2 
14.3 
16.8 
12.0 
14.5 
15.0 
21.2 
onset 
+S . D. ) 
+ 1.2 
+ 2.2 
+ 3.0 
+ 5.5 
+ 2.3 
+ 1.0 
+ 2.0 
+ 1.9 
+ 1.4 
+ 3.6 
+ 4.8 
Rats were housed under dark room conditions for 8 days postinfection 
and subsequently under normal, diurnal light-dark conditions (a 12 hr 
light, 250 1)(/12 hr dark cycle). 
Rhodopsin in FCA. Without co-injection of pertussis adjuvant 
the onset of uveoretinitis was delayed for a few days for all 
doses applied (Table 6.1) All rats injected with 100 or 250 μς 
rhodopsin developed severe EAU. Fig. 6.1 shows that during the 
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initial and middle stage of development of EAU the scores of 
inflammation induced by 100 μq rhodopsm in FCA alone are lower 
than induced by the same dose in both adjuvants. The rats 
receiving a dose of 50 μg in FCA alone exhibited a lower 
frequency of severe inflammation as compared to the animals 
receiving the same dose in both adjuvants. 
With respect to the first clinical signs of severe 
inflammation we observed a marked difference between the two 
modes of injection (Table 6.2). With pertussis adjuvant, the 
first clinical signs of severe inflammation were always detected 
in the anterior chamber, irrespective of the dose of antigen 
(Table 6.2). However with only FCA as adjuvant, the first signs 
were dose dependent. At lower doses severe inflammation started 
exlusively (50 μg) or mainly (100 /¿g) with cell infiltration of 
the vitreous. Only at the highest dose (250 μg) the pattern was 
similar to the one observed with PA. 
Mild inflammation was consistently restricted to the 
posterior segment of the eye, irrespective of the mode of 
injection used. 
Table 6.2: Effect of pertussis adjuvant as reflected in the first 
clinical features of rhodopsm or opsin induced severe 
uveoretim tis 
Antigen Adjuvant3 Incidence of . Inflammation starting 
dose uveoretimtis anteriorly 
(/¿g) (positive eyes/total) (% of inflamed eyes) 
24/24 100 
20/20 100 
15/20 92 
12/12 83 
12/12 17 
8/12 0 
Rhodopsm 
250 
100 
50 
250 
100 
50 
Opsin 
250 
250 
FCA+PA 
FCA+PA 
FCA+PA 
FCA 
FCA 
FCA 
FCA+PA 
FCA 
15/26 100 
6/12 17 
? Abbreviations as in Table 6.1. 
Housing of animals as in Table 6.1. 
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Opsin in FCA+PA. Rats injected with 250 μg opsin developed 
severe uveoretinitis with a frequency of 70% (Table 5.1). The 
pattern of development was similar to that of severe EAU induced 
by rhodopsin, although the anterior chamber was less seriously 
affected. Two rats showed mild, transient posterior uveitis. 
None of the animals injected with 50 or 100 /¿g opsin 
developed severe inflammation. Inflammatory cells were 
predominantly observed in the vitreous in eyes exhibiting mild 
disease. In these eyes virtually no cells were detected in the 
anterior chamber. 
score 
— ι — 
u 
— ι 1 1 1 1 
16 1Θ 20 
time (days postinjection) 
10 12 
Fig. 6.1: Clinical observations in rhodopsin-and opsin-induced 
EAU. 
Slit-lamp score per injected group (0-8) is plotted 
(i.e. mean score per rat; scores of 2 eyes added up). 
Animals were housed for 8 days in a dark room and 
subsequently in diurnal light conditions (rhodopsin), 
or exclusively in diurnal light conditions (opsin), 
i.e. 12 hr light (250 lx) and 12 hr darkness: 100 /xg 
rhodopsin FCA+PA (·); 100 ^g rhodopsin CFA (•); 100 
/ig opsin FCA+PA ( O ) . Vertical lines represent standard 
errors. 
129 
Opsin in FCA. Rats which received a dose of 250 /ig opsin in FCA 
alone still developed ocular inflammation, albeit with a lower 
incidence of severe uveoretinitis (Table 6.1 and 6.2). Half of 
the animals exhibited severe inflammation with involvement of the 
anterior chamber resembling EAU induced by opsin in FCA+PA. First 
signs of uveoretinitis were observed in the posterior part of the 
eye. 
The other rats developed transient, mild, posterior 
inflammation, with a relatively late onset (Table 6.1). Fig. 6.1 
shows that the score of the 100 /ig group (in FCA+PA) is always 
low ( < 2 ), in comparison to the 100 /ig rhodopsin (FCA+PA) group 
which soon attains a level of > 5. 
6.3.2 Histopathologic features of uveoretinitis induced by 
rhodopsin and opsin 
Different doses rhodopsin or opsin were injected in FCA+PA in 
order to study the histopathological changes during progression 
of clinical disease. We will describe the two major forms of 
uveoretinitis which could be distinguished, a severe form leading 
via panuveitis (total uveoretinitis) to a total elimination of 
photoreceptor cells and a mild form which resulted in focal 
elimination of these cells (Table 6.3). 
Table 6.3: Dose-dependency of rhodopsin induced EAU 
Stage of EAU Severe EAÜ Mild EAU 
(50-250 μ4/ΡΑ+?Ζλ) (20 Дд/РА+ГСА) 
Onset 
Peak of disease 
Final result 
Acute, anterior 
inflammation 
Panuveitis 
Mild posterior 
inflammation 
Focal retinitis 
Total elimination Focal elimination 
of the photoreceptor of photoreceptor 
layer cells 
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Severe form. This type of ocular inflammation developed after 
injection of 50-250 ßg rhodopsin or 250 μ9 opsin per animal. The 
features were essentially the same as those induced by 250 μς 
rhodopsin in agreement with our previous results (section 5.3). 
In short, after first signs of inflammation consisting of mild 
infiltration of mononuclear (MN) and polymorphonuclar (PMN) cells 
in ciliary body and pars plana, the inflammation rapidly extended 
into anterior chamber and retina. Dense infiltrations of PMN's 
and MN's were observed in the retina whereas the choroid became 
involved only in severe stages of disease. Extensive areas of 
edema were present in the nuclear layers together with subretinal 
exudations. 
A dose of 50 μ,ς rhodopsin induced somewhat less severe 
inflammation as reflected by a decreased involvement of the 
anterior chamber. Severe uveoretinitis finally resulted in the 
total absence of the photoreceptor layer in eyes recovered from 
inflammation. No permanent changes in other eye tissues were 
detectable. 
Mild form. A dose of 20 Цд rhodopsin or 50-100 μg opsin induced 
mostly a mild posterior retinitis. This form was also observed in 
a few of the rats injected with 50 /гд rhodopsin (Table 6.1) First 
signs of inflammation consisted of a slight infiltration of MN 
cells in retina and ciliary body (Fig. 6.1a). Subsequently, mild 
retinitis mainly consisting of perivasculitis developed (Fig. 
6.1b). At some sites the infiltration of MN and PMN cells 
extended from a retinal vessel towards the photoreceptor layer 
(Fig. 6.1c). No inflammatory cells were observed in the anterior 
chamber at any stage of inflammation. No involvement of the 
choroid was observed. Mild inflammation usually resulted in a 
typical multiple, focal absence of photoreceptor cells (Fig. 
6.Id). Some eyes exhibited a total elimination of the 
photoreceptor layer. 
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a ,„·. b 
Fig. 6.2: Mild retinitis induced by 20 дд rhodopsin. 
(a) A few mononuclear cells in inner and outer nuclear 
layer, (b) perivasculitis, (c) infiltration of MN and 
PMN cells in photoreceptor layer, (d) typical focal 
absence of photoreceptor cells in the final stage. Bar 
represents 50 μπι. 
6.3.3 Immunological studies 
The immunogenicity of rhodopsin and opsin was studied by 
determination of the humoral and cellular immune responses of 
rats injected with a dose of 100 ¿ig of the respective antigens in 
CFA+PA. This dose of antigen induced a maximum difference in 
pathogenicity between rhodopsin and opsin (Table 6.2; Fig. 6.3). 
Titers were determined at several time points between day 2 and 
13 postinjection. Stimulation indices were measured at 
termination of the experiment (day 13). On this day all rats 
injected with rhodopsin and only one of the rats injected with 
opsin exhibited clinical signs of uveoretinitis. 
All injected rats exhibited a pronounced humoral and cellular 
response against both rhodopsin and opsin. No marked differences 
in the humoral responses were observed between the two groups of 
rats with respect to the time course of development or the 
maximum levels of the titers attained, irrespective of the test 
antigen applied (Fig. 6.3a). 
The cellular immune responses of the two groups were very 
similar, irrespective which test antigen was applied (Fig. 6.3b). 
However, in both groups of rats the stimulation indices 
determined with rhodopsin as test antigen appeared to be 
significantly higher than those with opsin (p = 0.001). For this 
phenomenon we have as yet no explanation. 
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0 2 t 6 β 10 12 14 Rhu Ops Rho Ops testantigens 
days Rho Ops immunogens 
Fig. 6.3: Humoral (a) and cellular (b) immune responses in Lewis 
rats after injection of two groups of 6 animals with 
100 μς of rhodopsin ( О, · ) or opsin ( D, • ). The 
immune responses were determined with rhodopsin (closed 
symbols · / • ) or opsin (open symbols OF Π ) a s 
testantigens. Mean titers have been plotted (n=6; S.D.< 
0.8 ). The horizontal bars represent mean stimulation 
indices. 
6.3.4 Pathogenicity of C-terminal deprived rhodopsin 
In this experiment rats were injected with rhodopsin treated 
with thermolysin (rhodopsin-Th) or with proteinase К 
(rhodopsin-PK, Table 6.3). It has been reported that proteolyses 
of rhodopsin by these enzymes results in removal of a 3 kD 
C-terminal end of the protein (De Grip, 1985; De Grip et al., 
1985). In addition the pigment is clipped in the cytosolic loop 
230-250 (thermolysin), or in the same loop as well as around 
position 141 (proteinase K). However, in the dark adapted state 
the resulting fragments keep together. Hence, the most important 
difference with the native protein is the absence of a 3 kD 
C-terminal fragment (20-25 amino acids). Therefore, this 
preparation is further designated as C-terminal deprived 
rhodopsin. 
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Table 6.4: Clinical features of uveoretinitis induced by C-terminal 
deprived rhodopsin. 
Animals with uveoretinitis 
Antigen 
dose 
(jig) 
Adjuvants 
Incidence Mild 
(positive/total) 
Severe 
Day of onset 
(mean +S.D.) 
Rhodopsin-Th 
250 
Rhodo 
250 
100 
100 
50 
20 
Opsin 
100 
psin-
-PKd 
•PKC 
FCA+PA 
FCA+PA 
FCA+PA 
FCA 
FCA+PA 
FCA+PA 
FCA+PA 
5/5 
5/5 
6/6 
6/6 
6/6 
4/6 
5/6 
15.0 +1.9 
14.2 +1.8 
13.5 +2.8 
14.6 +2.4 
15.3 +2.7 
18.0 +3.8 
14.2 +0.4 
. Abbreviations as in Table 6.1. 
Rhodopsin digested with thermolysin (Th). 
. Rhodopsin digested with proteinase К (PK) 
Rhodopsin digested with proteinase K, and subsequently illuminated. 
All animals injected with 250 /¿g rhodopsin-Th or with 100-250 
μ<3 rhodopsin-PK in FCA+PA developed severe uveoretinitis. The 
onset of severe disease was delayed by 2-5 days as compared to 
rats injected with the same dose of undigested rhodopsin. 
Nevertheless, the pattern of development of severe ocular 
inflammation induced by proteolytic digests ( 100-250 μg ) was 
similar to that induced by rhodopsin. First signs of inflammation 
were observed in the anterior segment of the eye and severe 
panuveitis developed within 1-2 days after onset. 
None of the animals injected with 100 /ig opsin-PK developed 
severe inflammation. On the other hand a dose of 100 /ig 
rhodopsin-PK injected in FCA (without PA), still induced severe 
uveoretinitis in all rats. 
At low doses (20 or 50 μq) rhodopsin-PK, injected in FCA+PA, 
a similar frequency of mild and severe uveoretinitis was obtained 
as with undigested rhodopsin. A dose of 50 /ig induced severe 
posterior inflammation and mild anterior chamber involvement. A 
dose of 20 /ig elicited mild posterior inflammation. 
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The time of onset of uveoretinitis was related to the doses 
injected, as was also observed for the native protein (Table 
6.1). 
Histological examination demonstrated that severe 
uveoretinitis induced by C-terminal deprived rhodopsin (50-250 
/tg) always resulted in a total elimination of photoreceptor 
cells. Most of the eyes of rats injected with 20 μg rhodopsin-PK 
exhibited a total loss of photoreceptor cells as well,although in 
some eyes the photoreceptor cells had disappeared only focally. 
6.4 DISCUSSION 
6.4.1 Pathogenicity and immunogenicity of rhodopsin and opsin 
The observed uveitogenic activity of various doses of 
rhodopsin and opsin confirm our previous finding (chapter 5), 
that in the Lewis rat rhodopsin is considerably more pathogenic 
than opsin. Moreover, at low doses this difference appears to be 
more evident. A dose as low as 20 ¿ig rhodopsin is capable of 
inducing ocular inflammation in 80% of the rats injected. For 
opsin this requires a dose of 50-100 μg. The onset of 
uveoretinitis occurres earlier if higher doses (100-250 /xg/rat) 
are injected. Onset of severe inflammation is always detected 
earlier than that of mild inflammation. 
The higher pathogenicity of rhodopsin relative to opsin is 
also reflected in the differential requirement for PA as 
co-adjuvant. Co-injection of pertussis adjuvant is not a 
prerequisite for induction of severe disease by rhodopsin. For 
all doses tested, the incidence of inflammation is similar 
whether FCA or FCA+PA is used, and a dose of 100-250 ¿ig rhodopsin 
induces severe EAU in all rats injected. On the other hand the 
highest dose of opsin (250 /xg/rat), induces severe inflammation 
with only 50 % incidence when injected without perussis adjuvant. 
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The difference in pathogenicity between rhodopsin and opsin 
cannot be ascribed to a difference in immunogenicity, as far as 
this is measured by the techniques described above. Here we 
demonstrate that even at a dose of 100 ¿ig (where rhodopsin 
induces 100 % severe, bilateral inflammation while opsin induces 
only mild inflammation) no difference is detectable in the 
development and final levels of the antibody titers or in the 
13-day level of lymphocyte sensitization. Probably, immediate 
hypersensitivity phenomena, play a more important role like in 
S-antigen induced uveoretinitis (De Kozak et al., 1981a). 
Although the pathogenicity of rhodopsin is lower than that 
reported for S-antigen and IRBP, it is still of the same order of 
magnitude. A dose of 50 μg rhodopsin exhibits an uveitogenic 
capacity comparable to that of a 5 times lower dose (4-15 μς) 
IRBP or S-antigen (Rao et al., 1979; De Kozak et al. , 1981b; 
Gery et al., 1905; Broekhuyse et al., 1986). 
6.4.2 Dose-dependency of rhodopsin and opsin induced forms of 
uveoretinitis 
After injection of rhodopsin or opsin in FCA+PA considerable 
differences in the intensity and location of ocular inflammation 
relating to the amount of antigen injected are observed. Severe 
panuveitis, leading to a total elimination of the photoreceptor 
layer is noticed in rats receiving 50-250 .^g rhodopsin or 250 /ig 
opsin. Mild retinitis is predominantly observed in rats injected 
with 20 ¿ig rhodopsin or 50-100 дд opsin and results in a typical, 
multiple focal elimination of photoreceptor cells, which has not 
been observed as such in S-antigen and IRBP induced EAU (Gery, et 
al., 1986; Broekhuyse et al., 1986). 
The dose-dependency of EAU induced by rhodopsin appears to be 
more pronounced than that induced by S-antigen in Lewis rats ( De 
Kozak et al., 1981b). However, PMN leukocytes were lacking in 
cell infiltrates at the lowest dose levels (1-5 ^g) in 
S-antigen-induced EAU in guinea pig (Rao et al., 1979). This 
feature was not detected in EAU induced by the lowest dose of 
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rhodopsin (20 μς) applied in our studies. 
The issue of EAU as a model for human uveitic conditions has 
been extensively discussed (Gery et al., 1986). EAU shows 
variable homology with several types of human uveitic conditions 
depending on various parameters such as the type and dose of 
retinal antigen, the species and the type of adjuvant used to 
induce experimental disease. Therefore, it is to be expected that 
elucidation of the mechanisms responsible for the development of 
uveoretinitis in the different experimental models will shed 
light on human disease. 
6.4.3 Influence of pertussis adjuvant 
The time of onset of ocular inflammation is accelerated by 
co-injection of pertussis adjuvant (Table 6.1 and Fig. 6.1). This 
agrees well with findings reported for S-antigen and IRBP-induced 
uveoretinitis (De Kozak et al., 1981a; Broekhuyse et al., 1986). 
In addition, co-injection of pertussis adjuvant appears to 
have a pronounced influence on the localization of the 
inflammation induced by rhodopsin (Table 6.2). This is a 
phenomenon which has not been reported for any of the other 
retina-specific antigens (S-antigen or IRBP). The increased 
involvement of the anterior chamber after injection of rhodopsin 
in FCA+PA as compared to injection in FCA alone, is probably 
related to the more acute reaction induced by the additional use 
of pertussis adjuvant. It has been noted before ( De Kozak et 
al., 1981b; Gery et al., 1986) that acute ocular inflammation 
starts preferentially in the anterior segment. 
The effects of pertussis adjuvant are not yet fully 
understood. It has been reported to stimulate humoral and 
cellular immune responses in opsin-induced EAU (Broekhuyse et al. 
, 1987a).McAllister et al. (1986) recently reported a suppression 
of the antibody responses after injection of S-antigen in rats 
pretreated with pertussis toxin ( the purified active component 
138 
of Bordetella pertussis bacteria). Furthermore, by using adoptive 
transfer they found indications that pertussis toxin acts mainly 
at the afferent limb of the immunopathogenic process which evokes 
EAU. Possibly vasodilation caused by direct action of the 
adjuvant or indirectly via mast cell activation plays an 
important role. This may result in a partial breakdown of the 
blood-retina barrier, which enhances the contact between the 
immune system and the photoreceptor cell antigens. 
6.4.4 The C-terminal end does not contribute to the uveitogenic 
capacity of rhodopsin 
Soluble N-terminal polypeptides obtained by enzymatic 
digestion of rhodopsin were shown to lack pathogenic activity in 
guinea pig (Marak et al., 1980). In our studies in rat, 
C-terminal deprived rhodopsin (rhodopsin-PK), prepared by 
proteolytic digestion of rhodopsin, exhibits an uveitogenic 
activity similar to rhodopsin. The freguency of ocular 
inflammation, the pattern of development of severe uveoretinitis 
and the histological changes induced by rhodopsin-PK are similar 
to those induced by the same doses of rhodopsin. After 
proteolytic digestion of rhodopsin by proteinase К the pronounced 
difference in pathogenicity between rhodopsin and opsin is 
preserved. As in rhodopsin-induced EAU, co-injection of pertussis 
adjuvant is not a prerequisite for induction of severe 
uveoretinitis by rhodopsin-PK. 
In the pool of proteolytic fragments of rhodopsin-PK a 3 kD 
C-terminal end (20-25 amino acids) is absent (Fig. 1.4). 
Furthermore a small peptide of 14 residues is removed from the 
5-6 loop by cleavage with proteinase К around position 231 and 
245. Apparently these parts of the molecule contribute little to 
the pathogenicity of bovine rhodopsin. This indicates that no 
potent uveitogenic site is present on the C-terminal end of 
rhodopsin although it does contain an antigenic site (De Grip, 
1985). Probably the amino terminal part of rhodopsin, which 
contains the principal antigenic site (Hargrave et al., 1986), 
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also contains the main uveitogenic site. Interestingly, this part 
of the rhodopsin molecule is exposed to the extra-cellular matrix 
around the photoreceptor cell, as a consequence of its 
orientation in the plasma memmbrane. Thus, the N-terminal end of 
rhodopsin is relatively prone to interaction with the immune 
system (e.g antibodies or lymphocytes). 
Preliminary experiments carried out in our labotatory confirm 
this concept. A synthetic N-terminal peptide (residue 2-32), 
kindly provided by Dr. P.A. Hargrave, was linked to bovine serum 
albumin and injected in rats. Thirty percent of these rats 
exhibited mild signs of uveitis, which was confirmed by 
histology. Hence, this approach seems to be promising and further 
studies using purified peptide fragments of rhodopsin obtained by 
proteolytic or cyanogen bromide cleavage, or by organic 
synthesis, will be essential in identifying the dominant 
uveitogenic determinants of rhodopsin. 
6.5 CONCLUSIONS 
We have studied the clinicopathological features of 
experimental autoimmune uveoretinitis (EAU) induced in Lewis rat 
by injection of rhodopsin or opsin. Rhodopsin is clearly more 
pathogenic, injection of 50 /xg rhodopsin induces a similar 
frequency of severe EAU as of 250 μg opsin ( in Freund's complete 
adjuvant and pertussis adjuvant). Intensity, frequency and 
location of ocular inflammation in rhodopsin-induced EAU are dose 
dependent. A high dose (100-250 /xg) rhodopsin induces severe, 
bilateral uveoretinitis in all animals, starting with acute 
inflammation of the anterior eye segment at day 10-12, followed 
by chorioretinitis (predominantly retinitis). The photoreceptor 
cells are completely destroyed. A low dose (20 μg) induces mild 
transient inflammation in 60% of the animals, mainly consisting 
of mild posterior retinitis starting at day 20, leading to a 
typical multiple focal destruction of the photoreceptor cells. 
Moderate doses cause an intermediate type of disease. 
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Omission of pertussis adjuvant lowers the frequency of severe 
disease at low doses of rhodopsin, delays its onset and changes 
its features. The latter phenomenon has been observed in 
particular at moderate doses (50-100 μ<3). In these cases EAU 
starts usually by cell infiltration of the vitreous, while the 
anterior segment is only mildly affected. 
Injection of opsin in both adjuvants induces severe EAU with 
an acute inflammation only at a high dose. Without pertussis 
adjuvant the pathogenicity of opsin is low. 
As different from their uveitogenicity, the immunogenicity of 
rhodopsin and opsin is similar and thus seems not be to 
correlated with their pathogenicity. 
Rhodopsin lacking a 3 kD C-terminal fragment exhibits similar 
uveitogenic activity as the intact protein. Hence, this rhodopsin 
fragment does probably not contain an uveitogenic site. 
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CHAPTER 7 
RHODOPSIN-INDUCED EXPERIMENTAL AUTOIMMUNE UVEORETINITIS 
IN MONKEYS 
J.J. Schalken, H.J. Winkens, A.H.M. van Vugt, 
W.J. De Grip and R.M. Broekhuyse 

7.1 INTRODUCTION 
Autoimmune reactions against retina-specific proteins are 
suspected to play an important role in the pathogenesis of 
uveitis. Uveitis-like disease can be experimentally induced in 
animals like rat, guinea pig and monkey by injection of these 
proteins. 
As a model for human disease, primates are of particular 
interest in this kind of studies. Up till now three uveitogenic 
retinal antigens have been reported: S-antigen (Wacker,1981 ; De 
Kozak et al., 1981a; Marak and Rao, 1982) which is a soluble, 48 
kD, photoreceptor-specific protein involved in the 
phototransduction process; the rod visual pigment rhodopsin and 
its illuminated form opsin (Marak et al., 1980; Meyers-Elliott et 
al., 1983; Broekhuyse et al., 1984, 1987a) and the 
interphotoreceptor retinoid binding protein (IRBP; Gery et al., 
1986; Broekhuyse et al., 1986). In purified form ,these antigens 
have been reported to induce uveoretinitis in primates (Paure et 
al., 1981, Nussenblatt et al., 1981; Broekhuyse et al., 1987b,с). 
Impure preparations of rhodopsin were also shown to induce 
uveoretinic changes in primates at a high dose (5mg) (Wong et 
al., 1977). 
We have shown that in the Lewis rat rhodopsin is considerably 
more pathogenic than opsin (chapter 5 and 6). This might have 
consequences for the understanding of the pathogenesis of human 
uveitis and for the development of diagnostic immunological 
assays. In the present communication we report on the induction 
of uveoretinitis by purified rhodopsin in primates. The clinical 
state, histological changes and the cellular and humoral immune 
responses of the injected animals have been evaluated. 
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7.2 MATERIALS AND METHODS 
7.2.1 Preparation of antigens 
Bovine rod outer segment membranes and highly purified 
lipid-free rhodopsin were prepared as described before (De Grip 
et al., 1980; section 5.2). Only trace amounts of S-antigen (< 
0.01%) and no IRBP could be detected by Western-blotting 
(Broekhuyse et al., 1986,87a; section 5.2) using specific 
antisera. Because detergents interfere with the tests for the 
immune responses a reconstituted rhodopsin preparation was used 
as test antigen (section 5.2). All procedures involving rhodopsin 
were performed under dim red light (Λ> 620 nm). In order to 
prepare opsin,a rhodopsin preparation was illuminated just before 
use by means of a 100 W tungsten lamp at 30 cm distance for ten 
minutes at room temperature. Bovine S-antigen and IRBP were 
prepared as described before (Broekhuyse and Bessems, 1985; 
Broekhuyse et al., 1986). 
7.2.2 Immunization, clinical observation and histological 
evaluation 
Female stump-tailed macaques (Macaca artoides) were injected 
with 650 дд rhodopsin under dim red light. About 400 μg of 
antigen was emulsified in one ml Freund's complete adjuvant 
(Difco, Detroit) and injected subcutaneously on ten sites 
interscapularly. The rest of the antigen was injected 
intraperitoneally in one ml pertussis vaccin ( Hemophilus 
9 
pertussis, 10 microorganisms, 1.25 mg aluminium hydroxid, 
Institut Pasteur, Paris). The animals were housed under dark room 
conditions for ten days and subsequently housed under normal 
diurnal light-dark conditions. Under these conditions injected 
rhodopsin was protected against light during the critical phase 
of exposure to and interaction with the immune system. 
Experiments with rats showed that 8 days housing in darkness are 
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sufficient to reach this goal. Housing in darkness for such a 
short period does not significantly influence the development of 
EAU in rat (section 5.3). 
Clinical signs of uveitis were monitored at least twice a 
week by slit-lamp examination starting on day ten postinjection 
and were scored as described before ( Broekhuyse et al., 1987a). 
Occasionally fundi were examined by indirect ophthalmoscope. 
For histology animals were killed at various stages of 
clinical disease. Eyes were fixed in Bouin fluid, embedded in 
paraffin and 5 /im sections were stained with hematoxylin and 
eosin. One monkey (L64) was sacrificed immediately after onset 
of uveitis,one animal at an intermediate (L70) and one at a 
severe (L76) stage of inflammation. The fourth monkey (L77) was 
sacrificed about seven weeks after onset of ocular inflammation 
when the disease appeared clinically in the regression stage. 
7.2.3 Immune responses 
The humoral and cellular immune responses were determined 
weekly until the animals were sacrificed using an enzyme-linked 
immunosorbent assay (ELISA) and lymphocyte transformation test 
(LTT), respectively. In the latter assay rhodopsin, opsin and 
S-antigen were applied as test antigen. In the ELISA, IRBP was 
used as additional test antigen. Because IRBP was contaminated 
with a small amount of concanavalin A, this antigen could not be 
included in the LTT. Optimal antigen concentrations were 
determined in previous experiments. 
The ELISA was carried out essentially as described before 
(chapter 5.2) using a reconstituted rod outer segment membrane 
preparation containing 5 pmoles rhodopsin protein (based on 
absorbance spectroscopy) per ml 0.02 M phosphate buffered saline 
(pH 7.6 ) to coat the wells. As second antibody we used an 1:1000 
diluted mixture of anti-human IgG and anti-human IgM conjugated 
to alkaline phosphatase ( Sigma,St.Louis ) . Titers were 
determined graphically as the dilution of serum required to give 
an absorbance over a background of 0.5. A dilution of 1:50 
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corresponded to a titer of 1, 1:100 to a titer of 2, 1:200 to a 
titer of 3 and so on. Normal (negative) monkey sera exhibited a 
titer of 1. 
Cellular immune responses were determined using lymphocytes 
separated from heparinized blood by lymphocyte separation medium 
(Boehringer,Mannheim). The lymphocyte transformation test was 
carried out as described before (section 5.2; Broekhuyse et al., 
1984), with slight modifications. The cells (0.3x10 per ml) 
were incubated in MEM-medium (Gibco, Breda) containing 20 mM 
HEPES, 10% heat-inactivated monkey serum, 100 lU/ml penicilin and 
100 μg/ml streptomycin in presence or absence of antigen (in Nunc 
tubes). Five micrograms of one of the test antigens was added per 
ml cell suspension whereas functional viability was tested by 
addition of 25 pg of pokeweed mitogen (Gibco,Breda). After an 
incubation for two days, Η-thymidine (Amersham) was added at a 
concentration of 0.5 ¿ici per tube. Following a further incubation 
for 24 hr, the cells were harvested and filter-bound 
radioactivity was determined. All samples were manipulated under 
dark room conditions until the cells were harvested. Results were 
expressed as stimulation indices (SI), as follows: 
SI=counts per minute in presence of antigen/counts per minute in 
absence of antigen 
As described before (section 5.2), a stimulation index >2 was 
considered to be positive. 
148 
7.3 RESULTS 
7.3.1 Clinical evaluation 
Each of the four monkeys injected with rhodopsin developed 
clinical signs of uveoretinitis within 21-24 days postinjection 
(Table 7.1). The first clinical feature was a mild cell 
infiltration in anterior chamber and vitreous. Mild uveitis 
developed into a severe panuveitis within 2 weeks after onset 
(L76 and L77). The anterior chamber was seriously affected by 
then and dense cell infiltrations and Tyndall impaired 
observation of the vitreous and fundus. The ins was mildly 
affected, while virtually no hyperemia or adherence to the lens 
were observed. At this stage the retinopathy consisted of 
arterial and venous perivasculitis accompanied by sheating of the 
retinal blood vessels and a focally edematous retina. In addition 
edema of the nerve head and hyperemia of the optic disc were 
observed. About 6 weeks after clinical onset inflammatory cells 
had disappeared from the anterior segment, but some cells 
remained in the vitreous. 
Table 7.1: Clinical features of rhodopsin-induced uveoretinitis 
in monkey 
Monkey Day of Day of Slit-lamp score 
nr. onset listed 
score 
OS OD 
AC Vltr. AC Vltr. 
21 
24 
31 
24 
41 
48 
55 
70 
0 
2+/3 + 
4 + 
0 
2 + 
3+ 
1 + 
0 
0 
3 + 
-
1 + 
2+ 
2 + 
1 + 
1 + 
2+ 
1 + 
2+ 
0 
3 + 
3+ 
2 + 
0 
2 + 
2 + 
2+ 
0 
4+ 
2 + 
1 + 
1 + 
Score on the day the animal was sacrificed (L64, L70, L76); 
in addition for L77 also the score on days when the eyes 
, exhibited typical characteristics of inflammation are listed. 
A.C., anterior chamber; Vitr., vitreous. 
Conventional scores; 1+, a few cells; 4+, dense cell infiltrations. 
0, normal appearence; -, not visible. 
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L 64 21 
L 70 23 
L 76 24 
L 77 24 
7.3.2 Histopathology 
As described above the monkeys were sacrificed at various 
stages of ocular inflammation in order to study the development 
and regression of uveoretinitis by histology (Table 7.2). In each 
case the clinical features appeared to be in agreement with the 
histological observations. 
All monkeys showed first signs of ocular inflammation between 
day 21 and 24 postinjection and exhibited a similar course of 
disease in the early stages. In view of this homogenous response 
we assumed that the development of inflammation followed a 
similar pattern in all animals. 
Initial stage. At the first signs of clinical onset a few 
mononuclear (MN) cells were present in the ciliary body and pars 
plana while in the rest of the eye no signs of inflammation were 
detected (L64 OS and L70 OD, Table 7.2). 
One day after onset (slit-lamp score 1+/3+, L64 OD and L70 
OS) mainly peripheral chorioretinitis was observed. Dense 
infiltrations consisting of mononuclear (MN) and many 
polymorphonuclear (PMN) cells were locally present in choroid and 
retina together with a perivasculitis. The anterior chamber, 
ciliary body and pars plana exhibited a mild infiltration of MN 
and PMN cells, no inflammatory cells were detectable in the iris. 
Severe stage. This stage developed in OS of monkey L76 . Dense 
MN and PMN infiltrations were found in ciliary body, pars plana 
and ora serrata ( Fig. 7.1). Occasionally an accumulation of 
mononuclear cells was observed in the region of pars plana and 
ciliary body (Fig. 7.1c). The anterior chamber and iris were 
seriously affected. 
Severe edema was found in the peripheral choroid while the 
central part showed moderate edema (Fig. 7.2). 
In the entire retina, excudates and retinal détachements were 
observed together with a local damage of the photoreceptor cells. 
At these sites the pigment retinal pigment epithelium was 
disrupted. The central area of the retina exhibited most severe 
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s igns of inf lammation c o n s i s t i n g of MN's and many PMN's, 
p e r i v a s c u l i t i s and edematous a r e a s in the inner and ou te r nuc l ea r 
l a y e r s ( F i g . 7 . 2 ) . The o p t i c nerve showed mild p e r i v a s c u l i t i s of 
the manor c e n t r a l r e t i n a l v e s s e l s . 
Table 7.2: Review of histopathological features of rhodopsin-
induced EAU in monkeys 
Stage 
Initial 
Interme-
diate 
Severe 
Regres-
sion 
Eyea 
L64 OS 
L70 OD 
L64 00 
L70 OS 
L76 OD 
L76 OS 
L77 OS 
L77 OD 
Severity of 
AC 
1 + 
1 + 
1+/2+ 
2 + 
1 + 
3+ 
1 + 
2+ 
CB/PP 
1 + 
1+ 
2 + 
2 + 
1 + 
3 + 
1 + 
1 + 
inflammation 
Penph 
Choroid 
0 
0 
3+/4 + 
3+/4 + 
4 + 
4+ 
4+ 
4+ 
b 
1 
lery 
Retina 
0 
0 
3+/4 + 
3+/4 + 
4+ 
4 + 
1+ 
1 + 
Central 
Choroid 
0 
0 
0 
0 
0 
3+/4+ 
2 + 
1+/2 + 
Retina 
0 
0 
0 
0 
0 
3+/4 + 
3+/4 + 
3+/4 + 
ON 
0 
0 
0 
0 
0 
1 + 
2 + 
2 + 
. Monkey number and eye are i n d i c a t e d . 
Scores as in Table 7 . 1 . AC, a n t e r i o r chamber; CB c i l i a r y body; 
PP, pars p lana ; ON, op t i c nerve. 
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Fig. 7.1: Anterior segment of the eye during the stage of severe 
inflammation. 
Dense infiltrations of MN and PMN cells in ciliary body 
(a) and pars plana(b); accumulation of MN cells in the 
region of pars plana-ciliary body (c). Bar represents 
50 μιπ. 
.·» ρ, \ ·* 
Fig. 7.2: Posterior segment of the eye during the stage of severe 
inflammation. 
Peripheral chorioretinitis consisting of heavy MN and 
PMN cell infiltrations, exudate, retinal detachement 
and severe choroidal edema (a); severe retinitis in the 
central part with inflammatory cells, perivasculitis, 
edematous areas in the nuclear layers, accompanied by 
choroiditis (b). Bar represents 50 μη. 
Regression stage.Seven weeks after onset of uveitis, when the 
disease was in the regression stage (Table 7.1), signs of severe 
inflammation were still present. 
In pars plana and ciliary body mononuclear cells were 
observed (Fig. 7.3a). In the peripheral retina the photoreceptor 
cells had disappeared completely and no inflammatory cells were 
detectable. In the choroid there were still many mononuclear 
cells. Furhermore, severe edema and cells containing phagocytized 
pigment were observed. The pigment epithelium showed extensive 
focal damage with dispersion of pigment (Fig. 7.3b) In the 
periphery, pigmented cells were observed in exudates between 
retina and choroid (Fig. 7.3c). 
In the central area of the choroid, edema was relatively 
moderate whereas a mild infiltration of mononuclear cells was 
observed. The central retina still exhibited a mild inflammation 
with MN's and PMN's and perivasculitis. The photoreceptor cells 
were severely damaged or completely eliminated (Fig. 7.4). In the 
optic nerve head a dense infiltration of mononuclear cells was 
observed accompanied by perivasculitis of the retinal vessels. 
In general, retinitis dominated in the posterior part of the 
eye, while severe inflammation affected both choroid and retina 
in their peripheral region. 
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Fig. 7.3: Stage of regression of the inflammation. 
Edema and many mononuclear cells in pars plana (a). 
Peripheral retina and choroid: absence of photoreceptor 
cells, MN cells and edema in choroid and focal damage 
of pigment epithelium with dispersion of pigment (b); 
heavily pigmented cells in the subretinal space (c). 
Bar represents 50 μτη. 
^ 
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Central part of choroid and retina during regress: 
inflammation. 
Retinitis and moderate edema of the choroid 
infiltration of MN cells in optic nerve head, 
retinal perivasculitis (b). Bar represents 50 /im. 
(a); 
with 
7.3.3 Immune responses 
The cellular and humoral immune responses of the monkeys were 
determined at weekly intervals. No significant differences were 
observed between either rhodopsin or opsin as test antigen. The 
results obtained with rhodopsin as test antigen are shown in Fig. 
7.5. 
0 1 2 3 4 5 
time (weeks) 
stimulation index 
100 
Θ0 
60 
АО-
го 
1 0 -
6 -
0 1 2 3 4 5 
time (weeks) 
Fig. 7.5: Immune responses of monkeys injected with rhodopsin. 
Antibody titers were determined by ELISA (a), 
stimulation indices were determined by LTT (b), with 
rhodopsin as test antigen. Symbols represent the 
following animals: L64 ( O ) , L70 ( D ) , L76 (Δ) and L77 
( · ) . 
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The time course of the development of the antibody titers 
showed a similar pattern for all animals (Fig. 7.5a). The titers 
kept increasing at least up to 3-4 weeks postinfection. The 
antibody titer of monkey L77, which could be followd for a longer 
period, reached a maximum level of about 11 in week 6. This level 
was maintained for the subsequent weeks (not shown) until the 
animal was sacrificed. No antibodies against S-antigen or IRBP 
were detectable by ELISA. 
The cellular immune response, as determined by the lymphocyte 
transformation test exhibited a different pattern (Fig. 7.5b). 
The stimulation indices also increased sharply during the first 
two weeks postinfection but then appeared to level off (L70 and 
L76) or even to decrease (L64 and L77). The stimulation indices 
determined in week 4 for the remaining two monkeys (L76 and L77), 
confirm this trend. The stimulation index of monkey L77 which was 
measured until week 10 postinjection fluctuated during weeks 5-10 
postinfection around an average value of 5 ( ±3 S.D., n=5). 
Occasionally a slight cellular response against S-antigen was 
measured, but no consistent sensitization was detectable. 
7.4 DISCUSSION 
7.4.1 Pathogenicity of rhodopsin 
Rhodopsin appears to be markedly pathogenic in the monkey as 
shown by its capacity to induce a severe non-granulomatous 
uveoretinitis in all animals tested. The preparation used was 
highly purified (section 5.2) and a dose of 650 |ig per animal was 
injected. 
Constrains in the availability of the Macaca artoides did not 
allow us to investigate dose dependency. In our laboratory a dose 
of 650 /¿g opsin has recently been shown to induce severe EAU in 
only 2 out of 9 monkeys (also Macaca artoides) with much later 
onset (6-10 weeks, Broekhuyse et al., 1987a). In that study the 
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visual pigment was solubilized in a mild non-ionic detergent 
( Triton X-100) whereas in the experiments described above the 
very mild detergent nonylglucose was applied. In the Lewis rat 
the pathogenicity of opsin dissolved in either of these 
detergents was similar. (Broekhuyse et al., 1984; section 5.4). 
This indicates that when comparing the results described above, 
using rhodopsin in nonylglucose with those described by 
Broekhuyse et al. (1987a), using opsin in Triton X-100, detergent 
effects are of minor importance. Hence, we may conclude that also 
in monkey rhodopsin appears to be considerably more pathogenic 
than opsin, in agreement with the results obtained in rat 
(chapter 5 and б). 
For S-antigen-induced EAU in the monkey no extensive 
experiments with respect to dosimetry have been reported either. 
However, the doses employed (50-225 pq, cf. Paure et al. 1981; 
Nussenblatt et al., 1981), together with the frequency and 
severity of EAU and the time of onset (3-4 weeks) are indicative 
of a higher pathogenicity for S-antigen as compared to rhodopsin. 
7.4.2 Clinicopathological features of rhodopsin-induced EAU 
Rhodopsin induces a severe non-granulomatous chorioretinitis 
with an anterior uveitis and vitreal clouding. In comparison with 
opsin-induced uveoretinitis in monkey (Broekhuyse et al., 1987b), 
rhodopsin evokes a more severe chorioretinitis and an increased 
involvement of the anterior chamber, similar to that observed for 
S-antigen (Nussenblatt et al., 1981; Paure et al., 1981). The 
histological changes share some characteristics with those 
described for S-antigen-induced EAU in Cynomolgus monkeys, like 
vasculitis and chorioretinitis which remain active for a long 
period (Paure et al., 1981). This is in contrast with the lack of 
choroidal involvement in S-antigen-induced EAU in rhesus monkeys 
as reported by Nussenblatt et al. (1981). 
Rhodopsin-induced EAU in monkeys differs from uveoretinitis 
induced by rhodopsin or opsin in Lewis rats, where the choroid 
only becomes involved during severe stages of inflammation and 
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retinitis dominates (Broekhuyse et al., 1984; chapter 5). In 
guinea pig, opsin primarily induces chorioiditis, accompanied by 
retinopathy without any detectable inflammatory cells in the 
retina (Meyers-Elliott et al., 1983) or by focal extension of the 
inflammation into the photoreceptor outer segment layer (Marak et 
al., 1980). As discussed before, features of EAU may differ among 
the tested species due to anatomical factors such as absence of 
retinal blood vessels in guinea-pig. 
Uveoretinitis induced by rhodopsin shows some similarities 
with human uveitic conditions like in sympathetic ophthalmia. 
Some of the common features are non-granulomatous choroiditis, 
retinal detachment, intra-retinal inflammation and macular edema 
together with anterior uveitis and papillitis (Marak et al., 
1979; Lubin et al. , 1979). In rhodopsin-induced EAU we observed 
no Dalen-Fuchs nodules, which used to be considered a rather 
characteristic feature of sympathtic ophthalmia. In fact in 
sympathetic ophthalmia these cell accumulations are only observed 
in 25-35% of the cases. We observed that, like in the human 
disease, the inflammation in rhodopsin-induced EAU appears to 
start in the ora serrata and ciliary body and seems to extend 
anteriorly as well as posteriorly into the choroid, retina and 
vitreous. A similar developmental pattern was observed in EAU in 
monkeys induced by a low dose of IRBP (Broekhuyse et al., 1987c). 
7.4.3 Immune responses 
Monkeys injected with rhodopsin display a high cellular and 
humoral immune response against both rhodopsin and opsin. The 
maximum level of the humoral response apparently had not yet been 
reached at the time of onset of disease. In monkey L77 the 
antibody titer steadily increased until 5-6 weeks postinjection 
(2-3 weeks after onset). The stimulation index, however, appeared 
to level of or peak just before clinical onset of disease ( 2-3 
weeks postinjection). This may indicate that the cellular immune 
response plays a crucial role in the pathogenesis of 
rhodopsin-induced EAU in primates as was also found in various 
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forms of EAU in rat (Gery et al., 1986; Broekhuyse et al., 1986). 
The humoral response elicited in monkey by injection with 
opsin (Broekhuyse et al., 1987b) developed in a similar pattern 
as that in rhodopsin-injected animals. However, the cellular 
response of the animals injected with opsin was still at a low 
level 3 weeks postinjection ( SK3 ) and reached a maximum after 
5-6 weeks. This again indicates that the development of the 
cellular immune responses after injection with rhodopsin or opsin 
appears to be related to the time of onset of EAU. This further 
supports the concept that the cellular immune response is a major 
factor in the pathogenesis of (rhod)opsin-induced EAU. This is in 
accordance with the generally accepted idea of EAU being a model 
of a T-cell mediated autoimmune disease. 
Because of the similarities between the experimental, 
clinical and histological changes, and those seen in some human 
uveitic conditions, the model of rhodopsin-induced EAU in monkey 
might be a valuable tool in the study of pathogenesis of uveitis, 
in the development of highly sensitive immunological assays for 
diagnostic purposes as well as in therapeutical trials. 
7.5 CONCLUSIONS 
Rhodopsin is a potent pathogenic retinal protein which 
induces experimental autoimmune uveoretinitis upon injection in 
monkeys. A dose of 650 ^g of a highly purified rhodopsin 
preparation is shown to induce severe posterior uveoretinitis 
with concomitant anterior uveitis, in all animals tested. The 
first clinical features consist of cells in the anterior chamber 
and vitreous appearing 21 to 24 days postinjection, which are 
soon followed by uveoretinitis. The disease frequency is much 
higher and the inflammation is more severe than in EAU induced 
under equal conditions by opsin. 
By histology the first inflammatory cells are observed in 
ciliary body and pars plana. The next days the inflammation 
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extends into anterior chamber and into choroid and retina. In 
severe stages of disease dense cell infiltrations are present in 
choroid and retina whereas the choroid exhibits extensive edema. 
Retinitis dominates in the central area, while chorioretinitis is 
observed in the periphery. The photoreceptor cells are destroyed 
and seven weeks after clinical onset only a few of these cells 
are left. Optic nerve and choroid then still show signs of heavy 
inflammation. 
The monkeys develop high cellular and humoral immune 
responses against rhodopsin and opsin. The time course of the 
development of the cellular respons appears to be related to the 
time of onset of EAU, which indicates an important role for 
cellular immunity in the pathogenesis of rhodopsin-induced EAU. 
Because this experimental model shows some similarities with 
human uveitic conditions it may be a valuable tool in the study 
of the pathogenesis of human uveitis. 
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CHAPTER 8 
GENERAL DISCUSSION 

8.1 Introduction 
Autoantigens can be defined as tissue antigens that elicit an 
immune reaction leading to pathological manifestations in 
corresponding tissues. Many autoantigens are organ specific and 
exhibit a very limited species specificity. From the work 
described in this thesis it can be concluded that rhodopsin 
certainly fulfills these criteria. Antisera elicited against 
various bovine rhodopsin preparations showed considerable 
cross-reactivity with a range of vertebrate (rhod)opsins. 
There is no longer doubt about the participation of 
autoimmune processes in certain ocular diseases. The conclusion 
of the autoimmune nature of a given disease is to be drawn from a 
series of arguments. One of the most valuable arguments is the 
similarity of the lesions of human disease to those in an 
experimental model of autoimmune disease induced by immunization 
of animals with tissue antigens. Direct proof of autoimmunization 
can only be derived from positive serological and cellular 
hypersensitivity tests to tissue antigens in the patients. It 
must be emphasized that autoimmune mechanisms are not necessarily 
the primary cause of a disease. They may occur as well 
secondarily as a result of tissue alterations of other etiology 
and thus be responsible for prolongation and/or aggravation of 
the disease. In the following section some of the most prominent 
characteristics of rhodopsin-induced experimental autoimmune 
disease will be further discussed. 
8.2 Pathogenicity of rhodopsin 
The pathogenicity of the rod visual pigment in experimental 
autoimmune uveoretinitis in rats appears to be related to at 
least three factors: (1) the biochemical integrity of the antigen 
preparation, (2) the doses injected and (3) the adjuvant 
co-injected. Maximum ocular inflammatory response is obtained by 
injection of a relatively high dose ( 100-250 μg) of rhodopsin, 
solubilized in a very mild detergent (nonylglucose), using both 
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Freund's complete adjuvant and pertussis adjuvant. This high 
uveitogenicity or pathogenicity is reflected in the induction of 
severe disease in a high freguency, with an early onset and in 
the form of a panuveitis. 
As previously reported, the immunogenicity of opsin is 
related to its biochemical integrity. Opsin treated with the 
strongly denaturing detergent dodecyl sulfate was shown to be 
less immunogenic (and pathogenic) than opsin treated with the 
milder detergent Triton X-100. However in the present study no 
difference in immunogenicity was observed between rhodopsin and 
opsin. This indicates that either the differences in 
immunogenicity are beyond the accuracy and/or sensitivity of the 
applied assay, or that a too limited set of immunological 
parameters was determined. Apparently the difference in 
immunogenicity between opsin or rhodopsin in a mild detergent is 
less pronounced than the difference in immunogenicity between 
opsin solublized either in dodecyl sulfate or in Triton. 
The pathogenicity of the rhodopsin preparation used in this 
study is considerably higher than that of the opsin preparation 
used in the studies reported previously. In the Lewis rat its 
pathogenicity is a factor of 5-10 times higher. The pathogenicity 
of rhodopsin appears to be lower (5-10 times) than that of 
S-antigen or IRBP. No data are available yet on the relative 
immunogenicity of these retina-specific antigens. The molar ratio 
in the retina, of S-antigen:rhodopsin is reported varying from 
1:1 to 1:10, whereas the IRBP:rhodopsin ratio is about 1:10. 
Neglecting the differences in solubility, this means that these 
respective antigens would be released in similar quantities upon 
retinal trauma. This suggests that these three retina-specific 
antigens may all contribute to human uveoretinitis. It is 
therefore worthwhile to consider using a cocktail of these 
antigens to induce EAU and to investigate the differential immune 
responses. 
In rats injected with either rhodopsin or opsin no 
differences were found in the level of the cellular and humoral 
immune responses, or in the time course of development of the 
humoral response. However, in monkey the time course of 
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development of the cellular immune response appeared to be 
related to the onset of EAU. Probably, an early cellular response 
is related to a highly uveitogenic response. 
No explanation is available yet for the higher pathogenicity 
of rhodopsin in comparison to opsin. Possibly the difference in 
pathogenicity is not caused by a difference in the level or time 
course of the induced immune responses, but is it related to the 
avidity of the elicited immune response for the endogenous 
membrane bound pigment as it is present in the rod outer 
segments. This means that the most 'native' preparation would 
induce the immune response which best recognizes the rod visual 
pigment, and therefore would posses the highest pathogenicity. 
However, no evidence supporting such an argument was provided by 
the in vitro immunological assays. In rat the cellular immune 
response measured with rhodopsin as test antigen was 
significantly higher than measured with opsin as test antigen, 
but the same phenomenon occurred with either rhodopsin or opsin 
as pathogen. In monkey this was not observed. 
8.3 Clinicopathological and histological features 
The clinicopathological features of EAU induced by rhodopsin 
are dependent on the dose injected and on the adjuvant. In 
addition these features seem to differ between different 
species. In monkey severe chorioretinitis was observed throughout 
the inflammatory response, whereas in rat even at the highest 
doses injected the choroid became only involved during 
the progression phase of disease. Moreover, choroidal involvement 
in monkey was more pronounced. One cannot exclude the possibility 
that these differences in clinicipathological features are due to 
different doses of antigen used in these studies. Therefore, the 
dose dependency of EAU in monkeys should be further investigated. 
Clinicopathological features of EAU in Lewis rat induced by 
S-antigen, IRBP or rhodopsin show many similarities. However, the 
typical local lesions induced by low doses of rhodopsin have not 
been reported for the other two antigens. In monkey, for neither 
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of the three antigens extensive experiments with respect to 
dosimetry have been reported. Our data concerning Macaca artoides 
indicate a similarity in clinicopathological features of EAU in 
monkeys induced by injection of these antigens. 
With respect to the issue of EAU as a model for human uveitic 
conditions, the experimental disease induced with low doses of 
retinal antigens appears to be very interesting, especially when 
induced in primates. The most important conclusion to be drawn 
from clinical and histopathological studies of EAU, in view of 
its clinical implications, is the extreme variability of the 
induced disease, as far as topography and intensity of lesions 
are concerned. Research concerning retinal autoimmunity in humans 
must therefore be carried out over a large range of disorders in 
both retinal diseases and uveitis. 
8.4 Influence of environmental lightning on the development of 
EAU 
Induction of EAU in Lewis rat by relatively high doses of 
opsin appeared not to be significantly influenced by 
environmental light conditions during the first 8 days 
postinjection. This could not be determined for rhodopsin, since 
housing under diurnal light conditions resulted in illumination 
of the injected rhodopsin. Experiments in which was attempted to 
shield the injection site from environmental light, while 
exposing the eyes to diurnal light-dark conditions were not very 
succesful due to practical problems. One way to investigate these 
problems is to induce uveoretinitis by transfer to rats housed in 
darkness or normal light-dark conditions. 
In addition, the influence of environmental lightning on EAU 
induced by lower doses of (rhod)opsin could be studied. Another 
interesting investigation (which is in progress now) deals with 
the duration of darkness after injection needed to obtain 
'rhodopsin-like ' pathogenicity. This will give insight in the 
duration of the exposition phase of the antigen to the immune 
system. 
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8.5 Uveitogenic sites of rhodopsin 
The first approach to localize the uveitigenic sites of 
rhodopsin demonstrates that the 3 kD C-terminal end of rhodopsin 
does not contain an important uveitogenic site. This part of the 
molecule does, however posses immunogenic and antigenic 
determinants. Probably, the amino terminal part of rhodopsin, 
which contains the principal antigenic site, also contains the 
main uveitogenic site. The approach using purified peptide 
fragments of rhodopsin, obtained by proteolytic or cyanogen 
bromide cleavage, by organic synthesis or even by recombinant-DNA 
techniques, should be further elaborated. Once the dominant 
uveitogenic sites of rhodopsin are established, the purified 
peptide fragments containing these sites should be included in 
immunological assays in both EAU and human uveitis. 
8.6 General considerations 
In addition to the importance of rhodopsin-induced EAU as a 
model for human ocular inflammation, this model seems to be a 
powerful tool in the study of basic immunological mechanisms 
underlying organ-specific autoimmune diseases. Much is known 
about the biochemistry of rhodopsin and its peptide fragments,and 
on the immunochemistry of the visual pigment. The protein is 
available in farely large quantities and purification can be 
carried out relatively fast. The clinical evaluation of the 
progression of clinical disease is relatively simple and 
noninvasive. Finally, the availability of two forms of the 
protein (rhodopsin and opsin), which posses a pronounced 
difference in pathogenicity offers the unique possibility to 
study the afferent and efferent limb of the immune reaction in 
one experimental model. 
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SUMMARY 
The basic mechanisms underlying inflammatory diseases of the 
uvea and the retina are in most cases unknown, but immunogenic 
and autoimmune reactions are frequently suspected to play an 
important role. Ocular antigens capable of inducing an animal 
model of autoimmune uveoretinitis, useful for basic and clinical 
research have been sought for many years. Experimental autoimmune 
uveoretinitis (EAU) is an animal model in which uveitis-like 
disease is induced by extraocular injection with retinal 
antigens. Up till now three retina-specific autoantigens have 
been identified, S-antigen, (rhod)opsin and the 
interphotoreceptor retinoid binding protein (IRBP). (Rhod)opsin 
appears to be considerably less pathogenic than the two other 
retina-specific antigens. 
(Rhod)opsin is the photoreceptor protein of the rod 
photoreceptor cell. It is a light-sensitive, intrinsic membrane 
glycoprotein, which is embedded in plasma and disk membranes of 
the vertebrate rod outer segment. The immune responses elicited 
by immunization with (rhod)opsin (i.e. its immunogenicity) seem 
to correlate with its pathogenicity in EAU. Both its solvation 
state (membrane-bound or detergent solubilized) and its light 
sensitivity (an illuminated and a non-illuminated form) may 
influence the immunogenicity of the visual pigment. 
This thesis adresses several aspects of the 
immunopathogenicity of (rhod)opsin within the context of the 
animal model of experimental autoimmune uveoretinitis. Hereto, 
the immunogenicity of various rhodopsin preparations was 
investigated first. 
In chapter 2 the immunogenicity of various bovine rhodopsin 
preparations is evaluated by generation and characterization of 
antisera. Four types of non-illuminated rhodopsin preparations 
were tested: (1) rod outer segment membranes as such, (2) 
purified, lipid-free rhodopsin in the mild detergent nonylglucose 
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(3) rod outer segment membranes solubilized in nonylglucose or 
(4) rod outer segment membranes solubilized in Barlox IOS. Each 
of these four preparations induced a measurable humoral response, 
but no correlation was observed between the type of immunogen and 
the height of the antibody titer elicited. Apparently, 
solubilization of rhodopsin in mild detergents does not influence 
its immunogenicity. No reactivity towards other retinal antigens 
was detectable in antisera obtained by immunization with 
purified, lipid-free rhodopsin (anti-Rhod antisera). Each of the 
sera reacted with the carbohydrate containing proteolytic 
fragments of rhodopsin. This confirms earlier findings that 
rhodopsin's amino terminal forms a principal antigenic 
determinant. 
Purified, lipid-free rhodopsin solubilized in nonylglucose 
appears to be the most suitable preparation for the study of of 
the immunopathogenicity of (rhod)opsin in EAU. It combines a 
level of immunogenicity similar to that of the more native rod 
outer segment membrane preparation , with the capacity to induce 
a highly specific humoral response. 
Because of the lack of reaction with other retinal proteins, 
anti-Rhod antisera evidently can be applied in studies on the 
immunochemical cross-reactivity with vertebrate rhodopsins, as 
well as for the development of a quantitative immunoassay. Since, 
the other sera show only low or very low reactivity towards other 
retina-specific antigens these sera seem applicable in that kind 
of studies as well. 
Chapter 3 describes the development of a versatile, 
multispecies enzyme-linked immunosorbent assay (ELISA) for 
(rhod)opsin. For this study a serum prepared as described in 
chapter 2 was used. The assay presented is rapid, easy to 
perform, allows detergent concentrations up to 1 %, and has a 
sensitivity for bovine opsin similar to reported 
radioimmunoassays (i.e. 0.04 pmol/well). The high degree of 
specificity of the antiserum and its cross-reactivity with opsin 
from other species, already allowed quantitation of opsin content 
in crude ocular extracts of mouse, hamster, rat and quail with a 
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sensitivity similar to that of bovine opsin. Probably, similar 
types of multispecies immunoassays for quantitation of highly 
conserved (membrane) proteins can be developed using the 
described approach. This would only require a monospecific 
antiserum elicited against an easily accessible species and crude 
tissue extracts both for coating and as a source for inhibitory 
antigen. 
In chapter 4 the cross-reactivity of anti-bovine rhodopsin 
antisera with other vertebrate rhodopsins is studied in more 
detail. For this purpose the ELISA in both the antibody titration 
and the antigen inhibition mode was applied. Also, all species 
were examined by immunoblotting and immunohistochemistry. 
Four anti-bovine rhodopsin antisera elicited against various 
types of rhodopsin preparations (Chapter 2), all show 
considerable cross-reactivity with a range of vertebrate 
(rhod)opsins. This indicates a high degree of evolutionary 
conservation of the rod visual pigment, as usually seen with 
antigens which play an important role in autoimmune processes. So 
far, no cross-reactivity with invertebrate visual pigments has 
been observed, suggesting that these might have developed quite 
separately or have been considerably adapted during evolution. 
None of the sera seems to have affinity for cone pigments, as far 
as detectable by immunohistochemical techniques. Hence, these 
sera allow a very sensitive and very selective assay of 
vertebrate rod visual pigments and related proteins in crude 
ocular and brain extracts. In addition these sera have been shown 
to be very useful in immunohistochemical studies of retinal and 
extra-retinal photoreceptor systems in a range of vertebrate 
species. 
In chapters 5,6 and 7 an investigation of the 
immunopathogenicity of (rhod)opsin in rat and monkey is decribed. 
For this purpose a highly purified, lipid free bovine rhodopsin 
preparation in the very mild detergent nonylglucose was used. 
In chapter 5 the pathogenicity of rhodopsin was compared to 
that of opsin by induction of EAU in Lewis rats. Rhodopsin 
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appears to be more pathogenic than opsin. A dose of 250 μ,ς 
rhodopsin injected in Freund's complete adjuvant and pertussis 
adjuvant induces a non-granulomatous inflammation with both a 
significant higher frequency and an earlier onset than the same 
doses of opsin. Two weeks postinjection, the mean score of the 
rhodopsin-injected animals is more than twice as high as that of 
the opsin-injected animals. Whether or not animals were housed in 
darkness during the first 8 days postinjection seemed not to have 
significant influence on the development of uveoretinitis in the 
opsin-injected group. However, when rhodopsin-injected rats were 
housed immediately in diurnal light conditions development and 
level of EAU were significantly different from the parallel group 
housed in darkness (8 days postinjection), and actually were very 
'similar to opsin-injected groups. Apparently, the injected 
chodopsin was rapidly converted into opsin by the room 
illumination. The high pathogenicity of rhodopsin appears to be 
related to the biochemical integrity of the protein. The levels 
of the humoral and cellular immune responses ,measured at day 10 
postinjection, do not account for the pronounced difference on 
pathogenicity between rhodopsin and opsin. 
The patterns of development of severe uveoretinitis induced 
by rhodopsin or opsin have been evaluated by histology and appear 
similar. In both cases we observe dense mononuclear and 
polymorphonuclear cell infitrations in the retina and anterior 
uvea. However, rhodopsin causes a more pronounced involvement of 
ciliary body, pars plana and anterior chamber. The choroid 
becomes only involved during severe stages of inflammation. The 
severe inflammation finally results in total elimination of the 
photoreceptor cell layer. 
In chapter 6 the rhodopsin-induced EAÜ in rats is analyzed in 
more detail. The higher pathogenicity of rhodopsin as compared to 
opsin is more evident at low doses. Injection of 50 /ig rhodopsin 
induces a similar frequency of severe EAU as of 250 ^g opsin. 
Intensity, frequency and location of ocular inflammation in 
rhodopsin-induced EAU are dose dependent. A high dose (100-250 
/¿g) induces severe bilateral uveoretinitis in all animals, 
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starting with acute inflammation of the anterior eye segment at 
day 10-12, followed by chorioretinitis (predominantly retinitis). 
A low dose (20 pg) induces mild transient inflammation, mainly 
consisting of mild posterior retinitis, leading to a typical 
multiple focal destruction of photoreceptor cells. Omission of 
pertussis adjuvant lowers the frequency of severe disease at low 
doses of rhodopsin, delays its onset and changes its features. At 
moderate doses EAU starts usually by cell infitrations of the 
vitreous. Injection of opsin in both adjuvants induces severe EAU 
only at high doses. In spite of these differences in 
pathogenicity, the immunogenicity of rhodopsin and opsin is 
similar. 
C-terminal deprived rhodopsin, prepared by proteolytic 
digestion of rhodopsin, exhibits the same uveitogenic activity as 
rhodopsin. The frequency of ocular inflammation, the pattern of 
development of severe EAU and the histological changes induced by 
C-terminal deprived rhodopsin or rhodopsin are similar. This 
indicates that the C-terminal part of rhodopsin does not contain 
an important uveitogenic site. 
In chapter 7 the investigation of rhodopsin-induced EAU is 
extended to a clinically more relevant species the monkey. In 
addition, this provided the opportunity to analyze the 
time-course of both cellular and humoral immune responses of the 
injected animals. Also, rhodopsin is a potent pathogenic retinal 
protein in monkey , and appears to be considerably more 
pathogenic than opsin. A dose of 650 μg rhodopsin is shown to 
induce severe posterior uveoretinitis with concomitant anterior 
uveitis, in all animals tested. The first clinical signs consist 
of cells in the anterior chamber and vitreous appearing 21-24 
days postinjection, which are soon followed by uveoretinitis. By 
histology the first inflammatory cells are observed in ciliary 
body and pars plana. The following days the inflammation extends 
into anterior chamber and into choroid and retina. In severe 
stages of disease dense cell infiltrations are present in choroid 
and retina whereas the choroid exhibits extensive edema. 
Retinitis dominates in the central area, while chorioretinitis is 
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observed in the peripheral part. Meanwhile, the photoreceptor 
cells are being destroyed and seven weeks after onset only a few 
cells are left mainly in the central part of the retina. Optic 
nerve and choroid then still show signs of heavy inflammation. 
The monkeys develop high humoral and cellular immune 
responses against rhodopsin and opsin. The time course of the 
development of the cellular response seems to be related to the 
onset of of EAU, which indicates an important role for cellular 
immunity in the pathogenesis of rhodopsin-induced EAU. This 
experimental model shows some similarities with human uveitic 
conditions, like non-granulomatous choroiditis, retinal 
detachment, intra-retinal inflammation and macular edema which 
were observed frequently in sympathetic ophthalmia. Therefore, it 
may be a valuable tool in the study of the pathogenesis of human 
uveitis. 
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SAMENVATTING 
De mechanismen die ten grondslag liggen aan het onstaan van 
ontstekingen in uvea en retina zijn in de meeste gevallen 
onbekend. Men veronderstelt dat immunologische en auto-immuun 
reacties veelal een belangrijke rol spelen. Gedurende vele jaren 
is gezocht naar oogweefselantigenen die in staat zijn auto-immuun 
uveoretinitis op te wekken in proefdieren om zo een model te 
verkrijgen dat geschikt is voor fundamenteel en klinisch 
onderzoek. Experimentele auto-immuun uveoretinitis (EAU) is een 
model waarin een uveitisachtig ziektebeeld wordt opgeroepen door 
middel van systemische injectie van retina-specifieke eiwitten. 
Tot nu toe zijn een drietal retina-specifieke auto-antigenen 
aangetoond: (1) S-antigeen, (2) rhodopsine (en zijn belichte vorm 
opsine) en (3) het interfotoreceptor retinoide bindend eiwit. 
(Rhod)opsine blijkt aanzienlijk minder pathogeen te zijn dan de 
beide andere eiwitten. 
(Rhod)opsine is het visuele pigment van de staafjes 
fotoreceptor cel. Het is een lichtgevoelig glycoproteine, dat 
ligt ingebed in de plasma- en disk-membranen van het staafjes 
buitensegment. Er lijkt een verband te bestaan tussen de 
immunogeniciteit en de pathogeniciteit van het visueel pigment in 
EAU. De immunogeniciteit van (rhod)opsine wordt wellicht 
beïnvloed door zowel zijn lichtgevoeligheid als door zijn 
solvatie-toestand. 
In dit proefschrift worden een aantal aspecten bestudeerd van 
de immunopathogeniciteit van (rhod)opsine in het diermodel van de 
experimentele auto-immuun uveoretinitis. Als voorbereiding hierop 
is de immunogeniciteit van verschillende rhodopsineprepraten 
onderzocht en is een zeer gevoelige multispecies immunoassay 
ontwikkeld. 
In hoofdstuk 2 is de immunogeniciteit van een aantal 
verschillende runderrhodopsine preparaten geëvalueerd door middel 
van het opwekken en karakteriseren van antisera. Vier typen 
onbelichte rhodopsine preparaten werden getest: (1) staafjes 
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buitensegment membranen, (2) gezuiverd, lipide-vrij rhodopsine 
opgelost in het milde detergens nonylglucose, (3) staafjes 
buitensegment membranen opgelost in nonylglucose en (4) staafjes 
buitensegment membranen opgelost in Barlox IOS. Door ieder van de 
vier typen preparaten werd een meetbare humorale immuun reactie 
opgewekt. Er werd echter geen correlatie gevonden tussen de 
hoogte van de immuunrespons en het type immunogeen. De 
immunogeniciteit van rhodopsine wordt dus kennelijk niet 
beïnvloed door zuivering of het oplossen in een mild detergens. 
In de antisera vekregen door middel van immunisatie met gezuiverd 
lipide-vrij rhodopsine (anti-Rhod antisera) was geen reactiviteit 
tegen andere retina-eiwitten aantoonbaar. In de andere antisera 
werd slechts een lage reactiviteit met het zeer immunogene 
retina-specifieke eiwit S-antigeen waargenomen. Ieder van de sera 
blijkt te reageren met de suiker bevattende proteolytische 
fragmenten van rhodopsine. Dit bevestigt het reeds eerder 
gevonden fenomeen dat het N-terminale gedeelte van rhodopsine de 
belangrijkste antigene determinant bevat. Het preparaat, dat het 
meest geschikt lijkt ter bestudering van de immunopathogeniciteit 
van rhodopsine in EAU is het gezuiverde, lipide-vrije 'rhodopsine 
opgelost in nonylglucose. Dit preparaat combineert een 
immunogeniciteit die vrijwel gelijk is aan de meer natieve 
preparaten als de staafjes buitensegment membranen, met het 
vermogen een zeer specifieke (humorale) immuunrespons op te 
wekken. 
Omdat in de anti-Rhod antisera geen reactiviteit aanwezig is 
tegen andere retina eiwitten, zijn deze sera het meest geschikt 
om te gebruiken in een onderzoek naar de immunochemische 
verwantschap van runderrhodopsine met andere vertebrate 
rhodopsines, alsmede voor het ontwikkelen van kwantitatieve 
immunoassays. Gezien hun lage reactiviteit ten opzichte van 
andere retina-eiwitten, lijken ook de overige sera toepasbaar in 
dat type onderzoek. 
In hoofdstuk 3 wordt de ontwikkeling van een 
krachtige,multispecies 'enzyme-linked immunosorbent assay' 
(ELISA) voor (rhod)opsine beschreven. Hiertoe werd een antiserum 
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aangewend, dat is opgewekt als beschreven in hoofdstuk 2. De 
gepresenteerde bepaling is snel en eenvoudig uit te voeren, en 
geschikt voor detergent concentraties tot 1 %. De gevoeligheid 
komt overeen met die van reeds beschreven radio-immuno assays 
(0.04 pmol). Dankzij hun monospecificiteit en kruisreactiviteit 
met rhodopsines van andere species konden soortgelijke anti-rund 
antisera ook worden gebruikt voor de assay van andersoortige 
(rhod)opsines. Aldus konden reeds de hoeveelheden opsine aanwezig 
in ruwe oogextracten van muis, hamster, rat en kwartel worden 
bepaald , met dezelfde gevoeligheid als die voor runder-opsine. 
Dezelfe benadering lijkt ook toepasbaar op andere hoog 
geconserveerde (membraan)eiwitten. 
In hoofdstuk 4 werd de kruisreactiviteit van anti-runder 
rhodopsine antisera met rhodopsines van andere vertebraten in 
meer detail bestudeerd. Hierbij werd de ELISA toegepast, zowel 
antilichaamtitratie als in de antigeen-inhibitie uitvoering 
Daarnaast werden alle species onderzocht met behulp van 
immunoblotting en immunohistochemie. 
Vier anti-runderrhodopsine antisera, die werden opgewekt 
tegen verschillende typen rhodopsinepreparaten (hoofdstuk 2), 
vertonen een aanzienlijke kruisreactiviteit met een aantal 
vertebrate (rhod)opsines. Dit duidt op een aanzienlijke mate van 
evolutionaire conservering van het visueel pigment uit staafjes, 
zoals veelal wordt gevonden voor antigenen die een belangrijke 
rol spelen in auto-immuun processen. Tot nu toe kon geen 
kruisreactie met invertebrate visuele pigmenten worden 
aangetoond. Dit suggereert dat deze pigmenten zich onafhankelijk 
hebben ontwikkeld of dat ze in belangrijke mate zijn geadapteerd 
tijdens de evolutie. Voor zover dit aantoonbaar is met behulp van 
immunohistochemische technieken, lijkt geen van de sera 
affiniteit te hebben voor pigmenten uit kegeltjes. Deze sera zijn 
daarom geschikt om met een hoge gevoeligheid en specificiteit 
vertebrate rhodopsines en verwante eiwitten te bepalen in 
ongezuiverde extracten van oog of hersenen (extra-retinale 
fotoreceptoren in de pijnappelklier). Bovendien is gebleken dat 
deze sera erg geschikt zijn in immunohistochemische studies aan 
retinale en extra-retinale photoreceptoren in een aantal species. 
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In de hoofdstukken 5, 6 and 7 wordt een onderzoek naar de 
immunopathogemciteit van (rhod)opsine in rat en aap beschreven. 
Bi] dit onderzoek werd gebruik gemaakt van een hoog gezuiverd, 
lipide- гіз runderrhodopsine preparaat. 
In hoofdstuk 5 wordt de pathogeniciteit van rhodopsine 
vergeleken met die van opsine, aan de hand van het vermogen tot 
het induceren van experimentele auto-immuun uveoretimtis (EAU) 
in Lewis ratten. Rhodopsine (250 /¿g), geïnjecteerd in Freund's 
compleet adjuvant en pertussis adjuvant, induceerde een 
non-granulomateuse ontsteking met een significant hogere 
frequentie, een vroegere aanvang en van meer ernstige aard dan 
eenzelfde doses opsine. Het lijkt voor de ontwikkeling van 
uveoretimtis in de opsinegroep geen verschil te maken of de 
dieren wel of met werden gehuisvest in het donker tijdens de 
eerste 8 dagen na injectie. Echter, huisvesting van met 
rhodopsine geïnjecteerde ratten onder normale licht-donker 
condities onmiddelijk na injectie, veroorzaakte een significant 
andere ontwikkeling en ernst van EAU in vergelijking met een 
parallel bestudeerde groep die de eerste 8 dagen in het donker 
werd gehuisvest. De ontwikkeling en ernst van EAU in de 
eerstgenoemde groep vertoonde meer gelijkenis met die van de 
groep ratten die met opsine geïnjecteerde was. Klaarblijkelijk 
werd het geïnjecteerde rhodopsine vrij snel na injectie door 
belichting omgezet in opsine. De pathogeniciteit van rhodopsin 
lijkt gerelateerd te zijn aan de biochemische integriteit van dit 
eiwit. De hoogte van de immuunresponsen (cellulair en humoraal) 
werd bepaald op dag 10 na injectie en was niet significant 
verschillend voor rhodopsine of opsine. Op basis hiervan is 
uitgesproken verschil in pathogeniciteit tussen rhodopsine en 
opsine dus niet verklaren. 
Het ontwikkelingspatroon van ernstige uveoretimtis opgewekt 
door rhodopsine en opsine, geëvalueerd met behulp van histologie, 
komt overeen. In beide gevallen werden ernstige infiltraties van 
mononucléaire en polymorphonucleaire cellen in retina en uvea 
anterior waargenomen. Echter, rhodopsine veroorzaakte een meer 
uitgesproken reactie van corpus ciliaire, pars plana en de 
voorste oogkamer. Slechts in de ernstige fase breidde de 
182 
ontsteking zich uit tot de choroidea. De ernstige ontsteking 
leidde uiteindelijk tot volledige eliminatie van dl fotoreceptor 
cellaag. 
In hoofdstuk 6 wordt de door rhodopsine geïnduceerde EAU in 
meer detail bestudeerd. De relatief hoge pathogeniciteit van 
rhodopsine in vergelijking met die van opsine komt nog 
duidelijker tot uiting bij injectie van lagere doses. Injectie 
van 50 μ<3 rhodopsine veroorzaakte eenzelfde frequentie van 
ernstige uveoretinitis als injectie van 250 /xg opsine. 
Intensiteit, frequentie en localisatie van oogontsteking in door 
rhodopsine opgewekte EAU waren dosis afhankelijk. Een hoge 
dosering (100-250 μg)veroorzaakte een ernstige, bilaterale 
uveoretinitis in alle dieren, beginnend met een acute ontsteking 
van het voorste oogsegment op dag 10-12, gevolgd door 
Chorioretinitis (hoofdzakelijk retinitis). Een lage dosering (20 
/xg) induceerde een milde, voorbijgaande ontsteking, hoofdzakelijk 
een milde retinitis, die uiteindelijk leidde tot een typische, 
focale destructie van fotoreceptor cellen. Het weglaten van 
pertussus adjuvant veroorzaakte ernstige ziekte in een lagere 
frequentie, met name bij lagere doseringen rhodopsine. Bovendien 
trad een vertraging het aanvangstijdstip op terwijl de ontsteking 
begon in het achterste oogsegment. Injectie van opsine in beide 
adjuvantia veroorzaakte slechts ernstige ontsteking bij hoge 
dosering (250 fiq). Ondankse de hoge veschillen in 
pathogeniciteit, lijkt de immunogeniciteit van rhodopsine en 
opsine, zelfs bij lagere doses (100 μg) vrijwel gelijk. 
Rhodopsine zonder C-terminus, bereid door middel van 
proteolytische digestie, vertoonde eenzelfde pathogeniciteit als 
het intacte rhodopsine. Frequentie, ontwikkelingspatroon en 
histologische veranderingen van ernstige oogontsteking, zoals die 
werden opgewekt door beide preparaten, bleken niet te 
verschillen. Dit wijst erop dat het C-terminale gedeelte van 
rhodopsine geen belangrijke uveitogene determinanten bevat. 
In hoofdstuk 7 wordt de door rhodopsine opgewekte EAU 
bestudeerd in een diermodel dat klinisch meer relevant is, 
namelijk in de aap. Bovendien kan in de aap de ontwikkeling in de 
tijd van zowel de humorale als de cellulaire immuunrespon.*; worden 
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vervolgd. Ook in deze primaat blijkt rhodopsine een sterk 
pathogeen retina-eiwit, dat aanzienlijk pathogener blijkt te zijn 
dan opsine. Een dosering van 650 ¿¿g rhodopsine veroorzaakte een 
ernstige chorioretinitis met een bijbehorende uveitis anterior in 
alle geteste dieren. De eerste klinische verschijnselen waren het 
verschijnen van cellen in de voorste oogkamer en in het glasvocht 
ongeveer 21-24 dagen na injectie. Dit stadium werd snel gevolgd 
door een totale uveoretinitis. Histologisch werden de eerste 
cellen in het corpus ciliaire en de pars plana waargenomen. De 
daarop volgende dagen breidde de ontsteking zich uit naar de 
voorste oogkamer en naar de choroidea en retina. Tijdens het 
ernstige stadium van de ontsteking waren dichte cel-infiltraties 
aanwezig in choroidea en retina, terwijl de choroidea een 
uitgebreid oedeem vertoonde. In het centrale gedeelte overheerste 
retinitis terwijl in het perifere gedeelte een ernstige 
chorioretinitis werd waargenomen. De fotoreceptorcellen werden 
grotendeels vernietigd en 7 weken na aanvang van de ontsteking 
resteerden slechts enkele cellen , hoofdzakelijk in het centrale 
gedeelte. De oogzenuw en de choroidea vertoonden op dat moment 
nog steeds verschijnselen van ernstige ontsteking. 
De apen ontwikkelden een sterke humorale en cellulaire immuun 
respons tegen zowel rhodopsine als opsine. Het tijdsverloop van 
de ontwikkeling van de cellulaire immuunrespons lijkt gerelateerd 
te zijn aan het tijdstip van aanvang van EAU. Dit wijst op een 
mogelijke belangrijke rol van de cellulaire immuniteit in de 
Pathogenese van door rhodopsine opgewekte EAU. Dit experimentele 
model vertoont een aantal overeenkomsten met humane uveitiden, 
zoals non-granulomateuze choroiditis, retina-loslatingen, 
retinitis en macula oedeem. Derhalve zou dit model een belangrijk 
hulpmiddel kunnen worden in het onderzoek naar de Pathogenese van 
humane uveoretinale aandoeningen. 
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